http://www.or-live.com/mrss.xml OR-Live features live and on-demand Webcasts of breakthrough medical procedures from world renown medical centers and hospitals. en-us Copyright 2010 slp3D, Inc. Thu, 11 Mar 2010 14:53:36 EST slp3D, Inc. waf_2386 http://www.or-live.com/WFUBMC/2386 http://www.or-live.com/WFUBMC/2386 James J. Urbanic, M.D., a radiation oncologist, and Carnell J. Hampton, Ph.D., a physicist at the Comprehensive Cancer Center at Wake Forest University Baptist Medical Center, will use the most advanced linear accelerator to treat lung cancer. The Elekta Axesse™ image guided linear accelerator offers highly-accurate targeting of tumors and lesions virtually anywhere in the body. Typically requiring only one to five treatments, it achieves excellent results in fewer treatments than required by standard radiotherapy. "Axesse raises our technological and treatment capabilities to an even higher level," said Urbanic, lead physician on the Axesse team. "We are able to deliver higher and more conformal doses of radiation to the target in fewer fractions than with conventional radiation therapy techniques." For patients, that means more convenience and a faster return to their daily activities. The Axesse combines three-dimensional image guidance with highly conformal beam shaping and robotic 6D patient positioning to deliver fast, effective and accurate treatments. "Even the slightest patient misalignment can impact the accuracy of a dose," said Urbanic. With Axesse, the unit's built-in CT imaging can allow for targeting accuracy within just a couple of millimeters. This ability to precisely conform the dose to the size and shape of the target offers clinicians the confidence to treat targets more aggressively while avoiding healthy tissue and critical structures. Radiation therapy with these techniques is a treatment modality for a wide range of cancers including lung, prostate, head and neck, esophageal, spinal cord, pancreatic, liver metastases, recurrent gynecologic cancers, bone metastasis and adrenal cancer. ]]> Cancer Treated with Radiation Therapy http://www.or-live.com/WFUBMC/2386 James J. Urbanic, M.D., a radiation oncologist, and Carnell J. Hampton, Ph.D., a physicist at the Comprehensive Cancer Center at Wake Forest University Baptist Medical Center, will use the most advanced linear accelerator to treat lung cancer. The Elekta Axesse™ image guided linear accelerator offers highly-accurate targeting of tumors and lesions virtually anywhere in the body. Typically requiring only one to five treatments, it achieves excellent results in fewer treatments than required by standard radiotherapy. "Axesse raises our technological and treatment capabilities to an even higher level," said Urbanic, lead physician on the Axesse team. "We are able to deliver higher and more conformal doses of radiation to the target in fewer fractions than with conventional radiation therapy techniques." For patients, that means more convenience and a faster return to their daily activities. The Axesse combines three-dimensional image guidance with highly conformal beam shaping and robotic 6D patient positioning to deliver fast, effective and accurate treatments. "Even the slightest patient misalignment can impact the accuracy of a dose," said Urbanic. With Axesse, the unit's built-in CT imaging can allow for targeting accuracy within just a couple of millimeters. This ability to precisely conform the dose to the size and shape of the target offers clinicians the confidence to treat targets more aggressively while avoiding healthy tissue and critical structures. Radiation therapy with these techniques is a treatment modality for a wide range of cancers including lung, prostate, head and neck, esophageal, spinal cord, pancreatic, liver metastases, recurrent gynecologic cancers, bone metastasis and adrenal cancer. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. chr_2350 http://www.or-live.com/christianacare/2350 http://www.or-live.com/christianacare/2350 WILMINGTON, DE - On June 30 at 5 p.m. EDT, Christiana Care Health System will webcast two OR Live total knee replacement surgeries, back to back, demonstrating different techniques.Total knee replacement is a highly successful treatment for people who suffer from severe knee damage or degeneration, especially from arthritis. The surgeries will be performed by Alex B. Bodenstab, M.D., and Steven M. Dellose, M.D., and the event will be narrated by Leo W. Raisis, M.D., medical director of Christiana Care's Center for Advanced Joint Replacement at Wilmington Hospital. While the webcast is taking place, Christiana Care will also host a live chat via Twitter, which will include nurses from the Center for Advanced Joint Replacement and former patients who have undergone total knee or total hip replacement. An announcement on Christiana Care's Twitter feed will be made 30 minutes before the webcast, with instructions on how to join the Twitter chat. Click Here to Follow Christiana Care on Twitter. "This is an exciting event," said Dr. Leo Raisis. "This month we are celebrating the 10,000th patient at the Center for Advanced Joint Replacement. Since the program began in 2000, our team has done a phenomenal job at achieving excellence across the full continuum of care for joint-replacement patients. This is why we are ranked among the top programs in the country. This webcast gives us an opportunity to educate the public about joint replacement, but also to demonstrate some of what makes the Center for Advanced Joint Replacement so successful for our patients." The Center for Advanced Joint Replacement at Christiana Care's Wilmington Hospital comprises 12 surgeons, each with vast experience and expertise in joint-replacement surgery, plus a dedicated team of nurses, therapists, operating-room staff and support personnel who specialize in treating joint-replacement patients. ]]> Two Techniques for Total Knee Replacement Surgery http://www.or-live.com/christianacare/2350 WILMINGTON, DE - On June 30 at 5 p.m. EDT, Christiana Care Health System will webcast two OR Live total knee replacement surgeries, back to back, demonstrating different techniques.Total knee replacement is a highly successful treatment for people who suffer from severe knee damage or degeneration, especially from arthritis. The surgeries will be performed by Alex B. Bodenstab, M.D., and Steven M. Dellose, M.D., and the event will be narrated by Leo W. Raisis, M.D., medical director of Christiana Care's Center for Advanced Joint Replacement at Wilmington Hospital. While the webcast is taking place, Christiana Care will also host a live chat via Twitter, which will include nurses from the Center for Advanced Joint Replacement and former patients who have undergone total knee or total hip replacement. An announcement on Christiana Care's Twitter feed will be made 30 minutes before the webcast, with instructions on how to join the Twitter chat. Click Here to Follow Christiana Care on Twitter. "This is an exciting event," said Dr. Leo Raisis. "This month we are celebrating the 10,000th patient at the Center for Advanced Joint Replacement. Since the program began in 2000, our team has done a phenomenal job at achieving excellence across the full continuum of care for joint-replacement patients. This is why we are ranked among the top programs in the country. This webcast gives us an opportunity to educate the public about joint replacement, but also to demonstrate some of what makes the Center for Advanced Joint Replacement so successful for our patients." The Center for Advanced Joint Replacement at Christiana Care's Wilmington Hospital comprises 12 surgeons, each with vast experience and expertise in joint-replacement surgery, plus a dedicated team of nurses, therapists, operating-room staff and support personnel who specialize in treating joint-replacement patients. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. nep_2555 http://www.or-live.com/nyp/2555 http://www.or-live.com/nyp/2555 Ex vivo tumor resection with auto-transplantation is a technique that may be useful in the treatment of extensive, otherwise unresectable tumors and lesions. In the most recent case, the patient had a lemonsized, malignant tumor that was wedged behind several organs and attached to important arteries; other physicians diagnosed it as inoperable. Leveraging his expertise in multivisceral transplantation, Dr. Tomoaki Kato first removed the stomach, liver, pancreas, spleen, small intestine and two-thirds of the large intestine from the patient so that he could excise the tumor safely. He then performed an autotransplant to re-attach all of the patient's organs, minus the tumor. ]]> Clinical Perspectives: 7-Year-Old Girl Has 6 Organs Removed http://www.or-live.com/nyp/2555 Ex vivo tumor resection with auto-transplantation is a technique that may be useful in the treatment of extensive, otherwise unresectable tumors and lesions. In the most recent case, the patient had a lemonsized, malignant tumor that was wedged behind several organs and attached to important arteries; other physicians diagnosed it as inoperable. Leveraging his expertise in multivisceral transplantation, Dr. Tomoaki Kato first removed the stomach, liver, pancreas, spleen, small intestine and two-thirds of the large intestine from the patient so that he could excise the tumor safely. He then performed an autotransplant to re-attach all of the patient's organs, minus the tumor. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. smn_2754 http://www.or-live.com/smith-nephew/2754 http://www.or-live.com/smith-nephew/2754 Steven B. Haas, MD, will demonstrate techniques to address a challenging clinical condition with a total knee arthroplasty. This total knee replacement will feature the LEGION Total Knee System from Smith and Nephew Orthopaedics. The LEGION Total Knee System is a comprehensive and seamless system that empowers surgeons to address diverse surgical challenges and provide personalized joint care. The system includes simple solutions for addressing the increasingly diverse needs of your patients. This surgery will demonstrate the versatility of the LEGION Total Knee System by empowering the surgeon to deliver personalized joint care regardless of the challenges presented during surgery. This is the only system that allows for a seamless transition from bi-cruciate retaining partial knees to comprehensive total knee solutions. With the LEGION Total Knee System you can choose from the most advanced bearing endurance technologies. Select CoCr with standard polyethylene or choose our new VERILAST Technology, which combines OXINIUM Oxidized Zirconium with highly cross-linked polyethylene. This innovative system features intuitive, easy-to-use instrumentation that allows you to address diverse surgical challenges with one A-P Resection, one system and one company. The result is the best possible clinical outcome with optimum efficiency. That is The Power of Simplicity ]]> LEGION Total Knee System http://www.or-live.com/smith-nephew/2754 Steven B. Haas, MD, will demonstrate techniques to address a challenging clinical condition with a total knee arthroplasty. This total knee replacement will feature the LEGION Total Knee System from Smith and Nephew Orthopaedics. The LEGION Total Knee System is a comprehensive and seamless system that empowers surgeons to address diverse surgical challenges and provide personalized joint care. The system includes simple solutions for addressing the increasingly diverse needs of your patients. This surgery will demonstrate the versatility of the LEGION Total Knee System by empowering the surgeon to deliver personalized joint care regardless of the challenges presented during surgery. This is the only system that allows for a seamless transition from bi-cruciate retaining partial knees to comprehensive total knee solutions. With the LEGION Total Knee System you can choose from the most advanced bearing endurance technologies. Select CoCr with standard polyethylene or choose our new VERILAST Technology, which combines OXINIUM Oxidized Zirconium with highly cross-linked polyethylene. This innovative system features intuitive, easy-to-use instrumentation that allows you to address diverse surgical challenges with one A-P Resection, one system and one company. The result is the best possible clinical outcome with optimum efficiency. That is The Power of Simplicity surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. bio_2522 http://www.or-live.com/Biomet/2522 http://www.or-live.com/Biomet/2522 Minimally invasive hip replacement is more than just a shorter incision. Modern techniques focus on the way surgeons gain access to the hip joint. The Anterior Supine Intramuscular (ASI) approach uses an incision at the front of the hip instead of the side or back. This incision placement allows surgeons to directly approach the hip by going between, rather than through, the muscles that surround it. The goal is to minimize muscle and tendon disruption, making surgery less traumatic for patients, allowing for shorter hospital stays and quicker recoveries. Please join us as Keith Berend, M.D., of Mount Carmel New Albany Surgical Hospital, performs a Taperloc® Microplasty™ Hip replacement through the ASI approach. This procedure will be moderated by Roger Emerson, M.D. and will be performed on a standard OR table for the benefit of surgeons that do not have access to an OSI Hana® or Pro Fx® table. However, additional educational opportunities using these specialized tables are available through Biomet sponsored ASI cadaver courses. In addition to the ASI approach, Drs. Berend and Emerson will also explore the benefits of the Taperloc® Microplasty™ stem and E-Poly® Antioxidant Infused Technology during this live event. All trademarks herein are the property of Biomet, Inc. or its subsidiaries unless otherwise indicated. Hana® is a trademark of Mizuho OSI, Inc. Pro Fx® is a trademark of Orthopedic Systems, Inc. ]]> Taperloc® Microplasty™ http://www.or-live.com/Biomet/2522 Minimally invasive hip replacement is more than just a shorter incision. Modern techniques focus on the way surgeons gain access to the hip joint. The Anterior Supine Intramuscular (ASI) approach uses an incision at the front of the hip instead of the side or back. This incision placement allows surgeons to directly approach the hip by going between, rather than through, the muscles that surround it. The goal is to minimize muscle and tendon disruption, making surgery less traumatic for patients, allowing for shorter hospital stays and quicker recoveries. Please join us as Keith Berend, M.D., of Mount Carmel New Albany Surgical Hospital, performs a Taperloc® Microplasty™ Hip replacement through the ASI approach. This procedure will be moderated by Roger Emerson, M.D. and will be performed on a standard OR table for the benefit of surgeons that do not have access to an OSI Hana® or Pro Fx® table. However, additional educational opportunities using these specialized tables are available through Biomet sponsored ASI cadaver courses. In addition to the ASI approach, Drs. Berend and Emerson will also explore the benefits of the Taperloc® Microplasty™ stem and E-Poly® Antioxidant Infused Technology during this live event. All trademarks herein are the property of Biomet, Inc. or its subsidiaries unless otherwise indicated. Hana® is a trademark of Mizuho OSI, Inc. Pro Fx® is a trademark of Orthopedic Systems, Inc. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. chp_2449 http://www.or-live.com/bethisrael/2449/ http://www.or-live.com/bethisrael/2449/ Lung cancer is the leading cause of all cancer related deaths in the United States with over 200,000 deaths occurring each year. When surgery is the recommended option as part of lung cancer treatment, the Video-Assisted Thoracic Surgery (VATS) is one of the surgical options. VATS is a minimally invasive surgical technique to diagnose and treat problems in the chest. Surgeons make small chest incisions to insert a tiny fiber-optic camera and other surgical instruments. This minimally invasive procedure results in less pain, faster discharge from the hospital and less trauma to the body. In collaboration with the Continuum Cancer Centers of New York, Beth Israel Medical Center's team of thoracic surgeons, pulmonologists and medical and radiation oncologists, all work in one setting and at one time to treat lung cancer in the most minimally invasive way possible. Angelo Reyes, MD is the Chief of the Division of Thoracic Surgery both Manhattan and Brooklyn campuses of Beth Israel Medical Center. Dr. Reyes specializes in thoracic oncology, video-assisted (minimally invasive) thoracic surgery, surgery for diseases of the esophagus, surgical management of diseases of the chest wall and diaphragm, surgery for the treatment of hyperhidrosis, and thoracic access for orthopedic and neurosurgical procedures. In 2000, Dr. Reyes performed the first video-assisted, minimally invasive lung lobectomy at St Vincent's Hospital in Manhattan. Dr. Reyes is board-certified in both General Surgery and Thoracic Surgery. To learn more about treatments for lung cancer or to arrange a consultation with Dr. Angelo Reyes, please call (212) 844-6688. ]]> Minimally Invasive Treatment for Lung Cancer http://www.or-live.com/bethisrael/2449/ Lung cancer is the leading cause of all cancer related deaths in the United States with over 200,000 deaths occurring each year. When surgery is the recommended option as part of lung cancer treatment, the Video-Assisted Thoracic Surgery (VATS) is one of the surgical options. VATS is a minimally invasive surgical technique to diagnose and treat problems in the chest. Surgeons make small chest incisions to insert a tiny fiber-optic camera and other surgical instruments. This minimally invasive procedure results in less pain, faster discharge from the hospital and less trauma to the body. In collaboration with the Continuum Cancer Centers of New York, Beth Israel Medical Center's team of thoracic surgeons, pulmonologists and medical and radiation oncologists, all work in one setting and at one time to treat lung cancer in the most minimally invasive way possible. Angelo Reyes, MD is the Chief of the Division of Thoracic Surgery both Manhattan and Brooklyn campuses of Beth Israel Medical Center. Dr. Reyes specializes in thoracic oncology, video-assisted (minimally invasive) thoracic surgery, surgery for diseases of the esophagus, surgical management of diseases of the chest wall and diaphragm, surgery for the treatment of hyperhidrosis, and thoracic access for orthopedic and neurosurgical procedures. In 2000, Dr. Reyes performed the first video-assisted, minimally invasive lung lobectomy at St Vincent's Hospital in Manhattan. Dr. Reyes is board-certified in both General Surgery and Thoracic Surgery. To learn more about treatments for lung cancer or to arrange a consultation with Dr. Angelo Reyes, please call (212) 844-6688. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. hah_2604 http://www.or-live.com/Hartfordhospital/2604 http://www.or-live.com/Hartfordhospital/2604 More than 40,000 Americans are diagnosed with kidney cancer each year. Physicians can now preserve much of the kidney using a robotic partial nephrectomy technique. In this procedure, surgeons are able to operate and remove cancerous tumors with unmatched precision and control using only a few small incisions. Watch as nationally-renowned urologist Dr. Steven Shichman of Hartford Hospital uses the new da Vinci®Si surgical robot to bring you this procedure in a live Internet broadcast. This webcast is part of a day-long seminar held at Hartford Hospital, focusing on robotic renal surgery. Further information is available at www.hartfordhospital.org/RRS and CMEs are offered for those in attendance. Web cast will be archived at www.harthosp.org. ]]> LIVE Robotic-Assisted Partial Nephrectomy http://www.or-live.com/Hartfordhospital/2604 More than 40,000 Americans are diagnosed with kidney cancer each year. Physicians can now preserve much of the kidney using a robotic partial nephrectomy technique. In this procedure, surgeons are able to operate and remove cancerous tumors with unmatched precision and control using only a few small incisions. Watch as nationally-renowned urologist Dr. Steven Shichman of Hartford Hospital uses the new da Vinci®Si surgical robot to bring you this procedure in a live Internet broadcast. This webcast is part of a day-long seminar held at Hartford Hospital, focusing on robotic renal surgery. Further information is available at www.hartfordhospital.org/RRS and CMEs are offered for those in attendance. Web cast will be archived at www.harthosp.org. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. unm_2466 http://www.or-live.com/umm/2466/ http://www.or-live.com/umm/2466/ Step inside the operating room at the University of Maryland Heart Center for the premiere of a webcast featuring a totally endoscopic coronary artery bypass operation using the da Vinci® surgical system. Cardiac surgeon Johannes Bonatti, M.D., a professor of surgery at the University of Maryland School of Medicine, will perform a coronary artery bypass using just four or five small holes for the insertion of the instruments. The patient does not need a large chest incision, so there will be less pain, scarring and blood loss – resulting in a faster recovery. No foreign material is implanted and the bypass grafts will most likely stay open and supply the heart with blood for years to come. "My primary goal in performing heart bypass operations with the da Vinci® robot is to have a perfect graft, so that that he vessel will stay open and function for years. Using the robot, we can perform the surgery in a very precise way with out opening the chest. It is the same operation on the inside as the traditional bypass, but without the long recovery time and scar," Dr. Bonatti explains. To learn more about the procedure, click here. ]]> TECAB - Totally Endoscopic Coronary Artery Bypass http://www.or-live.com/umm/2466/ Step inside the operating room at the University of Maryland Heart Center for the premiere of a webcast featuring a totally endoscopic coronary artery bypass operation using the da Vinci® surgical system. Cardiac surgeon Johannes Bonatti, M.D., a professor of surgery at the University of Maryland School of Medicine, will perform a coronary artery bypass using just four or five small holes for the insertion of the instruments. The patient does not need a large chest incision, so there will be less pain, scarring and blood loss – resulting in a faster recovery. No foreign material is implanted and the bypass grafts will most likely stay open and supply the heart with blood for years to come. "My primary goal in performing heart bypass operations with the da Vinci® robot is to have a perfect graft, so that that he vessel will stay open and function for years. Using the robot, we can perform the surgery in a very precise way with out opening the chest. It is the same operation on the inside as the traditional bypass, but without the long recovery time and scar," Dr. Bonatti explains. To learn more about the procedure, click here. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. seh_2585 http://www.or-live.com/sentara/2585/ http://www.or-live.com/sentara/2585/ Sentara recently installed the first CyberKnife® radiosurgery device in Hampton Roads to offer cancer patients new treatment options. CyberKnife delivers high-dose radiation to tumors while protecting healthy surrounding tissues. Dr. Scott Williams, a radiation oncologist with Eastern Virginia Medical School Health Services, moderates this live CyberKnife Webcast that will feature spinal, liver and cranial procedures as well as patient stories and physician interaction to explain the benefits of CyberKnife radiosurgery for cancer patients. ]]> CyberKnife ® Offers Cancer Patients New Treatment Options http://www.or-live.com/sentara/2585/ Sentara recently installed the first CyberKnife® radiosurgery device in Hampton Roads to offer cancer patients new treatment options. CyberKnife delivers high-dose radiation to tumors while protecting healthy surrounding tissues. Dr. Scott Williams, a radiation oncologist with Eastern Virginia Medical School Health Services, moderates this live CyberKnife Webcast that will feature spinal, liver and cranial procedures as well as patient stories and physician interaction to explain the benefits of CyberKnife radiosurgery for cancer patients. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. nep_2556 http://www.or-live.com/nyp/2556 http://www.or-live.com/nyp/2556 "Every patient who comes to us with a stroke, whether they suffer weakness on one side or even loss of speech, has one major concern – what kind of limitations will I have? Will I be able to walk, dress myself? Can I go back to work? What will my life be like? And the answers are in the field of Neuro-Rehabilitation," says Randolph Marshall MD, Director of Stroke Division at NewYork-Presbyterian Hospital/Columbia University Medical Center. On May 26th at 7:00pm Eastern Time NewYork-Presbyterian Hospital will present an ORLive webcast featuring Robotic Stroke Therapy. "Robots provide both consistency and the ability to increase the amount of physical therapy we provide. They even help keep patients more engaged in therapy through the use of interactive games that standard methods don't provide. But the most interesting and encouraging sign in our research is that they may stimulate neuroplasticity in the brain, facilitating recovery of motor abilities," according to Joel Stein, MD, Physiatrist-in-Chief and Director, Rehabilitation Medicine at NewYork-Presbyterian Hospital. The robots being used for this research are the Reo Go, the Myomo e100 Neuro Robotic System and InMotion 2 Shoulder-Elbow and Wrist Robots. All three devices provide exercise therapy to different parts of the arm. Using varying amounts of assistance and resistance over constantly repeated exercises and games, many patients experience slow but steady restoration of limb use. The robots being used for this research are the Reo Go, the Myomo e100 Neuro Robotic System and InMotion 2 Shoulder-Elbow Robot. All three devices provide movement stimulation to different parts of the arm. Using varying amounts of assistance and resistance over constantly repeated exercises and games, many patients experience slow but steady restoration of limb use. ]]> Innovations in Robotic Stroke Rehabilitation http://www.or-live.com/nyp/2556 "Every patient who comes to us with a stroke, whether they suffer weakness on one side or even loss of speech, has one major concern – what kind of limitations will I have? Will I be able to walk, dress myself? Can I go back to work? What will my life be like? And the answers are in the field of Neuro-Rehabilitation," says Randolph Marshall MD, Director of Stroke Division at NewYork-Presbyterian Hospital/Columbia University Medical Center. On May 26th at 7:00pm Eastern Time NewYork-Presbyterian Hospital will present an ORLive webcast featuring Robotic Stroke Therapy. "Robots provide both consistency and the ability to increase the amount of physical therapy we provide. They even help keep patients more engaged in therapy through the use of interactive games that standard methods don't provide. But the most interesting and encouraging sign in our research is that they may stimulate neuroplasticity in the brain, facilitating recovery of motor abilities," according to Joel Stein, MD, Physiatrist-in-Chief and Director, Rehabilitation Medicine at NewYork-Presbyterian Hospital. The robots being used for this research are the Reo Go, the Myomo e100 Neuro Robotic System and InMotion 2 Shoulder-Elbow and Wrist Robots. All three devices provide exercise therapy to different parts of the arm. Using varying amounts of assistance and resistance over constantly repeated exercises and games, many patients experience slow but steady restoration of limb use. The robots being used for this research are the Reo Go, the Myomo e100 Neuro Robotic System and InMotion 2 Shoulder-Elbow Robot. All three devices provide movement stimulation to different parts of the arm. Using varying amounts of assistance and resistance over constantly repeated exercises and games, many patients experience slow but steady restoration of limb use. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. tag_2677 http://www.or-live.com/tgh/2677/ http://www.or-live.com/tgh/2677/ Tampa, Fla. – More than 35 million Americans suffer from bladder control problems at some time in their lives. Those suffering from uncontrollable bladder may experience unexpected urine leakage, frequent bathroom use, or have the feeling of not being able to completely empty the bladder. Many people experience a combination of these symptoms. Although it is more common in older adults, and more likely to occur in women than men, it can affect anyone. For many of these people the last hope is an implantable device known as InterStim® Therapy, which was designed to stimulate communication between the brain and bladder to better control urinary incontinence and retention. Before the device can be implanted, however, doctors must perform a test procedure to determine if it will be effective. At 4 p.m. on May 20, 2009, this test procedure will be performed live over the Internet from Tampa General Hospital. The test involves placing a thin wire near the tailbone, which is connected to a small stimulator worn on a belt. The stimulator sends mild electrical pulses through the thin wire to the sacral nerves that control the bladder and muscles related to urinary function. The test is an outpatient procedure typically completed in less than an hour. The patient is placed under a local anesthetic. After the procedure, the patient keeps a journal for a period ranging from five to ten days. If the electrical pulses result in an increase in proper bladder function, the patient may proceed to the surgical implementation procedure. Raul Ordorica, M.D., Associate Professor, Division of Urology, University of South Florida College of Medicine, will perform the procedure to test the effectiveness of the InterStim® device. Dr. Ordorica has had extensive experience with Interstim® Therapy since it was FDA approved in 1998, and was the first to perform the implant at Tampa General Hospital. The procedure will be narrated by Mark Swierzewski, M.D., Florida Urology Partners. InterStim® is unique because of the testing process. It allows the physician and patient to gauge its effectiveness prior to undergoing a slightly more invasive implantation of the permanent device. The physician will determine if the therapy is beneficial in helping to relieve the symptoms of uncontrollable bladder, including urge incontinence, urgency frequency, and urinary retention. This treatment is highly effective where other therapies have failed. The procedure to place the wire for testing is frequently performed within the hospital setting either in the radiology suite or the operating room to benefit from fluoroscopy (X-ray) capabilities. If the testing is successful, the implant procedure is also done as an outpatient. Complication rates are very low. The most common complication is that the device needs to be adjusted to assure patient comfort and therapy success. To view this procedure, log on to www.tgh.org and click on the link on the homepage. If you are unable to view the live broadcast, the procedure will be archived at www.tgh.org and www.or-live.com for future viewing at your convenience. Contact: Jean Mayer, Sr. Vice President, Strategic Services, 813-844-4828 ]]> InterStim® Testing Procedure http://www.or-live.com/tgh/2677/ Tampa, Fla. – More than 35 million Americans suffer from bladder control problems at some time in their lives. Those suffering from uncontrollable bladder may experience unexpected urine leakage, frequent bathroom use, or have the feeling of not being able to completely empty the bladder. Many people experience a combination of these symptoms. Although it is more common in older adults, and more likely to occur in women than men, it can affect anyone. For many of these people the last hope is an implantable device known as InterStim® Therapy, which was designed to stimulate communication between the brain and bladder to better control urinary incontinence and retention. Before the device can be implanted, however, doctors must perform a test procedure to determine if it will be effective. At 4 p.m. on May 20, 2009, this test procedure will be performed live over the Internet from Tampa General Hospital. The test involves placing a thin wire near the tailbone, which is connected to a small stimulator worn on a belt. The stimulator sends mild electrical pulses through the thin wire to the sacral nerves that control the bladder and muscles related to urinary function. The test is an outpatient procedure typically completed in less than an hour. The patient is placed under a local anesthetic. After the procedure, the patient keeps a journal for a period ranging from five to ten days. If the electrical pulses result in an increase in proper bladder function, the patient may proceed to the surgical implementation procedure. Raul Ordorica, M.D., Associate Professor, Division of Urology, University of South Florida College of Medicine, will perform the procedure to test the effectiveness of the InterStim® device. Dr. Ordorica has had extensive experience with Interstim® Therapy since it was FDA approved in 1998, and was the first to perform the implant at Tampa General Hospital. The procedure will be narrated by Mark Swierzewski, M.D., Florida Urology Partners. InterStim® is unique because of the testing process. It allows the physician and patient to gauge its effectiveness prior to undergoing a slightly more invasive implantation of the permanent device. The physician will determine if the therapy is beneficial in helping to relieve the symptoms of uncontrollable bladder, including urge incontinence, urgency frequency, and urinary retention. This treatment is highly effective where other therapies have failed. The procedure to place the wire for testing is frequently performed within the hospital setting either in the radiology suite or the operating room to benefit from fluoroscopy (X-ray) capabilities. If the testing is successful, the implant procedure is also done as an outpatient. Complication rates are very low. The most common complication is that the device needs to be adjusted to assure patient comfort and therapy success. To view this procedure, log on to www.tgh.org and click on the link on the homepage. If you are unable to view the live broadcast, the procedure will be archived at www.tgh.org and www.or-live.com for future viewing at your convenience. Contact: Jean Mayer, Sr. Vice President, Strategic Services, 813-844-4828 surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. ens_2646 http://www.or-live.com/EthiconEndo-Surgery/2646/ http://www.or-live.com/EthiconEndo-Surgery/2646/ On Tuesday, May 19, 2009 at 7:00 p.m. EDT, join thoracic surgeons, Dr. Scott Swanson and Dr. Daniel Miller, for a live webcast, including a discussion of surgical techniques used in Video Assisted Thoracic Surgery (or VATS) for lung cancer. The webcast will address the particular technical challenges of Right Lower Lobectomy, Left Upper Lobectomy, and Left-sided and Right-sided Lymphadenectomy and Segmentectomy. The one-hour presentation will feature video segments of the surgeries performed and selected by the panel. The webcast will also feature didactic and question and answer segments presented by the surgeons. Presenters: Scott James Swanson, MD, FACS Director, Minimally Invasive Thoracic Surgery Brigham and Women's Hospital Chief Surgical Officer Dana-Farber/Brigham and Women's Cancer CenterBoston, MA Daniel L. Miller, MD, FACS Chief of General Thoracic Surgery Emory Healthcare, Atlanta, GA Kamal A. Mansour Professor of Thoracic Surgery Emory University School of Medicine, Atlanta, GA VATS Lobectomy Over the past decade, VATS Lobectomy has emerged as a minimally invasive alternative to Thoracotomy for lung cancer. Since the surgery is performed thoracoscopically, lung cancer patients receiving a VATS Lobectomy may experience less pain, less morbidity and shorter hospital stays than with the traditional approach. The VATS technique however, can present some unique technical challenges for novice and experienced thoracic surgeons alike. During the one-hour webcast presentation, thoracic surgeons will hear some real-life strategies for addressing these challenges, including patient positioning, accessing critical structures, controlling bleeding, and navigating around major blood vessels. According to Dr. Scott Swanson of Brigham and Women's Hospital, "We hope to provide specific methodologies for getting from point A to point B –how to get around major pulmonary vessels, for example. We'll also demonstrate practical solutions to technical problems – if you can't see well, don't like the angle, problems of bleeding, and so on." The expert panel will also provide suggestions for teaching the VATS techniques to surgeons and OR personnel. According to Dr. Daniel Miller of the Emory University School of Medicine, "This is a process in learning that will help surgeons and OR personnel to evolve technically. We'll provide a timeline for learning the VATS techniques and strategies for adapting the learning process to the OR." The presentation will further provide information regarding indications for VATS lobectomy, advantages of selecting VATS over thoracotomy, and the ideal candidate for VATS. Equipment selection and application for stabilizing the various blood vessel types during VATS surgery, including the application of Harmonic® and Echelon™ technologies, will also be discussed. Left-sided and Right-sided Lymphadenectomy Video-assisted surgical techniques allow for minimally invasive access, isolation, and dissection of the lymph nodes for cancer staging and treatment. The presentation will focus on Left-sided and Right-sided Lymphadenectomy during a VATS lobectomy. Practical strategies for isolating and dissecting the lymph nodes, as well as equipment selection and application, will be discussed during the webcast. Methods for improving visualization when faced with difficult anatomy and/or pathology will also be addressed. VATS Segmentectomy With the increased use of computerized tomography (CT) scanning, lung cancers are now found at smaller sizes than in the past. In addition the epidemiology of lung cancer is changing such that they are found more peripherally in the lung. These two situations have focused a renewed interest on the use of anatomic segmental resection (segmentectomy) for lung cancer. Preserving lung tissue will provide the patient with superior lung function when compared with a lobectomy and allow more options for treatment should a second lung cancer develop in the future. Currently a large randomized intergroup study (CALGB 140503) is ongoing to evaluate segmentectomy versus lobectomy for small ( On Tuesday, May 19, 2009 at 7:00 p.m. EDT, join surgeons, Dr. Scott Swanson and Dr. Daniel Miller, for this informative webcast live from Boston, Massachusetts. Viewers may send their questions to the surgeons at any time up to, and during, the live webcast by clicking the Ask a Question button on your webcast screen. This procedure will include demonstration of the use of surgical devices such as the ENDOPATH® Echelon™ stapler and Harmonic® technology; it is not intended to be used as a surgical training guide. Other surgeons may employ different techniques. Individual surgeon preference and experience, as well as patient needs, should always dictate variation in procedure steps. Before using any medical device, including those demonstrated or referenced in this presentation, review all relevant package inserts, with particular attention to the indications, contraindications, warnings and precautions, and steps for use of the device. This program is presented by Ethicon Endo-Surgery, Inc. DSL 09-0367.09 ©2009 ]]> Video Assisted Thoracic Surgery (VATS) Lobectomy http://www.or-live.com/EthiconEndo-Surgery/2646/ On Tuesday, May 19, 2009 at 7:00 p.m. EDT, join thoracic surgeons, Dr. Scott Swanson and Dr. Daniel Miller, for a live webcast, including a discussion of surgical techniques used in Video Assisted Thoracic Surgery (or VATS) for lung cancer. The webcast will address the particular technical challenges of Right Lower Lobectomy, Left Upper Lobectomy, and Left-sided and Right-sided Lymphadenectomy and Segmentectomy. The one-hour presentation will feature video segments of the surgeries performed and selected by the panel. The webcast will also feature didactic and question and answer segments presented by the surgeons. Presenters: Scott James Swanson, MD, FACS Director, Minimally Invasive Thoracic Surgery Brigham and Women's Hospital Chief Surgical Officer Dana-Farber/Brigham and Women's Cancer CenterBoston, MA Daniel L. Miller, MD, FACS Chief of General Thoracic Surgery Emory Healthcare, Atlanta, GA Kamal A. Mansour Professor of Thoracic Surgery Emory University School of Medicine, Atlanta, GA VATS Lobectomy Over the past decade, VATS Lobectomy has emerged as a minimally invasive alternative to Thoracotomy for lung cancer. Since the surgery is performed thoracoscopically, lung cancer patients receiving a VATS Lobectomy may experience less pain, less morbidity and shorter hospital stays than with the traditional approach. The VATS technique however, can present some unique technical challenges for novice and experienced thoracic surgeons alike. During the one-hour webcast presentation, thoracic surgeons will hear some real-life strategies for addressing these challenges, including patient positioning, accessing critical structures, controlling bleeding, and navigating around major blood vessels. According to Dr. Scott Swanson of Brigham and Women's Hospital, "We hope to provide specific methodologies for getting from point A to point B –how to get around major pulmonary vessels, for example. We'll also demonstrate practical solutions to technical problems – if you can't see well, don't like the angle, problems of bleeding, and so on." The expert panel will also provide suggestions for teaching the VATS techniques to surgeons and OR personnel. According to Dr. Daniel Miller of the Emory University School of Medicine, "This is a process in learning that will help surgeons and OR personnel to evolve technically. We'll provide a timeline for learning the VATS techniques and strategies for adapting the learning process to the OR." The presentation will further provide information regarding indications for VATS lobectomy, advantages of selecting VATS over thoracotomy, and the ideal candidate for VATS. Equipment selection and application for stabilizing the various blood vessel types during VATS surgery, including the application of Harmonic® and Echelon™ technologies, will also be discussed. Left-sided and Right-sided Lymphadenectomy Video-assisted surgical techniques allow for minimally invasive access, isolation, and dissection of the lymph nodes for cancer staging and treatment. The presentation will focus on Left-sided and Right-sided Lymphadenectomy during a VATS lobectomy. Practical strategies for isolating and dissecting the lymph nodes, as well as equipment selection and application, will be discussed during the webcast. Methods for improving visualization when faced with difficult anatomy and/or pathology will also be addressed. VATS Segmentectomy With the increased use of computerized tomography (CT) scanning, lung cancers are now found at smaller sizes than in the past. In addition the epidemiology of lung cancer is changing such that they are found more peripherally in the lung. These two situations have focused a renewed interest on the use of anatomic segmental resection (segmentectomy) for lung cancer. Preserving lung tissue will provide the patient with superior lung function when compared with a lobectomy and allow more options for treatment should a second lung cancer develop in the future. Currently a large randomized intergroup study (CALGB 140503) is ongoing to evaluate segmentectomy versus lobectomy for small ( On Tuesday, May 19, 2009 at 7:00 p.m. EDT, join surgeons, Dr. Scott Swanson and Dr. Daniel Miller, for this informative webcast live from Boston, Massachusetts. Viewers may send their questions to the surgeons at any time up to, and during, the live webcast by clicking the Ask a Question button on your webcast screen. This procedure will include demonstration of the use of surgical devices such as the ENDOPATH® Echelon™ stapler and Harmonic® technology; it is not intended to be used as a surgical training guide. Other surgeons may employ different techniques. Individual surgeon preference and experience, as well as patient needs, should always dictate variation in procedure steps. Before using any medical device, including those demonstrated or referenced in this presentation, review all relevant package inserts, with particular attention to the indications, contraindications, warnings and precautions, and steps for use of the device. This program is presented by Ethicon Endo-Surgery, Inc. DSL 09-0367.09 ©2009 surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. pin_2548 http://www.or-live.com/pinnaclehealth/2548/ http://www.or-live.com/pinnaclehealth/2548/ PinnacleHealth's cardiovascular surgeons are using Stent Graft Repair procedures to repair and resolve ever more complex aortic aneurysms. "Up to about 15 years ago, there was a high risk of mortality associated with the open surgery required to resolve this issue. Today, instead of cutting open the chest, we can implant these grafts through small incisions in the groin or even percutaneously through the skin. The risk of mortality is significantly reduced, and patients usually go home the next day," says Brijeshwar Maini, MD, FACC, co-chair of Cardiovascular Research at PinnacleHealth. "An aneurysm is a swelling in the wall of an artery, in this case the aorta that is in danger of bursting. Usually, there are no symptoms for this condition. The whole point behind these stent grafts is to create blood flow through the graft past the aneurysm, thus eliminating the pressure on the aorta," adds Dr. Maini. On May 18 at 7 p.m. EDT PinnacleHealth will present an ORLive webcast of a Stent Graft Repair of a Thoracoabdominal Aneurysm. Dr. Maini along with Sung Jin Park, MD, cardiovascular surgeon, will explain the surgery as it takes place and also answer live email questions from viewers during and after the procedure. ]]> Aortic Aneurysms – Resolved Without Open Surgery http://www.or-live.com/pinnaclehealth/2548/ PinnacleHealth's cardiovascular surgeons are using Stent Graft Repair procedures to repair and resolve ever more complex aortic aneurysms. "Up to about 15 years ago, there was a high risk of mortality associated with the open surgery required to resolve this issue. Today, instead of cutting open the chest, we can implant these grafts through small incisions in the groin or even percutaneously through the skin. The risk of mortality is significantly reduced, and patients usually go home the next day," says Brijeshwar Maini, MD, FACC, co-chair of Cardiovascular Research at PinnacleHealth. "An aneurysm is a swelling in the wall of an artery, in this case the aorta that is in danger of bursting. Usually, there are no symptoms for this condition. The whole point behind these stent grafts is to create blood flow through the graft past the aneurysm, thus eliminating the pressure on the aorta," adds Dr. Maini. On May 18 at 7 p.m. EDT PinnacleHealth will present an ORLive webcast of a Stent Graft Repair of a Thoracoabdominal Aneurysm. Dr. Maini along with Sung Jin Park, MD, cardiovascular surgeon, will explain the surgery as it takes place and also answer live email questions from viewers during and after the procedure. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. geh_2751 http://www.or-live.com/genesishealth/2751 http://www.or-live.com/genesishealth/2751 To patients undergoing hemodialysis for end-stage kidney disease, circulation is everything. During hemodialysis, a machine takes the place of the kidneys, pumping blood from the patient's body through flexible tubing, cleaning it and then returning it to the patient's body through a separate tube. To connect to the machine, called a hemodialyzer, an access into the patient's blood vessels must be created. When an artery or vein carrying blood to or from a patient's dialysis access site, usually an arm or leg, narrows or develops a blockage, the limited blood flow makes hemodialysis more difficult and less effective. To restore blood flow, George Kontos, Jr., M.D., uses a minimally invasive treatment for the long-term management of vascular access in kidney dialysis patients. The procedure, an angioplasty with vascular stenting, will premiere Wednesday, May 13, at 7 p.m. CST, on OR-Live.com. The procedure is done at Genesis Medical Center, Illini Campus, Silvis, Ill. ]]> Significantly Improving Quality of Life for Kidney Dialysis http://www.or-live.com/genesishealth/2751 To patients undergoing hemodialysis for end-stage kidney disease, circulation is everything. During hemodialysis, a machine takes the place of the kidneys, pumping blood from the patient's body through flexible tubing, cleaning it and then returning it to the patient's body through a separate tube. To connect to the machine, called a hemodialyzer, an access into the patient's blood vessels must be created. When an artery or vein carrying blood to or from a patient's dialysis access site, usually an arm or leg, narrows or develops a blockage, the limited blood flow makes hemodialysis more difficult and less effective. To restore blood flow, George Kontos, Jr., M.D., uses a minimally invasive treatment for the long-term management of vascular access in kidney dialysis patients. The procedure, an angioplasty with vascular stenting, will premiere Wednesday, May 13, at 7 p.m. CST, on OR-Live.com. The procedure is done at Genesis Medical Center, Illini Campus, Silvis, Ill. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. bah_2635 http://www.or-live.com/BaptistHealth/2635/ http://www.or-live.com/BaptistHealth/2635/ Watch interventional radiologist Barry Katzen, M.D., medical director of Baptist Cardiac and Vascular Institute, and vascular surgeon Ignacio Rua, M.D., medical director of vascular surgery, as they repair an abdominal aortic aneurysm. The webcast will be moderated by interventional radiologist James Benenati, M.D., medical director of the Institute's peripheral vascular laboratory. Viewers can also choose to watch the procedure in Spanish. An aortic aneurysm is a weakened and bulging area in the major vessel that supplies blood to the body. The Institute's specialists were among the first in the nation to use stent-grafts to treat aortic aneurysms. Watch this fascinating procedure as it happens – without leaving your computer. The procedure, called endovascular repair, is performed by threading a stent-graft through a blood vessel in the groin and into the aorta to block the flow of blood into the aneurysm. The Institute's endovascular team, which includes highly qualified interventional radiologists and vascular surgeons, has performed endovascular repair of more than 870 abdominal aortic aneurysms and 75 thoracic aneurysms with excellent results. Baptist Cardiac and Vascular Institute was established at Baptist Hospital of Miami in 1987. Physicians from various medical and surgical specialties joined together to offer the Institute's comprehensive approach to cardiovascular care. The Institute's medical staff is actively involved in many federally approved clinical research studies to find better, less invasive ways of diagnosing and treating cardiovascular disease. Dr. Katzen is past president of the Society of Interventional Radiology and serves on the board of trustees of the RSNA Research and Education Foundation. Dr. Rua has served as section chief of Baptist Hospital's vascular surgery section and is a Fellow of the American College of Surgeons. Dr. Benenati is president-elect of the Society of Interventional Radiology and president of the Intersocietal Commission for the Accreditation of Vascular Laboratories. Baptist Cardiac and Vascular Institute is part of Baptist Health South Florida, the largest faith-based, not-for-profit healthcare organization in the region. It also includes Baptist Hospital, Baptist Children's Hospital, South Miami Hospital, Doctors Hospital, Homestead Hospital, Mariners Hospital in the Upper Keys and Baptist Outpatient Services. Baptist Health Foundation, the organization's fundraising arm, supports services at all hospitals and facilities affiliated with Baptist Health. ]]> Aortic Aneurysm Repair http://www.or-live.com/BaptistHealth/2635/ Watch interventional radiologist Barry Katzen, M.D., medical director of Baptist Cardiac and Vascular Institute, and vascular surgeon Ignacio Rua, M.D., medical director of vascular surgery, as they repair an abdominal aortic aneurysm. The webcast will be moderated by interventional radiologist James Benenati, M.D., medical director of the Institute's peripheral vascular laboratory. Viewers can also choose to watch the procedure in Spanish. An aortic aneurysm is a weakened and bulging area in the major vessel that supplies blood to the body. The Institute's specialists were among the first in the nation to use stent-grafts to treat aortic aneurysms. Watch this fascinating procedure as it happens – without leaving your computer. The procedure, called endovascular repair, is performed by threading a stent-graft through a blood vessel in the groin and into the aorta to block the flow of blood into the aneurysm. The Institute's endovascular team, which includes highly qualified interventional radiologists and vascular surgeons, has performed endovascular repair of more than 870 abdominal aortic aneurysms and 75 thoracic aneurysms with excellent results. Baptist Cardiac and Vascular Institute was established at Baptist Hospital of Miami in 1987. Physicians from various medical and surgical specialties joined together to offer the Institute's comprehensive approach to cardiovascular care. The Institute's medical staff is actively involved in many federally approved clinical research studies to find better, less invasive ways of diagnosing and treating cardiovascular disease. Dr. Katzen is past president of the Society of Interventional Radiology and serves on the board of trustees of the RSNA Research and Education Foundation. Dr. Rua has served as section chief of Baptist Hospital's vascular surgery section and is a Fellow of the American College of Surgeons. Dr. Benenati is president-elect of the Society of Interventional Radiology and president of the Intersocietal Commission for the Accreditation of Vascular Laboratories. Baptist Cardiac and Vascular Institute is part of Baptist Health South Florida, the largest faith-based, not-for-profit healthcare organization in the region. It also includes Baptist Hospital, Baptist Children's Hospital, South Miami Hospital, Doctors Hospital, Homestead Hospital, Mariners Hospital in the Upper Keys and Baptist Outpatient Services. Baptist Health Foundation, the organization's fundraising arm, supports services at all hospitals and facilities affiliated with Baptist Health. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. ens_2574 http://www.or-live.com/EthiconEndo-Surgery/2574 http://www.or-live.com/EthiconEndo-Surgery/2574 On May, 6th at 6:00 pm EDT, join surgeon, Dr. Paul J. MacKoul, for a webcast presentation of a laparoscopic retroperitoneal hysterectomy. Surgeons viewing the webcast will learn the advantages of this alternative approach to hysterectomy and GYN surgery. ]]> Innovations in Gynecologic Surgery http://www.or-live.com/EthiconEndo-Surgery/2574 On May, 6th at 6:00 pm EDT, join surgeon, Dr. Paul J. MacKoul, for a webcast presentation of a laparoscopic retroperitoneal hysterectomy. Surgeons viewing the webcast will learn the advantages of this alternative approach to hysterectomy and GYN surgery. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. deo_2496 http://www.or-live.com/DePuy/2496 http://www.or-live.com/DePuy/2496 Jack Farr, M.D., will perform a bi-compartmental knee replacement with the Sigma® High Performance Partial Knee. During this procedure, Dr. Farr will replace the medial and patellofemoral compartments of the knee. The broadcast will be moderated by David Fisher, M.D. "Bi-compartmental arthroplasty as opposed to total knee arthroplasty is a resurfacing concept, where we are trying to put the surfaces of the components where the articular surfaces were of the knee," explains Dr. Farr. "We retain both cruciate ligaments, hopefully adapting the knee to more natural kinematics as opposed to a total knee replacement." The live surgery will be performed at the Indiana Orthopaedic Hospital in Indianapolis, Indiana. As one of the designing surgeons for the High Performance Partial Knee, Dr. Farr has been instrumental in surgeon education with this new product offering. DePuy Orthopaedics, Inc., a company that has taken a leading role in educating surgeons, is making the broadcast available for free via www.OR-Live.com. Sigma High Performance Partial Knee for early knee intervention For early intervention, the Sigma High Performance Partial Knee System is the only partial knee solution on the market that can replace the medial, lateral and/or patellofemoral compartments while providing low wear and up to 155 degrees of flexion. The tibial implants utilize a moderately cross-linked, oxidatively stable polyethylene. "This is a truly patient and knee specific system that can work across the continuum of early interventional care," said Dr. Farr. "The System has individual compartment components that were designed specifically to work independently or together to give the surgeon flexibility during surgery and in subsequent surgeries depending on disease progression." Important Safety Information As with any medical treatment, individual results may vary. Only an orthopaedic surgeon can determine whether an orthopaedic implant is an appropriate course of treatment. There are potential risks, and recovery takes time. The performance of the new joint depends on weight, activity level, age and other factors. ]]> Sigma® High Performance Partial Knee http://www.or-live.com/DePuy/2496 Jack Farr, M.D., will perform a bi-compartmental knee replacement with the Sigma® High Performance Partial Knee. During this procedure, Dr. Farr will replace the medial and patellofemoral compartments of the knee. The broadcast will be moderated by David Fisher, M.D. "Bi-compartmental arthroplasty as opposed to total knee arthroplasty is a resurfacing concept, where we are trying to put the surfaces of the components where the articular surfaces were of the knee," explains Dr. Farr. "We retain both cruciate ligaments, hopefully adapting the knee to more natural kinematics as opposed to a total knee replacement." The live surgery will be performed at the Indiana Orthopaedic Hospital in Indianapolis, Indiana. As one of the designing surgeons for the High Performance Partial Knee, Dr. Farr has been instrumental in surgeon education with this new product offering. DePuy Orthopaedics, Inc., a company that has taken a leading role in educating surgeons, is making the broadcast available for free via www.OR-Live.com. Sigma High Performance Partial Knee for early knee intervention For early intervention, the Sigma High Performance Partial Knee System is the only partial knee solution on the market that can replace the medial, lateral and/or patellofemoral compartments while providing low wear and up to 155 degrees of flexion. The tibial implants utilize a moderately cross-linked, oxidatively stable polyethylene. "This is a truly patient and knee specific system that can work across the continuum of early interventional care," said Dr. Farr. "The System has individual compartment components that were designed specifically to work independently or together to give the surgeon flexibility during surgery and in subsequent surgeries depending on disease progression." Important Safety Information As with any medical treatment, individual results may vary. Only an orthopaedic surgeon can determine whether an orthopaedic implant is an appropriate course of treatment. There are potential risks, and recovery takes time. The performance of the new joint depends on weight, activity level, age and other factors. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. chr_2349 http://www.or-live.com/christianacare/2349 http://www.or-live.com/christianacare/2349 NEWARK, DE - Hyperparathyroidism is a common disease that can cause depression or chronic fatigue, kidney stones and even osteoporosis. It is also a disease for which a focused surgical treatment—called a parathyroidectomy—has dramatic, almost instant results. On April 30 at 5 p.m. EDT, Christiana Care Health System will webcast an ORLive minimally invasive parathyroidectomy performed by Dr. Raafat Abdel-Misih. This procedure not only removes the enlarged parathyroid gland that is the cause of the disease; it incorporates a laboratory procedure that allows the surgeon to verify that the operation was successful while the patient is still in the operating room, which makes the entire process easier on the patient. "By measuring the patient's hormone level immediately after the surgery, we know almost instantly that we have successfully removed all of the growth that was causing the symptoms," said Dr. Abdel-Misih. "This prevents a situation where we would have to bring the patient back into the operating room and redo the procedure." Most patients are able to go home within hours after the surgery, and the results are often dramatic. "Groans, stones, moans and bones. That's what we traditionally teach medical students when diagnosing hyperparathyroidism," said Dr. Michael Rhodes, Chair of Christiana Care's Department of Surgery and narrator for the live webcast. "Abdominal groans may occur from nausea and pain resulting from ulcers or pancreatitis, stones refer to the prevalence of kidney stones, occasional psychiatric moans may result from fatigue and depression, and the bones may be affected by osteoporosis. Often, patients who undergo the surgery discover within hours, days or weeks that their mood and energy level are greatly improved." Hyperparathyroidism is the result of a tumor on one or more of the parathyroid glands, which are four tiny glands in the front of the neck. They produce a hormone known as PTH (parathyroid hormone), which regulates calcium levels in the blood. When one of the glands becomes enlarged, it causes the body to move calcium out of the bones and into the bloodstream. Patients seldom realize that they have the disease, but it is typically detected in a routine blood test. Viewers will be able to e-mail live questions to the doctors during the procedure and receive answers in real time. This will be the first of several ORLive presentations from Christiana Care Health System. ]]> Dramatic Advance in Parathyroidectomy http://www.or-live.com/christianacare/2349 NEWARK, DE - Hyperparathyroidism is a common disease that can cause depression or chronic fatigue, kidney stones and even osteoporosis. It is also a disease for which a focused surgical treatment—called a parathyroidectomy—has dramatic, almost instant results. On April 30 at 5 p.m. EDT, Christiana Care Health System will webcast an ORLive minimally invasive parathyroidectomy performed by Dr. Raafat Abdel-Misih. This procedure not only removes the enlarged parathyroid gland that is the cause of the disease; it incorporates a laboratory procedure that allows the surgeon to verify that the operation was successful while the patient is still in the operating room, which makes the entire process easier on the patient. "By measuring the patient's hormone level immediately after the surgery, we know almost instantly that we have successfully removed all of the growth that was causing the symptoms," said Dr. Abdel-Misih. "This prevents a situation where we would have to bring the patient back into the operating room and redo the procedure." Most patients are able to go home within hours after the surgery, and the results are often dramatic. "Groans, stones, moans and bones. That's what we traditionally teach medical students when diagnosing hyperparathyroidism," said Dr. Michael Rhodes, Chair of Christiana Care's Department of Surgery and narrator for the live webcast. "Abdominal groans may occur from nausea and pain resulting from ulcers or pancreatitis, stones refer to the prevalence of kidney stones, occasional psychiatric moans may result from fatigue and depression, and the bones may be affected by osteoporosis. Often, patients who undergo the surgery discover within hours, days or weeks that their mood and energy level are greatly improved." Hyperparathyroidism is the result of a tumor on one or more of the parathyroid glands, which are four tiny glands in the front of the neck. They produce a hormone known as PTH (parathyroid hormone), which regulates calcium levels in the blood. When one of the glands becomes enlarged, it causes the body to move calcium out of the bones and into the bloodstream. Patients seldom realize that they have the disease, but it is typically detected in a routine blood test. Viewers will be able to e-mail live questions to the doctors during the procedure and receive answers in real time. This will be the first of several ORLive presentations from Christiana Care Health System. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. hrs_2426 http://www.or-live.com/RealityEP/2426 http://www.or-live.com/RealityEP/2426 Expert Faculty: Edward P. Gerstenfeld, MD, MS University of Pennsylvania Health System Bradley P. Knight, MD, FACC, FHRS University of Chicago Medical Center Sofiane Benali, CVT/CCT University of Chicago Medical Center Program Description: This Heart Rhythm Society live webcast will feature video of an ablation procedure for a patient left atrial tachycardia post atrial fibrillation ablation procedure. 2.0 AMA-PRA Category 1 CME credits are available for this program. 2.0 CE credits are available for this program. Target Audience: Cardiac electrophysiologists Cardiac surgeons Pediatric electrophysiologists Other cardiologists Physician assistants Nurse practitioners Registered nurses Members of industry Learning Objectives: Upon completion of this educational activity, participants will be able to: Identify common sources of atrial flutter after a left atrial ablation for AF Prepare a strategy for difficult repeat transseptal punctures Recognize the proper approach to left atrial flutters using activation patterns and pacing maneuvers List methods to isolate recovered pulmonary vein fascicles Patient Medical History The patient is a 67-year-old woman with medically-refractory idiopathic atrial fibrillation and typical atrial flutter since 1998. The patient underwent pulmonary vein isolation and ablation of the cavotricuspid isthmus on August 19th, 2008. The patient now has atypical appearing atrial flutter, most likely from the left atrium, which is refractory to propafenone and cardioversion. Highlights of the Procedure Challenges related to transseptal catheterization for repeat left-sided procedures Reisolation of recovered pulmonary vein potentials during redo procedures Value of initial pacing maneuvers with periodic reconfirmation to identify the mechanism of tachycardias after atrial fibrillation ablation This program is part of the Heart Rhythm Society's AF 360® Initiative. ]]> Reality EP: Tackling Left Atrial Tachycardias http://www.or-live.com/RealityEP/2426 Expert Faculty: Edward P. Gerstenfeld, MD, MS University of Pennsylvania Health System Bradley P. Knight, MD, FACC, FHRS University of Chicago Medical Center Sofiane Benali, CVT/CCT University of Chicago Medical Center Program Description: This Heart Rhythm Society live webcast will feature video of an ablation procedure for a patient left atrial tachycardia post atrial fibrillation ablation procedure. 2.0 AMA-PRA Category 1 CME credits are available for this program. 2.0 CE credits are available for this program. Target Audience: Cardiac electrophysiologists Cardiac surgeons Pediatric electrophysiologists Other cardiologists Physician assistants Nurse practitioners Registered nurses Members of industry Learning Objectives: Upon completion of this educational activity, participants will be able to: Identify common sources of atrial flutter after a left atrial ablation for AF Prepare a strategy for difficult repeat transseptal punctures Recognize the proper approach to left atrial flutters using activation patterns and pacing maneuvers List methods to isolate recovered pulmonary vein fascicles Patient Medical History The patient is a 67-year-old woman with medically-refractory idiopathic atrial fibrillation and typical atrial flutter since 1998. The patient underwent pulmonary vein isolation and ablation of the cavotricuspid isthmus on August 19th, 2008. The patient now has atypical appearing atrial flutter, most likely from the left atrium, which is refractory to propafenone and cardioversion. Highlights of the Procedure Challenges related to transseptal catheterization for repeat left-sided procedures Reisolation of recovered pulmonary vein potentials during redo procedures Value of initial pacing maneuvers with periodic reconfirmation to identify the mechanism of tachycardias after atrial fibrillation ablation This program is part of the Heart Rhythm Society's AF 360® Initiative. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. ola_2472 http://www.or-live.com/ololrmc/2472 http://www.or-live.com/ololrmc/2472 What does it take to provide the most comprehensive and advanced treatment for cancer? This live, interactive webcast will offer patients and families the latest information on the services available from the Cancer Program of Our Lady of the Lake and Mary Bird Perkins. From the comfort of your own home, learn more about coping with a cancer diagnosis, advances in cancer care, a multidisciplinary team approach to treating colorectal cancer, the stem cell transplant program to treat certain cancers and clinical trials that work to individualize your cancer care. During this hour-long webcast you will hear from doctors and other professionals to learn how this team approach is delivering the best possible outcomes for patients. ]]> Experts in Cancer Care http://www.or-live.com/ololrmc/2472 What does it take to provide the most comprehensive and advanced treatment for cancer? This live, interactive webcast will offer patients and families the latest information on the services available from the Cancer Program of Our Lady of the Lake and Mary Bird Perkins. From the comfort of your own home, learn more about coping with a cancer diagnosis, advances in cancer care, a multidisciplinary team approach to treating colorectal cancer, the stem cell transplant program to treat certain cancers and clinical trials that work to individualize your cancer care. During this hour-long webcast you will hear from doctors and other professionals to learn how this team approach is delivering the best possible outcomes for patients. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. met_2588 http://www.or-live.com/methodisthealth/2588/ http://www.or-live.com/methodisthealth/2588/ Methodist University Hospital (MUH) will become the first hospital in the Mid-South to broadcast an Awake Craniotomy when it hosts a surgical webcast on Tuesday, April 21, 2009. The webcast, which can be viewed at 4 p.m., will feature neurosurgeon Allen K. Sills, Jr., M.D., in concert with the Mid-South's only team qualified to execute this highly complex brain surgery. Your questions about the procedure can be answered live via email from 4 pm- 5 pm (CDT). After this time, the hour-long webcast will be archived and available to view by visiting methodisthealth.org and clicking "Surgical Webcasts." ]]> Awake Craniotomy http://www.or-live.com/methodisthealth/2588/ Methodist University Hospital (MUH) will become the first hospital in the Mid-South to broadcast an Awake Craniotomy when it hosts a surgical webcast on Tuesday, April 21, 2009. The webcast, which can be viewed at 4 p.m., will feature neurosurgeon Allen K. Sills, Jr., M.D., in concert with the Mid-South's only team qualified to execute this highly complex brain surgery. Your questions about the procedure can be answered live via email from 4 pm- 5 pm (CDT). After this time, the hour-long webcast will be archived and available to view by visiting methodisthealth.org and clicking "Surgical Webcasts." surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. waf_2385 http://www.or-live.com/WFUBMC/2385 http://www.or-live.com/WFUBMC/2385 WINSTON-SALEM, N.C. – Ethan R. Wiesler, M.D., an orthopaedic surgeon at Wake Forest University Baptist Medical Center, will perform a total shoulder replacement that will be broadcast at 5:00 pm, Tuesday, April 21, 2009. Christopher Tuohy, M.D., an orthopaedic surgeon who also performs shoulder replacements, will narrate the procedure. The webcast will be archived here and on the Wake Forest Baptist website. Patients interested in making appointments can call (866) 511-1932. The most common reason for needing a shoulder replacement is osteoarthritis, which causes a deterioration of the joint. Other causes are rheumatoid arthritis and trauma to the joint. Arthritis and trauma can cause pain, inflammation, swelling and stiffness in the joint, decreased activity and an impaired lifestyle, including an inability to sleep or use that shoulder. In addition to damage to the arm bone and shoulder blade within the joint, patients may have damage to the cartilage that supports the joint. Conservative treatments include lifestyle changes, less invasive surgeries, physical therapy, supplements, rest and ice, as well as pain management that includes anti-inflammatory medications, analgesics and steroid injections. If these treatments do not work, a patient may need to explore shoulder replacement. In order to properly diagnose shoulder problems, physicians will perform a complete medical history, a complete physical exam of the patient and a detailed exam of the affected joint, X-rays and a CT scan. The benefits of replacement of the shoulder joint include pain relief, enhancement of movement and mobility and improved quality of life. Replacement of the joint includes resurfacing or replacing the humeral head, which is the top or ball of the humerus or long arm bone, and the glenoid or socket of the joint that is part of the scapula or shoulder blade. Standard components for a total shoulder replacement include the humeral stem, which goes down into the long arm bone called the humerus; the humeral head, which replaces the ball or rounded top of the humerus bone; and the glenoid components which replaces the socket that is part of the shoulder blade and attaches to the shoulder blade. With total shoulder replacement, regional anesthesia in addition to general anesthesia will be given to the patient to assist with pain management following surgery. The surgeon will replace the damaged shoulder joint by resurfacing the bone ends of the arm bone and shoulder blade, capping with metal pieces and placing plastic in between to ensure support, flexibility and motion, without the pain. A variety of designs of shoulder joints are available, including one used for partial shoulder replacement that is as simple as replacing only the humerus head or top of the arm bone. The appropriate size and design is based on the patient's condition, age, weight, activity, and health. During a total shoulder joint replacement, the physician trims off the top of the arm bone and prepares the hollow inside of the arm bone for the stem. Any remaining cartilage inside the glenoid or socket is cleared way using a burr, which also drills the holes inside the shoulder blade used for anchoring the glenoid tray. The humeral stem is placed inside the top of the bone. The glenoid component is placed inside the old socket. The humeral ball is attached to the top of the stem. The joint is then tested for a proper fit. After surgery, supervised physical therapy will continue for about three months. After about six months, the patient should be able to return to full activities. Joint replacement patients are cared for by physicians, physical therapists, nurses and staff who all have special training in joint replacement care. In addition to the high volume of joint replacements, resurfacings, repairs and preservations, Wake Forest University Baptist Medical Center also does research and trains future surgeons.  Media contacts: Ann Hopkins, ahopkins@wfubmc.edu, at (336) 716-1280; Lisa Long, lclong@wfubmc.edu; or Bonnie Davis, bdavis@wfubmc.edu, at 716-4587. Wake Forest University Baptist Medical Center ( www.wfubmc.edu ) is an academic health system comprised of North Carolina Baptist Hospital, Brenner Children's Hospital, Wake Forest University Physicians, and Wake Forest University Health Sciences, which operates the university's School of Medicine and Piedmont Triad Research Park. The system comprises 1,056 acute care, rehabilitation and long-term care beds and has been ranked as one of "America's Best Hospitals" by U.S. News and World Report since 1993. Wake Forest Baptist is ranked 32nd in the nation by America's Top Doctors for the number of its doctors considered best by their peers. The institution ranks in the top third in funding by the National Institutes of Health and fourth in the Southeast in revenues from its licensed intellectual property. ]]> Total Shoulder Replacement http://www.or-live.com/WFUBMC/2385 WINSTON-SALEM, N.C. – Ethan R. Wiesler, M.D., an orthopaedic surgeon at Wake Forest University Baptist Medical Center, will perform a total shoulder replacement that will be broadcast at 5:00 pm, Tuesday, April 21, 2009. Christopher Tuohy, M.D., an orthopaedic surgeon who also performs shoulder replacements, will narrate the procedure. The webcast will be archived here and on the Wake Forest Baptist website. Patients interested in making appointments can call (866) 511-1932. The most common reason for needing a shoulder replacement is osteoarthritis, which causes a deterioration of the joint. Other causes are rheumatoid arthritis and trauma to the joint. Arthritis and trauma can cause pain, inflammation, swelling and stiffness in the joint, decreased activity and an impaired lifestyle, including an inability to sleep or use that shoulder. In addition to damage to the arm bone and shoulder blade within the joint, patients may have damage to the cartilage that supports the joint. Conservative treatments include lifestyle changes, less invasive surgeries, physical therapy, supplements, rest and ice, as well as pain management that includes anti-inflammatory medications, analgesics and steroid injections. If these treatments do not work, a patient may need to explore shoulder replacement. In order to properly diagnose shoulder problems, physicians will perform a complete medical history, a complete physical exam of the patient and a detailed exam of the affected joint, X-rays and a CT scan. The benefits of replacement of the shoulder joint include pain relief, enhancement of movement and mobility and improved quality of life. Replacement of the joint includes resurfacing or replacing the humeral head, which is the top or ball of the humerus or long arm bone, and the glenoid or socket of the joint that is part of the scapula or shoulder blade. Standard components for a total shoulder replacement include the humeral stem, which goes down into the long arm bone called the humerus; the humeral head, which replaces the ball or rounded top of the humerus bone; and the glenoid components which replaces the socket that is part of the shoulder blade and attaches to the shoulder blade. With total shoulder replacement, regional anesthesia in addition to general anesthesia will be given to the patient to assist with pain management following surgery. The surgeon will replace the damaged shoulder joint by resurfacing the bone ends of the arm bone and shoulder blade, capping with metal pieces and placing plastic in between to ensure support, flexibility and motion, without the pain. A variety of designs of shoulder joints are available, including one used for partial shoulder replacement that is as simple as replacing only the humerus head or top of the arm bone. The appropriate size and design is based on the patient's condition, age, weight, activity, and health. During a total shoulder joint replacement, the physician trims off the top of the arm bone and prepares the hollow inside of the arm bone for the stem. Any remaining cartilage inside the glenoid or socket is cleared way using a burr, which also drills the holes inside the shoulder blade used for anchoring the glenoid tray. The humeral stem is placed inside the top of the bone. The glenoid component is placed inside the old socket. The humeral ball is attached to the top of the stem. The joint is then tested for a proper fit. After surgery, supervised physical therapy will continue for about three months. After about six months, the patient should be able to return to full activities. Joint replacement patients are cared for by physicians, physical therapists, nurses and staff who all have special training in joint replacement care. In addition to the high volume of joint replacements, resurfacings, repairs and preservations, Wake Forest University Baptist Medical Center also does research and trains future surgeons.  Media contacts: Ann Hopkins, ahopkins@wfubmc.edu, at (336) 716-1280; Lisa Long, lclong@wfubmc.edu; or Bonnie Davis, bdavis@wfubmc.edu, at 716-4587. Wake Forest University Baptist Medical Center ( www.wfubmc.edu ) is an academic health system comprised of North Carolina Baptist Hospital, Brenner Children's Hospital, Wake Forest University Physicians, and Wake Forest University Health Sciences, which operates the university's School of Medicine and Piedmont Triad Research Park. The system comprises 1,056 acute care, rehabilitation and long-term care beds and has been ranked as one of "America's Best Hospitals" by U.S. News and World Report since 1993. Wake Forest Baptist is ranked 32nd in the nation by America's Top Doctors for the number of its doctors considered best by their peers. The institution ranks in the top third in funding by the National Institutes of Health and fourth in the Southeast in revenues from its licensed intellectual property. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. chp_2446 http://www.or-live.com/stlukes/2446/ http://www.or-live.com/stlukes/2446/ New York City- Chronic and severe hip pain due to osteoarthritis, rheumatoid arthritis or a severe fracture can be debilitating and keep you from the activities you enjoy. When a hip joint is damaged beyond repair, and pain is occurring during ordinary tasks, hip replacement is the treatment of choice for patients seeking a return to a more active lifestyle. But even though hip replacement can relieve the existing pain in the hip joint, it can often require a prolonged hospital stay, significant surgical pain and weeks to months of rehabilitation. In traditional hip replacement surgery, a 10 to 12 inch incision is made, and muscles and tendons often have to be cut to access the hip joint. However, cutting of these muscles and tendons causes considerable surgical trauma, is the primary source of pain and limping after surgery, and can prolong rehabilitation and a return to regular activity significantly. Dr. Douglas B. Unis, a board certified and fellowship trained orthopedic surgeon at St. Luke's-Roosevelt Hospital Center and an expert in minimally invasive joint replacement, is now offering a new "Micro Hip" hip replacement technique that dramatically reduces hospital stay, post-surgical pain, and recovery time for qualified hip replacement patients. St. Luke's-Roosevelt Hospital Center was a United HealthCare Premium Specialty Center for Joint Replacement in 2008, and is well known for its outstanding orthopedic care. To make an appointment with Dr. Douglas Unis, orthopedic surgeon, for a consultation on hip replacement surgery at St. Luke's-Roosevelt Hospital Center in NYC, please call (212) 636-3800. ]]> Minimally Invasive Hip Replacement http://www.or-live.com/stlukes/2446/ New York City- Chronic and severe hip pain due to osteoarthritis, rheumatoid arthritis or a severe fracture can be debilitating and keep you from the activities you enjoy. When a hip joint is damaged beyond repair, and pain is occurring during ordinary tasks, hip replacement is the treatment of choice for patients seeking a return to a more active lifestyle. But even though hip replacement can relieve the existing pain in the hip joint, it can often require a prolonged hospital stay, significant surgical pain and weeks to months of rehabilitation. In traditional hip replacement surgery, a 10 to 12 inch incision is made, and muscles and tendons often have to be cut to access the hip joint. However, cutting of these muscles and tendons causes considerable surgical trauma, is the primary source of pain and limping after surgery, and can prolong rehabilitation and a return to regular activity significantly. Dr. Douglas B. Unis, a board certified and fellowship trained orthopedic surgeon at St. Luke's-Roosevelt Hospital Center and an expert in minimally invasive joint replacement, is now offering a new "Micro Hip" hip replacement technique that dramatically reduces hospital stay, post-surgical pain, and recovery time for qualified hip replacement patients. St. Luke's-Roosevelt Hospital Center was a United HealthCare Premium Specialty Center for Joint Replacement in 2008, and is well known for its outstanding orthopedic care. To make an appointment with Dr. Douglas Unis, orthopedic surgeon, for a consultation on hip replacement surgery at St. Luke's-Roosevelt Hospital Center in NYC, please call (212) 636-3800. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. cos_2619 http://www.or-live.com/CovidienSurgical/2619 http://www.or-live.com/CovidienSurgical/2619 In a live internet web cast on April 7, 2009, at 6:00 pm Eastern Time, and 6pm Pacific time, Dr. Kevin Stepp will perform a hysterectomy with single incision laparoscopic approach using the CovidienTM SILSTM Port Multiple Instrument Access Port. The SILSTM Port leaves a hidden umbilical scar which may result in better cosmesis and eliminate multiple trocar site closures. This advanced port offers maximal maneuverability for laparoscopic surgery through a single incision. The flexible port accepts (3) 5mm cannulas or (2) 5mm cannulas and (l) 5mm-12mm cannula, enabling advanced MIS procedures through a single incision. The cannula positions are adjustable within the flexible port. The surgery will be performed at the MetroHealth Medical Center in Cleveland, OH by Dr. Kevin Stepp. He is currently one of only a few gynecologists in the world performing laparoscopic surgery through a single incision, with the goal faster recovery with less pain. SILSTM Hysterectomy is performed through a tiny incision in the belly button and has the cosmetic advantage of essentially no visible scar. Accordingly to Dr. Stepp, "the abdominal incision approach for hysterectomy is not the most minimally invasive approach and it does not need to be the most common way anymore." ABOUT COVIDIEN: Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry leading product lines in four segments: Medical Devices, Imaging Solutions, Pharmaceutical Products and Medical Supplies. With 2008 revenue of nearly $10 billion, Covidien has more than 41,000 employees worldwide in 59 countries, and its products are sold in over 140 countries. Please visit www.covidien.com to learn more about our business. SILS™ is an advanced laparoscopic procedure for which specialty training is strongly recommended. Contact your local Covidien Surgical Device Specialist for training opportunities. ]]> Live SILS™ Hysterectomy Procedure Webcast http://www.or-live.com/CovidienSurgical/2619 In a live internet web cast on April 7, 2009, at 6:00 pm Eastern Time, and 6pm Pacific time, Dr. Kevin Stepp will perform a hysterectomy with single incision laparoscopic approach using the CovidienTM SILSTM Port Multiple Instrument Access Port. The SILSTM Port leaves a hidden umbilical scar which may result in better cosmesis and eliminate multiple trocar site closures. This advanced port offers maximal maneuverability for laparoscopic surgery through a single incision. The flexible port accepts (3) 5mm cannulas or (2) 5mm cannulas and (l) 5mm-12mm cannula, enabling advanced MIS procedures through a single incision. The cannula positions are adjustable within the flexible port. The surgery will be performed at the MetroHealth Medical Center in Cleveland, OH by Dr. Kevin Stepp. He is currently one of only a few gynecologists in the world performing laparoscopic surgery through a single incision, with the goal faster recovery with less pain. SILSTM Hysterectomy is performed through a tiny incision in the belly button and has the cosmetic advantage of essentially no visible scar. Accordingly to Dr. Stepp, "the abdominal incision approach for hysterectomy is not the most minimally invasive approach and it does not need to be the most common way anymore." ABOUT COVIDIEN: Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry leading product lines in four segments: Medical Devices, Imaging Solutions, Pharmaceutical Products and Medical Supplies. With 2008 revenue of nearly $10 billion, Covidien has more than 41,000 employees worldwide in 59 countries, and its products are sold in over 140 countries. Please visit www.covidien.com to learn more about our business. SILS™ is an advanced laparoscopic procedure for which specialty training is strongly recommended. Contact your local Covidien Surgical Device Specialist for training opportunities. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. chp_2448 http://www.or-live.com/bethisrael/2448/ http://www.or-live.com/bethisrael/2448/ New York, NY-- Beth Israel Orthopedics, a premier hospital-based provider of orthopedics services in New York City, will present a four-segment webcast featuring common orthopedic conditions that can be corrected with orthopedic surgery. The Department of Orthopedic Surgery at Beth Israel provides comprehensive care in every subspecialty of orthopedics, and their fellowship trained surgeons are recognized experts in their respective areas of subspecialty. Beth Israel was rated "Best in Manhattan for Overall Orthopedics Services" and was 5-Star rated in Spine Surgery, Joint Replacement and Hip Fracture Repair in 2008 by Healthgrades, an independent hospital ratings agency. The webcast will highlight: Welcome message from Dr. Peter D. McCann, Chair, Department of Orthopedic Surgery Carpal Tunnel Surgery Dr. Charles P. Melone, Chief of Hand Surgery at Beth Israel and a nationally known hand surgeon, will perform carpal tunnel release surgery. Carpal tunnel syndrome is a debilitating condition that can produce symptoms such as pain, numbness, weakness and tingling in the hand or fingers, and is caused by increased pressure on the median nerve, at the wrist, from the transverse carpal ligament. During carpal tunnel surgery, the transverse carpal ligament is cut, releasing the pressure on the median nerve, often relieving symptoms immediately. If conservative treatment has failed to relieve carpal tunnel syndrome symptoms after 3-12 months, carpal tunnel surgery should be considered. Carpal tunnel surgery is an outpatient procedure, and typically takes less than 30 minutes to complete. The hand surgeons at Beth Israel Orthopedics also perform surgery for relief of De Quervain's Tendinitis, a condition similar to carpal tunnel syndrome that affects the thumb. Spine Surgery: Anterior Cervical Discectomy Dr. Andrew M. Casden, Associate Director of the Spine Institute of New York at Beth Israel and an expert in minimally invasive spine surgery, will perform a minimally invasive Anterior Cervical Discectomy with Fusion and Instrumentation. Anterior Cervical Discectomy is typically done for patients who have a rupture, or herniation, of the shock absorbing disc between two cervical (neck) vertebrae, or who have arthritic spurs of bone. The pressure on the nerve and spinal cord from the disc or spur results in pain and/or weakness in the neck or arms. More severe symptoms can include difficulty with walking and loss of balance. If non-operative treatment fails to relieve the symptoms, surgery may be performed to relieve the compression. The surgery is comprised of three parts. First is the removal of the disc or spur causing the compression of the nerve or spinal cord. Next, a bone graft is put in place to fill the area where the disc/spur was removed, which will unite the adjacent vertebrae together; this is called a fusion. Lastly, a titanium plate is fixed to the spine to add stability and keep the bone graft in place. Surgery is performed with the use of an operating microscope, giving the spine surgeon a greatly magnified view of the affected area through a smaller incision. The majority of patients are up and walking a few hours after surgery. Hip and Knee Replacement Dr. Steven F. Harwin, Chief of Adult Reconstruction (hip and knee replacement) at Beth Israel, and an innovator and design consultant for numerous hip and knee replacement implants, will demonstrate, with anatomic models and animations, how hip and knee replacement surgery is performed and how it can benefit patients. Hip and knee replacement is recommended when osteoarthritis has seriously limited a patient's normal activity level due to joint pain, or a serious fracture has damaged the joint beyond repair. There are over 500,000 hip and knee replacement surgeries in the United States every year. Hip and knee replacement has a very high success rate, a low level of complications, can relieve severe joint pain and allows patients to return to most of the activities they used to enjoy.  Anterior Cruciate Ligament (ACL) Reconstruction Surgery Dr. Jerry A. Lubliner, Chief of Sports Medicine at Beth Israel Orthopedics and vastly experienced in surgical treatment of sports injuries, will be performing an Anterior Cruciate Ligament (ACL) reconstruction surgery. The anterior cruciate ligament is one of the many ligaments that provide stability to the knee. The ACL is frequently injured, and when this occurs, usually requires surgical reconstruction. Surgery to reconstruct a torn ACL involves replacing the ligament precisely in the knee, either with the patient's own donor graft, called an autograft, or a cadaver graft, called an allograft. Using minimally invasive arthroscopic surgery techniques (a little as 1 cm incisions), the surgeon removes the torn ends of the existing anterior cruciate ligament and repairs any damage to the surrounding tissues. Tunnels are then drilled into the tibia (shin bone) and the femur (thigh bone) for placement of the new tendon graft, in the exact position of the original ACL. The tendon graft is then threaded into these new tunnels and held in place by specially engineered plastic or metal screws and other fixation devices, creating a new anterior cruciate ligament. The surgeon tests the tension of the new ACL and makes sure there is full range of motion before closing. ACL reconstruction surgery patients go home the same day of surgery, and often return to work within one week. After six months, the patient is allowed to return to sports without restrictions and without a brace. To find an orthopedic surgeon affiliated with Beth Israel Orthopedics in New York City, go to www.bethisraelortho.com.   ]]> Spotlight on Beth Israel Orthopedics, New York City http://www.or-live.com/bethisrael/2448/ New York, NY-- Beth Israel Orthopedics, a premier hospital-based provider of orthopedics services in New York City, will present a four-segment webcast featuring common orthopedic conditions that can be corrected with orthopedic surgery. The Department of Orthopedic Surgery at Beth Israel provides comprehensive care in every subspecialty of orthopedics, and their fellowship trained surgeons are recognized experts in their respective areas of subspecialty. Beth Israel was rated "Best in Manhattan for Overall Orthopedics Services" and was 5-Star rated in Spine Surgery, Joint Replacement and Hip Fracture Repair in 2008 by Healthgrades, an independent hospital ratings agency. The webcast will highlight: Welcome message from Dr. Peter D. McCann, Chair, Department of Orthopedic Surgery Carpal Tunnel Surgery Dr. Charles P. Melone, Chief of Hand Surgery at Beth Israel and a nationally known hand surgeon, will perform carpal tunnel release surgery. Carpal tunnel syndrome is a debilitating condition that can produce symptoms such as pain, numbness, weakness and tingling in the hand or fingers, and is caused by increased pressure on the median nerve, at the wrist, from the transverse carpal ligament. During carpal tunnel surgery, the transverse carpal ligament is cut, releasing the pressure on the median nerve, often relieving symptoms immediately. If conservative treatment has failed to relieve carpal tunnel syndrome symptoms after 3-12 months, carpal tunnel surgery should be considered. Carpal tunnel surgery is an outpatient procedure, and typically takes less than 30 minutes to complete. The hand surgeons at Beth Israel Orthopedics also perform surgery for relief of De Quervain's Tendinitis, a condition similar to carpal tunnel syndrome that affects the thumb. Spine Surgery: Anterior Cervical Discectomy Dr. Andrew M. Casden, Associate Director of the Spine Institute of New York at Beth Israel and an expert in minimally invasive spine surgery, will perform a minimally invasive Anterior Cervical Discectomy with Fusion and Instrumentation. Anterior Cervical Discectomy is typically done for patients who have a rupture, or herniation, of the shock absorbing disc between two cervical (neck) vertebrae, or who have arthritic spurs of bone. The pressure on the nerve and spinal cord from the disc or spur results in pain and/or weakness in the neck or arms. More severe symptoms can include difficulty with walking and loss of balance. If non-operative treatment fails to relieve the symptoms, surgery may be performed to relieve the compression. The surgery is comprised of three parts. First is the removal of the disc or spur causing the compression of the nerve or spinal cord. Next, a bone graft is put in place to fill the area where the disc/spur was removed, which will unite the adjacent vertebrae together; this is called a fusion. Lastly, a titanium plate is fixed to the spine to add stability and keep the bone graft in place. Surgery is performed with the use of an operating microscope, giving the spine surgeon a greatly magnified view of the affected area through a smaller incision. The majority of patients are up and walking a few hours after surgery. Hip and Knee Replacement Dr. Steven F. Harwin, Chief of Adult Reconstruction (hip and knee replacement) at Beth Israel, and an innovator and design consultant for numerous hip and knee replacement implants, will demonstrate, with anatomic models and animations, how hip and knee replacement surgery is performed and how it can benefit patients. Hip and knee replacement is recommended when osteoarthritis has seriously limited a patient's normal activity level due to joint pain, or a serious fracture has damaged the joint beyond repair. There are over 500,000 hip and knee replacement surgeries in the United States every year. Hip and knee replacement has a very high success rate, a low level of complications, can relieve severe joint pain and allows patients to return to most of the activities they used to enjoy.  Anterior Cruciate Ligament (ACL) Reconstruction Surgery Dr. Jerry A. Lubliner, Chief of Sports Medicine at Beth Israel Orthopedics and vastly experienced in surgical treatment of sports injuries, will be performing an Anterior Cruciate Ligament (ACL) reconstruction surgery. The anterior cruciate ligament is one of the many ligaments that provide stability to the knee. The ACL is frequently injured, and when this occurs, usually requires surgical reconstruction. Surgery to reconstruct a torn ACL involves replacing the ligament precisely in the knee, either with the patient's own donor graft, called an autograft, or a cadaver graft, called an allograft. Using minimally invasive arthroscopic surgery techniques (a little as 1 cm incisions), the surgeon removes the torn ends of the existing anterior cruciate ligament and repairs any damage to the surrounding tissues. Tunnels are then drilled into the tibia (shin bone) and the femur (thigh bone) for placement of the new tendon graft, in the exact position of the original ACL. The tendon graft is then threaded into these new tunnels and held in place by specially engineered plastic or metal screws and other fixation devices, creating a new anterior cruciate ligament. The surgeon tests the tension of the new ACL and makes sure there is full range of motion before closing. ACL reconstruction surgery patients go home the same day of surgery, and often return to work within one week. After six months, the patient is allowed to return to sports without restrictions and without a brace. To find an orthopedic surgeon affiliated with Beth Israel Orthopedics in New York City, go to www.bethisraelortho.com.   surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. fih_2563 http://www.or-live.com/FHC/2563 http://www.or-live.com/FHC/2563 PINEHURST, N.C. – On Thursday, April 2, 2009, at 5 p.m. Eastern Time, surgeons and others are invited to join cardiothoracic surgeon John E. Streitman, M.D., as he presents a webcast of a minimally invasive aortic valve replacement from FirstHealth Moore Regional Hospital in Pinehurst, N.C. ]]> Minimally Invasive Aortic Valve Replacement http://www.or-live.com/FHC/2563 PINEHURST, N.C. – On Thursday, April 2, 2009, at 5 p.m. Eastern Time, surgeons and others are invited to join cardiothoracic surgeon John E. Streitman, M.D., as he presents a webcast of a minimally invasive aortic valve replacement from FirstHealth Moore Regional Hospital in Pinehurst, N.C. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. mom_2479 http://www.or-live.com/montefiore/2479/ http://www.or-live.com/montefiore/2479/ Atrial fibrillation currently effects 2.2 million people in the U.S. and because our population is aging, this number will continue to rise over the next several years. "Atrial Fibrillation is an epidemic," says Andrew Krumerman, MD, attending physician and assistant professor of medicine at Albert Einstein College of Medicine. "Atrial Fibrillation occurs when the atrium (upper part of the heart) begins to beat rapidly causing the ventricles (beating chambers of the heart) to beat in an irregular fashion. This frequently causes palpitation and shortness of breath. The primary danger associated with this condition is stroke." On April 1 at 7:00pm Eastern time, Montefiore-Einstein Heart Center will present a live webcast of a Left Atrial Catheter Ablation for treatment of persistent atrial fibrillation. Dr. Andrew Krumerman will moderate the webcast and he will be joined by John D. Fisher, MD, director Montefiore-Einstein Heart Center's Arrhythmia program and Eugene C. Palma, M.D., director of Montefiore's East Division Arrhythmia program. Left Atrial Catheter Ablation is a treatment for patients who have not responded to drug therapy. "More than 95% of the triggers that initiate atrial fibrillation arise from the pulmonary venous-left atrial junction. Multiple studies have demonstrated that elimination of these electrical triggers results in restoration of normal sinus rhythm," explains Dr. Krumerman. "85% of patients with intermittent (paroxysmal) atrial fibrillation can expect to be cured by this treatment." In addition to the exceptional medical staff, The Montefiore-Einstein Heart Center's legendary Arrhythmia and Pacemaker services are equipped with cutting edge tools for performing complex catheter ablation, device implantation and extraction. Viewers will be able to email live questions to the doctors during the webcast. ]]> Advanced Treatment for Chronic Atrial Fibrillation http://www.or-live.com/montefiore/2479/ Atrial fibrillation currently effects 2.2 million people in the U.S. and because our population is aging, this number will continue to rise over the next several years. "Atrial Fibrillation is an epidemic," says Andrew Krumerman, MD, attending physician and assistant professor of medicine at Albert Einstein College of Medicine. "Atrial Fibrillation occurs when the atrium (upper part of the heart) begins to beat rapidly causing the ventricles (beating chambers of the heart) to beat in an irregular fashion. This frequently causes palpitation and shortness of breath. The primary danger associated with this condition is stroke." On April 1 at 7:00pm Eastern time, Montefiore-Einstein Heart Center will present a live webcast of a Left Atrial Catheter Ablation for treatment of persistent atrial fibrillation. Dr. Andrew Krumerman will moderate the webcast and he will be joined by John D. Fisher, MD, director Montefiore-Einstein Heart Center's Arrhythmia program and Eugene C. Palma, M.D., director of Montefiore's East Division Arrhythmia program. Left Atrial Catheter Ablation is a treatment for patients who have not responded to drug therapy. "More than 95% of the triggers that initiate atrial fibrillation arise from the pulmonary venous-left atrial junction. Multiple studies have demonstrated that elimination of these electrical triggers results in restoration of normal sinus rhythm," explains Dr. Krumerman. "85% of patients with intermittent (paroxysmal) atrial fibrillation can expect to be cured by this treatment." In addition to the exceptional medical staff, The Montefiore-Einstein Heart Center's legendary Arrhythmia and Pacemaker services are equipped with cutting edge tools for performing complex catheter ablation, device implantation and extraction. Viewers will be able to email live questions to the doctors during the webcast. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. saj_2509 http://www.or-live.com/STJoseph/2509 http://www.or-live.com/STJoseph/2509 Diagnosis of cancer of the liver or pancreas as well as other invasive cancers of the abdomen can be devastating. At Saint Joseph's Hospital and Marshfield Clinic Marshfield WI – options for treatment and palliation of disease are available that give patients hope and improved quality of life. The Cancer Center in Marshfield has capabilities that offer patients treatment options for any cancer diagnosis. Two surgeries/procedures for treatment of these rare and complex cancers will be featured on the 10th webcast sponsored by Saint Joseph's Hospital and Marshfield Clinic. The webcast will air from 5-6 p.m. Wednesday, March 25. Procedures featured are (1) Chemoembolization; and (2) Cytoreductive Surgery and Hyperperthermic Intraperitoneal Chemotherapy (HIPEC). During the webcast, Marshfield Clinic physicians on staff at Saint Joseph's Hospital will discuss the surgeries. The program will feature the pre-taped procedures, and a real-time panel discussion and analysis. Moderator will be William Hocking, MD, hematologist/oncologist. Others serving on the panel will be Kristin Gerndt, MD, interventional radiologist; Sanjoy Saha, MD, FACS, surgical oncologist, and Seth Fagbemi, MD, hematologist/medical oncologist. Chemoembolization, a minimally invasive treatment for liver cancer or metastasis to the liver, involves giving chemotherapy drugs directly into the vessels that supply blood to the liver tumors. It involves a small needle puncture in the patient's femoral artery at the groin and inserting a catheter into a branch of the liver artery. It is not a cure for the cancer, but it can extend and preserve the quality of a patient's life, with minimal side effects. The combination of Cytoreductive Surgery and Hyperperthermic Intraperitoneal Chemotherapy (HIPEC) is a newer modality of treatment for peritoneal surface malignancy. Cytoreduction removes all or the majority of the cancer that has spread to the peritoneal surfaces of the abdomen. The long and complicated surgery is best performed by a surgical oncologist who specializes in these types of surgery. It is followed by HIPEC, a newer treatment, which involves giving chemotherapy solutions directly into the abdomen while the patient is still in the operating room. The chemotherapy solution is heated to a temperature higher than normal body temperature. When the chemotherapy is heated, it is thought to be more effective in killing cancer cells. Saint Joseph's Hospital is a 500-plus bed tertiary care teaching institution. One of the largest rural referral medical centers and one of only three Children's Hospitals in Wisconsin, it provides health care, including all major medical and surgical specialties and subspecialties, to an ever increasing service area in Wisconsin and Upper Michigan.. Saint Joseph's Hospital, a member of Ministry Health Care, was founded nearly 120 years ago by the Sisters of the Sorrowful Mother. Its Mission is to continually improve the health and well being of all people, especially the poor, in the communities it serves. The Marshfield Clinic system provides patient care, research and education with more than 40 locations in northern, central and western Wisconsin, making it one of the largest comprehensive medical systems in the United States. ]]> Treatments for Rare and Complex Cancers http://www.or-live.com/STJoseph/2509 Diagnosis of cancer of the liver or pancreas as well as other invasive cancers of the abdomen can be devastating. At Saint Joseph's Hospital and Marshfield Clinic Marshfield WI – options for treatment and palliation of disease are available that give patients hope and improved quality of life. The Cancer Center in Marshfield has capabilities that offer patients treatment options for any cancer diagnosis. Two surgeries/procedures for treatment of these rare and complex cancers will be featured on the 10th webcast sponsored by Saint Joseph's Hospital and Marshfield Clinic. The webcast will air from 5-6 p.m. Wednesday, March 25. Procedures featured are (1) Chemoembolization; and (2) Cytoreductive Surgery and Hyperperthermic Intraperitoneal Chemotherapy (HIPEC). During the webcast, Marshfield Clinic physicians on staff at Saint Joseph's Hospital will discuss the surgeries. The program will feature the pre-taped procedures, and a real-time panel discussion and analysis. Moderator will be William Hocking, MD, hematologist/oncologist. Others serving on the panel will be Kristin Gerndt, MD, interventional radiologist; Sanjoy Saha, MD, FACS, surgical oncologist, and Seth Fagbemi, MD, hematologist/medical oncologist. Chemoembolization, a minimally invasive treatment for liver cancer or metastasis to the liver, involves giving chemotherapy drugs directly into the vessels that supply blood to the liver tumors. It involves a small needle puncture in the patient's femoral artery at the groin and inserting a catheter into a branch of the liver artery. It is not a cure for the cancer, but it can extend and preserve the quality of a patient's life, with minimal side effects. The combination of Cytoreductive Surgery and Hyperperthermic Intraperitoneal Chemotherapy (HIPEC) is a newer modality of treatment for peritoneal surface malignancy. Cytoreduction removes all or the majority of the cancer that has spread to the peritoneal surfaces of the abdomen. The long and complicated surgery is best performed by a surgical oncologist who specializes in these types of surgery. It is followed by HIPEC, a newer treatment, which involves giving chemotherapy solutions directly into the abdomen while the patient is still in the operating room. The chemotherapy solution is heated to a temperature higher than normal body temperature. When the chemotherapy is heated, it is thought to be more effective in killing cancer cells. Saint Joseph's Hospital is a 500-plus bed tertiary care teaching institution. One of the largest rural referral medical centers and one of only three Children's Hospitals in Wisconsin, it provides health care, including all major medical and surgical specialties and subspecialties, to an ever increasing service area in Wisconsin and Upper Michigan.. Saint Joseph's Hospital, a member of Ministry Health Care, was founded nearly 120 years ago by the Sisters of the Sorrowful Mother. Its Mission is to continually improve the health and well being of all people, especially the poor, in the communities it serves. The Marshfield Clinic system provides patient care, research and education with more than 40 locations in northern, central and western Wisconsin, making it one of the largest comprehensive medical systems in the United States. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. seh_2584 http://www.or-live.com/sentara/2584 http://www.or-live.com/sentara/2584 Experienced surgeons show you the laparoscopic procedure for removing a kidney from a healthy donor to transplant into a person suffering from kidney disease. Email your questions to the OR for a live response from the experts. Over 1,700 kidney transplants have been performed at Sentara Norfolk General Hospital where the kidney program is ranked among the top 50 hospitals in the nation by the US News and World Report. ]]> Living Donor Kidney Transplant Surgery http://www.or-live.com/sentara/2584 Experienced surgeons show you the laparoscopic procedure for removing a kidney from a healthy donor to transplant into a person suffering from kidney disease. Email your questions to the OR for a live response from the experts. Over 1,700 kidney transplants have been performed at Sentara Norfolk General Hospital where the kidney program is ranked among the top 50 hospitals in the nation by the US News and World Report. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. meh_2261 http://www.or-live.com/MercyHospital/2261 http://www.or-live.com/MercyHospital/2261 On March 17th at 5pm EDT, Dr. Carlos Lavernia, renowned orthopaedic surgeon and Dr. J. Pieter Hommen, team physician for Miami FC, will perform live over the internet, two surgeries side by side; a small incision total knee replacement and knee arthroscopy. The procedures will be performed at Mercy Hospital in Miami, FL. View the live webcast and experience first-hand the use of new technologies and techniques used to perform less invasive, life-enhancing knee surgeries. Don't be sidelined from your injury, know your options. ]]> Knee Pain and the Weekend Warriors http://www.or-live.com/MercyHospital/2261 On March 17th at 5pm EDT, Dr. Carlos Lavernia, renowned orthopaedic surgeon and Dr. J. Pieter Hommen, team physician for Miami FC, will perform live over the internet, two surgeries side by side; a small incision total knee replacement and knee arthroscopy. The procedures will be performed at Mercy Hospital in Miami, FL. View the live webcast and experience first-hand the use of new technologies and techniques used to perform less invasive, life-enhancing knee surgeries. Don't be sidelined from your injury, know your options. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. meh_2703 http://www.or-live.com/MercyHospital/2703 http://www.or-live.com/MercyHospital/2703 El 17 de marzo a las 5pm EDT el Dr. Carlos Lavernia, reconocido cirujano ortopédico, y el Dr. J. Pieter Hommen, médico integrante del equipo de Miami FC, van a efectuar en vivo a través del Internet, dos cirugías simultáneamente; artroscopia de la rodilla y reemplazo total de rodilla con una incisión pequeña. Los procedimientos se van a efectuar en el Mercy Hospital en Miami, FL. Participe de esta transmisión en vivo a través del Internet y aproveche la oportunidad de presenciar el uso de nuevas tecnologías y técnicas menos invasivas para cirugías de la rodilla que ayudan a mejorar la calidad de vida del paciente. No permita que sus lesiones lo dejen sentado, investigue sus opciones. ]]> El Dolor de Rodilla y los Guerreros del Fin de Semana: http://www.or-live.com/MercyHospital/2703 El 17 de marzo a las 5pm EDT el Dr. Carlos Lavernia, reconocido cirujano ortopédico, y el Dr. J. Pieter Hommen, médico integrante del equipo de Miami FC, van a efectuar en vivo a través del Internet, dos cirugías simultáneamente; artroscopia de la rodilla y reemplazo total de rodilla con una incisión pequeña. Los procedimientos se van a efectuar en el Mercy Hospital en Miami, FL. Participe de esta transmisión en vivo a través del Internet y aproveche la oportunidad de presenciar el uso de nuevas tecnologías y técnicas menos invasivas para cirugías de la rodilla que ayudan a mejorar la calidad de vida del paciente. No permita que sus lesiones lo dejen sentado, investigue sus opciones. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. zim_2463 http://www.or-live.com/zimmer/2463/ http://www.or-live.com/zimmer/2463/ Zimmer, a manufacturer of orthopaedic prosthetics, will air an ORLive webcast on March 12th at 7:00pm featuring the new Zimmer® M/L Taper Hip Prosthesis with Kinectiv Technology. Dr. John Maltry Of Tucson Orthopaedics Institute performs the procedure with moderating assistance from Dr. Audrey Tsao. This webcast will train surgeons on the safe and effective use of the M/L Kinectiv stem. Restoring leg length, joint stability, and range of motion involve distinct and separate surgical challenges. The Zimmer M/L Taper Hip Prosthesis with Kinectiv Technology introduces a system of modular stem and neck components designed to help the surgeon restore the hip joint center intraoperatively by addressing leg length, offset, and version independently. "This system offers the neck variability needed for straight, anteverted and retroverted measurements as well as offset options," says Dr. John Maltry. This also allows surgeons to independently adjust leg length and offset intraoperatively. "You can place stem position within the femoral canal and then independently adjust your Varus, Valgus and offset positions," adds Dr. Tsao. Viewers will be able to participate in a live email forum during the webcast. Dr. Maltry will answer pertinent questions about the procedure. ]]> M/L Taper Hip Prosthesis with Kinectiv™ Technology http://www.or-live.com/zimmer/2463/ Zimmer, a manufacturer of orthopaedic prosthetics, will air an ORLive webcast on March 12th at 7:00pm featuring the new Zimmer® M/L Taper Hip Prosthesis with Kinectiv Technology. Dr. John Maltry Of Tucson Orthopaedics Institute performs the procedure with moderating assistance from Dr. Audrey Tsao. This webcast will train surgeons on the safe and effective use of the M/L Kinectiv stem. Restoring leg length, joint stability, and range of motion involve distinct and separate surgical challenges. The Zimmer M/L Taper Hip Prosthesis with Kinectiv Technology introduces a system of modular stem and neck components designed to help the surgeon restore the hip joint center intraoperatively by addressing leg length, offset, and version independently. "This system offers the neck variability needed for straight, anteverted and retroverted measurements as well as offset options," says Dr. John Maltry. This also allows surgeons to independently adjust leg length and offset intraoperatively. "You can place stem position within the femoral canal and then independently adjust your Varus, Valgus and offset positions," adds Dr. Tsao. Viewers will be able to participate in a live email forum during the webcast. Dr. Maltry will answer pertinent questions about the procedure. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. cov_2457 http://www.or-live.com/covidien/2457 http://www.or-live.com/covidien/2457 On Wednesday March 11, Prof. Ellis Downes and Prof. Rudy De Wilde, will present case reports, including follow-up through second look laparoscopies, and will demonstrate the use of the SprayShield™ Adhesion Barrier. During the program, participants can send questions via e-mail, and they will be answered during the broadcast. This program features SprayShield™ Adhesion Barrier System. It is intended for audiences outside the United States where SprayShield™ has CE Mark approval, and is indicated for patients undergoing laparotomy or laparoscopic abdominopelvic surgery as an adjunct to good surgical technique intended to reduce the incidence, severity, and extent of postsurgical adhesions. ]]> Preventing Adhesions in Gynaecologic Surgery http://www.or-live.com/covidien/2457 On Wednesday March 11, Prof. Ellis Downes and Prof. Rudy De Wilde, will present case reports, including follow-up through second look laparoscopies, and will demonstrate the use of the SprayShield™ Adhesion Barrier. During the program, participants can send questions via e-mail, and they will be answered during the broadcast. This program features SprayShield™ Adhesion Barrier System. It is intended for audiences outside the United States where SprayShield™ has CE Mark approval, and is indicated for patients undergoing laparotomy or laparoscopic abdominopelvic surgery as an adjunct to good surgical technique intended to reduce the incidence, severity, and extent of postsurgical adhesions. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. cov_2457 http://www.or-live.com/covidien/2457 http://www.or-live.com/covidien/2457 On Wednesday March 11, Prof. Ellis Downes and Prof. Rudy De Wilde, will present case reports, including follow-up through second look laparoscopies, and will demonstrate the use of the SprayShield™ Adhesion Barrier. During the program, participants can send questions via e-mail, and they will be answered during the broadcast. This program features SprayShield™ Adhesion Barrier System. It is intended for audiences outside the United States where SprayShield™ has CE Mark approval, and is indicated for patients undergoing laparotomy or laparoscopic abdominopelvic surgery as an adjunct to good surgical technique intended to reduce the incidence, severity, and extent of postsurgical adhesions. ]]> Preventing Adhesions in Gynaecologic Surgery http://www.or-live.com/covidien/2457 On Wednesday March 11, Prof. Ellis Downes and Prof. Rudy De Wilde, will present case reports, including follow-up through second look laparoscopies, and will demonstrate the use of the SprayShield™ Adhesion Barrier. During the program, participants can send questions via e-mail, and they will be answered during the broadcast. This program features SprayShield™ Adhesion Barrier System. It is intended for audiences outside the United States where SprayShield™ has CE Mark approval, and is indicated for patients undergoing laparotomy or laparoscopic abdominopelvic surgery as an adjunct to good surgical technique intended to reduce the incidence, severity, and extent of postsurgical adhesions. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. cov_2457 http://www.or-live.com/covidien/2457 http://www.or-live.com/covidien/2457 On Wednesday March 11, Prof. Ellis Downes and Prof. Rudy De Wilde, will present case reports, including follow-up through second look laparoscopies, and will demonstrate the use of the SprayShield™ Adhesion Barrier. During the program, participants can send questions via e-mail, and they will be answered during the broadcast. This program features SprayShield™ Adhesion Barrier System. It is intended for audiences outside the United States where SprayShield™ has CE Mark approval, and is indicated for patients undergoing laparotomy or laparoscopic abdominopelvic surgery as an adjunct to good surgical technique intended to reduce the incidence, severity, and extent of postsurgical adhesions. ]]> Preventing Adhesions in Gynaecologic Surgery http://www.or-live.com/covidien/2457 On Wednesday March 11, Prof. Ellis Downes and Prof. Rudy De Wilde, will present case reports, including follow-up through second look laparoscopies, and will demonstrate the use of the SprayShield™ Adhesion Barrier. During the program, participants can send questions via e-mail, and they will be answered during the broadcast. This program features SprayShield™ Adhesion Barrier System. It is intended for audiences outside the United States where SprayShield™ has CE Mark approval, and is indicated for patients undergoing laparotomy or laparoscopic abdominopelvic surgery as an adjunct to good surgical technique intended to reduce the incidence, severity, and extent of postsurgical adhesions. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. cov_2457 http://www.or-live.com/covidien/2457 http://www.or-live.com/covidien/2457 On Wednesday March 11, Prof. Ellis Downes and Prof. Rudy De Wilde, will present case reports, including follow-up through second look laparoscopies, and will demonstrate the use of the SprayShield™ Adhesion Barrier. During the program, participants can send questions via e-mail, and they will be answered during the broadcast. This program features SprayShield™ Adhesion Barrier System. It is intended for audiences outside the United States where SprayShield™ has CE Mark approval, and is indicated for patients undergoing laparotomy or laparoscopic abdominopelvic surgery as an adjunct to good surgical technique intended to reduce the incidence, severity, and extent of postsurgical adhesions. ]]> Preventing Adhesions in Gynaecologic Surgery http://www.or-live.com/covidien/2457 On Wednesday March 11, Prof. Ellis Downes and Prof. Rudy De Wilde, will present case reports, including follow-up through second look laparoscopies, and will demonstrate the use of the SprayShield™ Adhesion Barrier. During the program, participants can send questions via e-mail, and they will be answered during the broadcast. This program features SprayShield™ Adhesion Barrier System. It is intended for audiences outside the United States where SprayShield™ has CE Mark approval, and is indicated for patients undergoing laparotomy or laparoscopic abdominopelvic surgery as an adjunct to good surgical technique intended to reduce the incidence, severity, and extent of postsurgical adhesions. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. bio_2521 http://www.or-live.com/Biomet/2521 http://www.or-live.com/Biomet/2521 Uniting the research power of Massachusetts General Hospital with Biomet's polyethylene expertise, E-Poly™ Antioxidant Infused Technology is unlike any other bearing surface currently available for joint replacement. With the addition of vitamin E, a natural antioxidant, E-Poly™ bearings avoid the limitations of remelted and annealed polyethylenes, providing high mechanical strength and preventing oxidative degradation of the polyethylene.1 Reference 1. Data on file at Biomet. Bench test results not necessarily indicative of clinical performance. All trademarks herein are the property of Biomet, Inc. or its subsidiaries unless otherwise indicated. ]]> E-volve. http://www.or-live.com/Biomet/2521 Uniting the research power of Massachusetts General Hospital with Biomet's polyethylene expertise, E-Poly™ Antioxidant Infused Technology is unlike any other bearing surface currently available for joint replacement. With the addition of vitamin E, a natural antioxidant, E-Poly™ bearings avoid the limitations of remelted and annealed polyethylenes, providing high mechanical strength and preventing oxidative degradation of the polyethylene.1 Reference 1. Data on file at Biomet. Bench test results not necessarily indicative of clinical performance. All trademarks herein are the property of Biomet, Inc. or its subsidiaries unless otherwise indicated. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. zim_2464 http://www.or-live.com/zimmer/2464/ http://www.or-live.com/zimmer/2464/ Zimmer, a manufacturer of orthopaedic prosthetics, will air an OR-Live webcast on March 5th at 7:00pm featuring the NexGen® LPS-Flex Mobile Bearing Knee. This new device provides an anteriorly positioned pivot near the entry point of the anterior cruciate ligament (ACL), replicating the anatomic center of rotation. This leads to lower patellofemoral forces that cause anterior knee pain, patellar subluxation and dislocation. Dr. John Maltry of the Tucson Orthopedics Institute will perform the procedure with moderating assistance from Dr. Todd Sekundiak of the Creighton University Medical Center. "The extended posterior flange of this device safely accommodates tibiofemoral contact of flexion up to 155°," says Dr. Maltry. As an extra feature, viewers are encouraged to participate in a live email forum with Dr. Maltry. He will answer pertinent questions concerning the procedure during the webcast. ]]> NexGen® LPS-Flex Mobile and LPS-Mobile Bearing Knees http://www.or-live.com/zimmer/2464/ Zimmer, a manufacturer of orthopaedic prosthetics, will air an OR-Live webcast on March 5th at 7:00pm featuring the NexGen® LPS-Flex Mobile Bearing Knee. This new device provides an anteriorly positioned pivot near the entry point of the anterior cruciate ligament (ACL), replicating the anatomic center of rotation. This leads to lower patellofemoral forces that cause anterior knee pain, patellar subluxation and dislocation. Dr. John Maltry of the Tucson Orthopedics Institute will perform the procedure with moderating assistance from Dr. Todd Sekundiak of the Creighton University Medical Center. "The extended posterior flange of this device safely accommodates tibiofemoral contact of flexion up to 155°," says Dr. Maltry. As an extra feature, viewers are encouraged to participate in a live email forum with Dr. Maltry. He will answer pertinent questions concerning the procedure during the webcast. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. hrs_2425 http://www.or-live.com/RealityEP/2425/ http://www.or-live.com/RealityEP/2425/ OBJECTIVES: Through this presentation, the participant will learn to: 1) Use the surface ECG to identify potential sites of VT origin, and plan optimal mapping strategies prior to the procedure 2) understand the differences between, and limitations of, both transvenous and percutaneous transpericardial approaches to epicardial mapping of outflow tract VT 3) Use 3-D echo to construct anatomic mapping templates, and guide ablation of outflow tract VT CASE HISTORY: The patient is a 37 year old woman with frequent PVCs noted on routine examination several months ago. She complained of progressive generalized fatigue and an irregular pulse. She had no history of dizziness, syncope or sustained palpitations. A 24 hour Holter demonstrated frequent uniform PVCs comprising 23% of all QRS complexes. A 12 lead electrocardiogram documented a LBBB - right inferior axis QRS configuration with a broad R wave in V1 and V2 most compatible with an origin in the left ventricular outflow tract or pulmonary artery. An echocardiogram demonstrated global left ventricular hypokinesis with an ejection fraction of 40%. A coronary angiogram performed one month ago was unremarkable. Treatment with beta blockers resulted in no change in symptoms, ventricular function, or the frequency of ectopic beats. She was considered to have a possible tachycardia mediated myopathy, and was referred for catheter ablation. The case will demonstrate the use of 3-D ultrasound, coronary venous mapping, and possible percutaneous epicardial mapping in determining the site of origin of the ectopic beats, and in guiding ablation. ]]> Reality EP: Role of 3-D ICE and Epicardial Mapping http://www.or-live.com/RealityEP/2425/ OBJECTIVES: Through this presentation, the participant will learn to: 1) Use the surface ECG to identify potential sites of VT origin, and plan optimal mapping strategies prior to the procedure 2) understand the differences between, and limitations of, both transvenous and percutaneous transpericardial approaches to epicardial mapping of outflow tract VT 3) Use 3-D echo to construct anatomic mapping templates, and guide ablation of outflow tract VT CASE HISTORY: The patient is a 37 year old woman with frequent PVCs noted on routine examination several months ago. She complained of progressive generalized fatigue and an irregular pulse. She had no history of dizziness, syncope or sustained palpitations. A 24 hour Holter demonstrated frequent uniform PVCs comprising 23% of all QRS complexes. A 12 lead electrocardiogram documented a LBBB - right inferior axis QRS configuration with a broad R wave in V1 and V2 most compatible with an origin in the left ventricular outflow tract or pulmonary artery. An echocardiogram demonstrated global left ventricular hypokinesis with an ejection fraction of 40%. A coronary angiogram performed one month ago was unremarkable. Treatment with beta blockers resulted in no change in symptoms, ventricular function, or the frequency of ectopic beats. She was considered to have a possible tachycardia mediated myopathy, and was referred for catheter ablation. The case will demonstrate the use of 3-D ultrasound, coronary venous mapping, and possible percutaneous epicardial mapping in determining the site of origin of the ectopic beats, and in guiding ablation. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. uho_2419 http://www.or-live.com/RainbowBabies/2419 http://www.or-live.com/RainbowBabies/2419 Cleveland - On Tuesday, February 24th, watch a Sequential Bilateral Cochlear Implant performed from University Hospitals Case Medical Center Rainbow Babies and Children's Hospital. A cochlear implant is an electronic device that helps provide a sense of sound to children and adults who are deaf or severely hard-of-hearing. Cliff Megerian, MD, The Richard and Patricia Pogue Chair in Auditory Surgery and Hearing Sciences at University Hospitals Case Medical Center will perform the procedure and provide a detailed narration. Audiologist Gail Murray PhD., Clinical Director of the Cochlear Implant Program, will supply additional commentary. The physicians will be available during the webcast to answer any email questions from viewers. ]]> Sequential Bilateral Cochlear Implant http://www.or-live.com/RainbowBabies/2419 Cleveland - On Tuesday, February 24th, watch a Sequential Bilateral Cochlear Implant performed from University Hospitals Case Medical Center Rainbow Babies and Children's Hospital. A cochlear implant is an electronic device that helps provide a sense of sound to children and adults who are deaf or severely hard-of-hearing. Cliff Megerian, MD, The Richard and Patricia Pogue Chair in Auditory Surgery and Hearing Sciences at University Hospitals Case Medical Center will perform the procedure and provide a detailed narration. Audiologist Gail Murray PhD., Clinical Director of the Cochlear Implant Program, will supply additional commentary. The physicians will be available during the webcast to answer any email questions from viewers. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. chp_2445 http://www.or-live.com/bethisrael/2445 http://www.or-live.com/bethisrael/2445 New York City - There are numerous causes for male infertility, such as varicoceles, hormonal dysfunction, physical trauma, obstructions, diseases (sexually transmitted diseases, cancer, anemia) and side effects from certain drugs. Varicoceles are the most common cause of male infertility. Varicoceles are abnormal and/or enlarged veins that surround the testicles, and are similar to varicose veins in the leg. Normally the blood drains from the testicle upwards into the abdominal cavity. When patients have varicoceles, the blood does not drain normally and flows back towards the testicles, keeping them at a higher than normal temperature. Varicoceles are present in nearly 15% of all men, and up to 40% of men visiting infertility clinics. However, varicoceles do not always lead to fertility problems, nor do all require treatment. Varicoceles are primarily diagnosed by a physical exam or by ultrasound, and may be treated surgically, laparoscopically or percutaneously (venographic embolization). Harris M. Nagler, MD, Chairman of the Sol and Margaret Berger Department of Urology at Beth Israel Medical Center in New York City, and Professor of Urology, Albert Einstein College of Medicine, will be performing today's surgery to correct a varicocele condition. Dr. Nagler is a nationally renowned expert on male infertility, with vast experience diagnosing and treating varicocele conditions, utilizing a microscopic surgical technique which results in high success rates with minimal complications. Dr. Nagler is also well known for his high level of expertise in restoring fertility with vasectomy reversal. Dr. Nagler is on the board of the Society for the Study of Male Reproduction, is President-elect of the New York Section of the American Urological Association and has been routinely named as one of New York Magazine's Best Doctors. To arrange a consultation with Dr. Harris M. Nagler for male infertility or for varicocele surgery at Beth Israel Medical Center in New York City, please call (212) 844-8700. To learn about the comprehensive urology services offered at the Berger Department of Urology at Beth Israel, visit our website at www.biurology.com. ]]> Varicocele Surgery http://www.or-live.com/bethisrael/2445 New York City - There are numerous causes for male infertility, such as varicoceles, hormonal dysfunction, physical trauma, obstructions, diseases (sexually transmitted diseases, cancer, anemia) and side effects from certain drugs. Varicoceles are the most common cause of male infertility. Varicoceles are abnormal and/or enlarged veins that surround the testicles, and are similar to varicose veins in the leg. Normally the blood drains from the testicle upwards into the abdominal cavity. When patients have varicoceles, the blood does not drain normally and flows back towards the testicles, keeping them at a higher than normal temperature. Varicoceles are present in nearly 15% of all men, and up to 40% of men visiting infertility clinics. However, varicoceles do not always lead to fertility problems, nor do all require treatment. Varicoceles are primarily diagnosed by a physical exam or by ultrasound, and may be treated surgically, laparoscopically or percutaneously (venographic embolization). Harris M. Nagler, MD, Chairman of the Sol and Margaret Berger Department of Urology at Beth Israel Medical Center in New York City, and Professor of Urology, Albert Einstein College of Medicine, will be performing today's surgery to correct a varicocele condition. Dr. Nagler is a nationally renowned expert on male infertility, with vast experience diagnosing and treating varicocele conditions, utilizing a microscopic surgical technique which results in high success rates with minimal complications. Dr. Nagler is also well known for his high level of expertise in restoring fertility with vasectomy reversal. Dr. Nagler is on the board of the Society for the Study of Male Reproduction, is President-elect of the New York Section of the American Urological Association and has been routinely named as one of New York Magazine's Best Doctors. To arrange a consultation with Dr. Harris M. Nagler for male infertility or for varicocele surgery at Beth Israel Medical Center in New York City, please call (212) 844-8700. To learn about the comprehensive urology services offered at the Berger Department of Urology at Beth Israel, visit our website at www.biurology.com. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. hal_2300 http://www.or-live.com/HalifaxHealth/2300 http://www.or-live.com/HalifaxHealth/2300 Halifax Health will present a live panel discussion of an Automatic Implantable Cardiac Defibrillator case on Thursday, February 19, at 7:00 pm. A majority of the 200,000 – 400,000 people that die suddenly in the United States each year do so as a result of heart rhythm abnormalities known as ventricular tachycardia and ventricular fibrillation. An implantable cardioverter-defibrillator (ICD) is a battery-powered device that significantly improves the chances of survival in people at high risk for these arrhythmias. Modern ICDs are sophisticated devices that are able to perform three general functions: treatment of dangerous ventricular arrhythmias, record the heart's activity in the device memory, and standard pacemaker functions. Hanscy Seide, MD, who performed the procedure will be joined by Donald Stoner, MD, Chief Medical Officer at Halifax Health Medical Center. Dr. Seide, who is with Cardiology Consultants in Daytona Beach, has implanted more than 350 defibrillators during the past three years. Halifax Health Medical Center is the first and only medical center in Central Florida to be certified by The Joint Commission as a Center of Excellence in Acute Myocardial Infarction care and has been named one of the Top 100 Cardiac Hospitals in the country. "Halifax Health continues to lead the way in patient outcomes and clinical procedures," said Dr. Stoner. "This effort is just another way that we are able to showcase our modern technology and medical talent to our community." ]]> Automatic Implantable Cardiac Defibrillator http://www.or-live.com/HalifaxHealth/2300 Halifax Health will present a live panel discussion of an Automatic Implantable Cardiac Defibrillator case on Thursday, February 19, at 7:00 pm. A majority of the 200,000 – 400,000 people that die suddenly in the United States each year do so as a result of heart rhythm abnormalities known as ventricular tachycardia and ventricular fibrillation. An implantable cardioverter-defibrillator (ICD) is a battery-powered device that significantly improves the chances of survival in people at high risk for these arrhythmias. Modern ICDs are sophisticated devices that are able to perform three general functions: treatment of dangerous ventricular arrhythmias, record the heart's activity in the device memory, and standard pacemaker functions. Hanscy Seide, MD, who performed the procedure will be joined by Donald Stoner, MD, Chief Medical Officer at Halifax Health Medical Center. Dr. Seide, who is with Cardiology Consultants in Daytona Beach, has implanted more than 350 defibrillators during the past three years. Halifax Health Medical Center is the first and only medical center in Central Florida to be certified by The Joint Commission as a Center of Excellence in Acute Myocardial Infarction care and has been named one of the Top 100 Cardiac Hospitals in the country. "Halifax Health continues to lead the way in patient outcomes and clinical procedures," said Dr. Stoner. "This effort is just another way that we are able to showcase our modern technology and medical talent to our community." surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. chp_2444 http://www.or-live.com/bethisrael/2444 http://www.or-live.com/bethisrael/2444 New York City - Among the men who have chosen a vasectomy procedure for family planning purposes, some, for any number of reasons, have later decided to attempt to restore their fertility with a vasectomy reversal. Vasectomy reversal is often successful, but is a very delicate and technically demanding microsurgical procedure that requires special surgical skill. Harris M. Nagler, MD, Chairman of the Sol and Margaret Berger Department of Urology at Beth Israel Medical Center in New York City, and Professor of Urology, Albert Einstein College of Medicine, will be performing the vasectomy reversal procedure. Dr. Nagler is a nationally renowned expert in vasectomy reversal and male infertility, with vast experience performing vasectomy reversal and also in the surgical correction of varicoceles, a common cause of male infertility. Dr. Nagler is on the board of the Society for the Study of Male Reproduction, is President-elect of the New York Section of the American Urological Association and has been routinely named as one of New York Magazine's Best Doctors. Vasectomy reversal, or vasovasostomy, is an outpatient (no overnight stay) microsurgical procedure that will reconnect the tubes (vas deferens) that carry sperm from the testicles. The vas deferens is a very small structure (about the width of spaghetti). The surgical microscope and the hands of a skilled surgeon allow for a successful reconnection and restoration of fertility. To arrange a consultation with Dr. Harris M. Nagler for vasectomy reversal at Beth Israel Medical Center in New York City, please call (212) 844-8700. To learn about the comprehensive urology services offered at the Berger Department of Urology at Beth Israel, visit our website at www.biurology.com. ]]> Vasectomy Reversal http://www.or-live.com/bethisrael/2444 New York City - Among the men who have chosen a vasectomy procedure for family planning purposes, some, for any number of reasons, have later decided to attempt to restore their fertility with a vasectomy reversal. Vasectomy reversal is often successful, but is a very delicate and technically demanding microsurgical procedure that requires special surgical skill. Harris M. Nagler, MD, Chairman of the Sol and Margaret Berger Department of Urology at Beth Israel Medical Center in New York City, and Professor of Urology, Albert Einstein College of Medicine, will be performing the vasectomy reversal procedure. Dr. Nagler is a nationally renowned expert in vasectomy reversal and male infertility, with vast experience performing vasectomy reversal and also in the surgical correction of varicoceles, a common cause of male infertility. Dr. Nagler is on the board of the Society for the Study of Male Reproduction, is President-elect of the New York Section of the American Urological Association and has been routinely named as one of New York Magazine's Best Doctors. Vasectomy reversal, or vasovasostomy, is an outpatient (no overnight stay) microsurgical procedure that will reconnect the tubes (vas deferens) that carry sperm from the testicles. The vas deferens is a very small structure (about the width of spaghetti). The surgical microscope and the hands of a skilled surgeon allow for a successful reconnection and restoration of fertility. To arrange a consultation with Dr. Harris M. Nagler for vasectomy reversal at Beth Israel Medical Center in New York City, please call (212) 844-8700. To learn about the comprehensive urology services offered at the Berger Department of Urology at Beth Israel, visit our website at www.biurology.com. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. shm_2224 http://www.or-live.com/shawneemission/2224 http://www.or-live.com/shawneemission/2224 On Wednesday, February 18, surgeons at Shawnee Mission Medical Center will perform an angioplasty stent placement during a live webcast. Jhulan Mukharji, MD, FACC, will perform the procedure aimed at treating patients who are candidates for a heart attack. Jay Jackson, MD, will also provide additional commentary. Viewers are invited to e-mail questions to the doctors during the procedure. ]]> Coronary Angioplasty Stent Placement http://www.or-live.com/shawneemission/2224 On Wednesday, February 18, surgeons at Shawnee Mission Medical Center will perform an angioplasty stent placement during a live webcast. Jhulan Mukharji, MD, FACC, will perform the procedure aimed at treating patients who are candidates for a heart attack. Jay Jackson, MD, will also provide additional commentary. Viewers are invited to e-mail questions to the doctors during the procedure. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. pin_2547 http://www.or-live.com/PinnacleHealth/2547/ http://www.or-live.com/PinnacleHealth/2547/ On Wednesday, February 18 at 7:00pm EST PinnacleHealth will present an OR-Live webcast of an Anterior Cervical Discectomy. Dr. William Beutler, a neurosurgeon at PinnacleHealth will perform the procedure while Dr. Walter Peppelman will moderate. "With this new technology, we're able to put in an artificial disc that allows natural motion. In other words, I try and replicate the disc that I just took out. Unlike the older fusion technique, this usually inhibits degeneration of adjacent discs." During the program, viewers will have the opportunity to participate in a live question and answer forum with Drs. Beutler and Peppelman. ]]> Artificial Cervical Disc Replacement Improves Mobility http://www.or-live.com/PinnacleHealth/2547/ On Wednesday, February 18 at 7:00pm EST PinnacleHealth will present an OR-Live webcast of an Anterior Cervical Discectomy. Dr. William Beutler, a neurosurgeon at PinnacleHealth will perform the procedure while Dr. Walter Peppelman will moderate. "With this new technology, we're able to put in an artificial disc that allows natural motion. In other words, I try and replicate the disc that I just took out. Unlike the older fusion technique, this usually inhibits degeneration of adjacent discs." During the program, viewers will have the opportunity to participate in a live question and answer forum with Drs. Beutler and Peppelman. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. shm_2226 http://www.or-live.com/shawneemission/2226 http://www.or-live.com/shawneemission/2226 On Tuesday, February 17, see how transesophageal echocardiogram, or TEE is used to detect blood clots, masses and tumors inside the heart during a live webcast from Shawnee Mission Medical Center. Jeffrey W. Bissing, DO, will perform the procedure and will be joined by moderator William S. Ritter, MD, FACC. Transesophageal echocardiograms offer a clearer image of the rear structures of the heart than a standard echo used outside the chest. Viewers are invited to e-mail questions to the doctors during procedure. ]]> Transesophageal Echocardiogram (TEE) http://www.or-live.com/shawneemission/2226 On Tuesday, February 17, see how transesophageal echocardiogram, or TEE is used to detect blood clots, masses and tumors inside the heart during a live webcast from Shawnee Mission Medical Center. Jeffrey W. Bissing, DO, will perform the procedure and will be joined by moderator William S. Ritter, MD, FACC. Transesophageal echocardiograms offer a clearer image of the rear structures of the heart than a standard echo used outside the chest. Viewers are invited to e-mail questions to the doctors during procedure. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. nep_2553 http://www.or-live.com/NYP/2553 http://www.or-live.com/NYP/2553 The typical treatment for the life-threatening condition of hydrocephalus has been revolutionized with advanced minimally invasive endoscopic approaches. Standard practice for children or adults with "water on the brain" or hydrocephalus, has been to insert a shunt, a tube-like structure from inside the brain to the abdominal compartment. These devices, although very effective, are known to carry a substantial life-long risk from problems including infection and blockage. With the development of small caliber endoscopes, minimally invasive techniques are now possible in the brain. One procedure that has gained wide spread appeal replaces the need for placing shunts in patients with hydrocephalus. This minimally invasive procedure, called endoscopic third ventriculostomy (ETV), involves making a small 3-4 mm communication between the third ventricle and the subarachnoid space. The procedure can be done is as little as 15 minutes through a small incision behind the hairline. The majority of patients stay in the hospital for only 1 night. Because there is no implanted device there is no risk of shunt infection or mechanical malfunction. In the ensuing OR Live segment a young child with hydrocephalus is treated with ETV. You will meet the child and his family, listen to a detailed discussion regarding the treatment and how ETV compares with shunting, hear about the potential risks of ETV, and learn which patients are candidates for this exciting and newest available treatment for hydrocephalus. Additionally, you will actually witness this minimally invasive surgery as an observer in the operating room and through the lens of the endoscope within the brain. ]]> Minimally Invasive Treatment of Hydrocephalus http://www.or-live.com/NYP/2553 The typical treatment for the life-threatening condition of hydrocephalus has been revolutionized with advanced minimally invasive endoscopic approaches. Standard practice for children or adults with "water on the brain" or hydrocephalus, has been to insert a shunt, a tube-like structure from inside the brain to the abdominal compartment. These devices, although very effective, are known to carry a substantial life-long risk from problems including infection and blockage. With the development of small caliber endoscopes, minimally invasive techniques are now possible in the brain. One procedure that has gained wide spread appeal replaces the need for placing shunts in patients with hydrocephalus. This minimally invasive procedure, called endoscopic third ventriculostomy (ETV), involves making a small 3-4 mm communication between the third ventricle and the subarachnoid space. The procedure can be done is as little as 15 minutes through a small incision behind the hairline. The majority of patients stay in the hospital for only 1 night. Because there is no implanted device there is no risk of shunt infection or mechanical malfunction. In the ensuing OR Live segment a young child with hydrocephalus is treated with ETV. You will meet the child and his family, listen to a detailed discussion regarding the treatment and how ETV compares with shunting, hear about the potential risks of ETV, and learn which patients are candidates for this exciting and newest available treatment for hydrocephalus. Additionally, you will actually witness this minimally invasive surgery as an observer in the operating room and through the lens of the endoscope within the brain. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. ola_2471 http://www.or-live.com/ololrmc/2471 http://www.or-live.com/ololrmc/2471 Baton Rouge, LA – See how physicians at Our Lady of the Lake Regional Medical Center are using a minimally invasive procedure to treat atrial fibrillation, an abnormal heart rhythm also known as an arrhythmia. Kenneth Civello, MD, who performed the procedure will be joined by Andrew Smith, MD, for a live interactive discussion featuring case footage. Viewers are invited to send the physicians e-mail questions during the one hour program. ]]> Atrial Fibrillation Ablation http://www.or-live.com/ololrmc/2471 Baton Rouge, LA – See how physicians at Our Lady of the Lake Regional Medical Center are using a minimally invasive procedure to treat atrial fibrillation, an abnormal heart rhythm also known as an arrhythmia. Kenneth Civello, MD, who performed the procedure will be joined by Andrew Smith, MD, for a live interactive discussion featuring case footage. Viewers are invited to send the physicians e-mail questions during the one hour program. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. geh_2046 http://www.or-live.com/genesishealth/2046 http://www.or-live.com/genesishealth/2046 The live panel webcast will include Surgeon Matthew Christophersen, M.D., FACS, Medical Director of the Genesis Center for Bariatric Surgery and a partner in the Davenport Surgical Group, and Teresa Fraker, Nurse Manager of the Genesis Center for Bariatric Surgery. ]]> Genesis to Webcast Sleeve Gastrectomy Weight-Loss Surgery http://www.or-live.com/genesishealth/2046 The live panel webcast will include Surgeon Matthew Christophersen, M.D., FACS, Medical Director of the Genesis Center for Bariatric Surgery and a partner in the Davenport Surgical Group, and Teresa Fraker, Nurse Manager of the Genesis Center for Bariatric Surgery. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. bah_2390 http://www.or-live.com/BaptistHealth/2390 http://www.or-live.com/BaptistHealth/2390 Watch Baptist Hospital neurosurgeon Sergio Gonzalez-Arias, M.D., perform a minimally invasive lumbar discectomy. The procedure, to correct a herniated disc in the lower back, involves delicate instrumentation that allows the surgeon to operate through a small incision, spreading muscles rather than cutting them. Compared to open surgical procedures, minimally invasive spine surgery has many advantages, including less blood loss, less pain, smaller incisions and a faster recovery. Most patients can go home the day of surgery. ]]> Minimally Invasive Lumbar Discectomy http://www.or-live.com/BaptistHealth/2390 Watch Baptist Hospital neurosurgeon Sergio Gonzalez-Arias, M.D., perform a minimally invasive lumbar discectomy. The procedure, to correct a herniated disc in the lower back, involves delicate instrumentation that allows the surgeon to operate through a small incision, spreading muscles rather than cutting them. Compared to open surgical procedures, minimally invasive spine surgery has many advantages, including less blood loss, less pain, smaller incisions and a faster recovery. Most patients can go home the day of surgery. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. chh_2494 http://www.or-live.com/childrenshospitalboston/2494 http://www.or-live.com/childrenshospitalboston/2494 BOSTON, Massachusetts–On Wednesday, January 28, 2009 at 4 p.m. EST, during a LIVE Webcast, specialists at Children's Hospital Boston will show excerpts from a surgical procedure performed to repair frontal encephalocele (protruding brain tissue through an opening in the skull which also causes elongation of the orbits and forehead) and a life-threatening arachnoid cyst in a young patient who traveled to Children's from Haiti. Diagnosis and surgical treatment of the arachnoid cyst; removal of the encephalocele to expose the opening in the skull; and reconstruction of the elongated forehead bones, orbital areas and nose will be discussed, as well as lifelong management for patients with this anomaly. Additionally, David Walton, MD, a physician with Partners in Health, will share his perspective on the medical care required by a child with encephalocele, and the journey that this family had to take to bring the child from a developing nation to Children's, where he received world-class care. John Meara, MD, DMD, MBA, plastic surgeon-in-chief at Children's Hospital Boston and associate professor at Harvard Medical School will discuss this patient's diagnosis and treatment for encephalocele during the January Webcast. He will be joined by Edward Smith, MD, assistant in Neurosurgery at Children's Hospital Boston and assistant professor at Harvard Medical School, who will comment on diagnosis and treatment of the arachnoid cyst. This 60-minute Webcast is part of Children's ongoing effort to bring advanced care and technology to specialists and referring physicians around the world, and to educate patients and families about the latest and most innovative medical treatments available. About encephalocele Encephalocele is a rare defect, characterized by sac-like protrusions of the meninges (membranes that cover the brain) through openings in the skull. Encephalocele can present in various locations on a patients head – either as a groove down the middle of the skull, between the forehead and nose or on the back side of the skull. Severity varies depending on its location. Although the exact cause is unknown, encephalocele is the result of the neural tube in the brain failing to close completely during fetal development and occurs rarely, at a rate of one per 5,000 live births worldwide. Ethnic, genetic and environmental factors, as well as parental age, can all influence the likelihood of encephalocele, which can also occur in families with a history of spina bifida. If surgical treatment is successful, and developmental delays have not occurred, a patient will likely develop normally. In cases where neurologic and developmental damage has occurred, specialists will focus on minimizing both mental and physical disabilities. Dr. Meara will narrate the reparative surgery performed on the 11-month-old patient. After the removal of the protruding brain tissue, Dr. Meara reconstructed the elongated forehead bones, orbital areas and created support for a new nose. About arachnoid cysts Arachnoid cysts are fluid collections within the space around the brain that are thought to be made during the development of the child before birth. They are sacs of normal spinal fluid, contained by a thin membrane called the "arachnoid" (like a spider web). These arachnoid cysts are very common, with the majority being found incidentally, such as in this patient's case. Most of these cysts do not need any treatment whatsoever and have no effect on the normal development of the brain. However, a small number of arachnoid cysts, like the one found in this patient's neurological exam, are large enough to put excessive pressure on the surrounding brain and require surgical treatment. Dr. Smith will narrate the craniotomy, opening holes in the "bubble" of the cyst (fenestration) and the creation of a drainage path. Children with arachnoid cysts who require treatment often do quite well. Hospital stays are usually short, ranging from overnight to a few days. Children's Department of Plastic Surgery is one of the largest of its kind in the country. In addition to formal training in plastic surgery, the team's eight surgeons have had specialized training in various sub-specialty areas of plastic surgery, including cleft and craniofacial surgery, hand and microsurgery, oral and maxillofacial surgery, orthopedics and otolaryngology. Additionally, the plastic surgery team works hand in hand with numerous other departments on multi-disciplinary treatment teams to care for patients with complex congenital anomalies. To learn more about the Department of Plastic Surgery at Children's Hospital Boston, visit: childrenshospital.org/plastic. Children's Hospital Boston is home to the world's largest research enterprise based at a pediatric medical center, where its discoveries have benefited both children and adults since 1869. More than 500 scientists, including nine members of the National Academy of Sciences, seven members of the Institute of Medicine and 13 members of the Howard Hughes Medical Institute comprise Children's research community. Founded as a 20-bed hospital for children, Children's Hospital Boston today is a 397-bed comprehensive center for pediatric and adolescent health care grounded in the values of excellence in patient care and sensitivity to the complex needs and diversity of children and families. Children's also is the primary pediatric teaching affiliate of Harvard Medical School. For more information about the hospital and its research visit: www.childrenshospital.org/newsroom. ]]> Craniofacial Procedure to Treat Encephalocele http://www.or-live.com/childrenshospitalboston/2494 BOSTON, Massachusetts–On Wednesday, January 28, 2009 at 4 p.m. EST, during a LIVE Webcast, specialists at Children's Hospital Boston will show excerpts from a surgical procedure performed to repair frontal encephalocele (protruding brain tissue through an opening in the skull which also causes elongation of the orbits and forehead) and a life-threatening arachnoid cyst in a young patient who traveled to Children's from Haiti. Diagnosis and surgical treatment of the arachnoid cyst; removal of the encephalocele to expose the opening in the skull; and reconstruction of the elongated forehead bones, orbital areas and nose will be discussed, as well as lifelong management for patients with this anomaly. Additionally, David Walton, MD, a physician with Partners in Health, will share his perspective on the medical care required by a child with encephalocele, and the journey that this family had to take to bring the child from a developing nation to Children's, where he received world-class care. John Meara, MD, DMD, MBA, plastic surgeon-in-chief at Children's Hospital Boston and associate professor at Harvard Medical School will discuss this patient's diagnosis and treatment for encephalocele during the January Webcast. He will be joined by Edward Smith, MD, assistant in Neurosurgery at Children's Hospital Boston and assistant professor at Harvard Medical School, who will comment on diagnosis and treatment of the arachnoid cyst. This 60-minute Webcast is part of Children's ongoing effort to bring advanced care and technology to specialists and referring physicians around the world, and to educate patients and families about the latest and most innovative medical treatments available. About encephalocele Encephalocele is a rare defect, characterized by sac-like protrusions of the meninges (membranes that cover the brain) through openings in the skull. Encephalocele can present in various locations on a patients head – either as a groove down the middle of the skull, between the forehead and nose or on the back side of the skull. Severity varies depending on its location. Although the exact cause is unknown, encephalocele is the result of the neural tube in the brain failing to close completely during fetal development and occurs rarely, at a rate of one per 5,000 live births worldwide. Ethnic, genetic and environmental factors, as well as parental age, can all influence the likelihood of encephalocele, which can also occur in families with a history of spina bifida. If surgical treatment is successful, and developmental delays have not occurred, a patient will likely develop normally. In cases where neurologic and developmental damage has occurred, specialists will focus on minimizing both mental and physical disabilities. Dr. Meara will narrate the reparative surgery performed on the 11-month-old patient. After the removal of the protruding brain tissue, Dr. Meara reconstructed the elongated forehead bones, orbital areas and created support for a new nose. About arachnoid cysts Arachnoid cysts are fluid collections within the space around the brain that are thought to be made during the development of the child before birth. They are sacs of normal spinal fluid, contained by a thin membrane called the "arachnoid" (like a spider web). These arachnoid cysts are very common, with the majority being found incidentally, such as in this patient's case. Most of these cysts do not need any treatment whatsoever and have no effect on the normal development of the brain. However, a small number of arachnoid cysts, like the one found in this patient's neurological exam, are large enough to put excessive pressure on the surrounding brain and require surgical treatment. Dr. Smith will narrate the craniotomy, opening holes in the "bubble" of the cyst (fenestration) and the creation of a drainage path. Children with arachnoid cysts who require treatment often do quite well. Hospital stays are usually short, ranging from overnight to a few days. Children's Department of Plastic Surgery is one of the largest of its kind in the country. In addition to formal training in plastic surgery, the team's eight surgeons have had specialized training in various sub-specialty areas of plastic surgery, including cleft and craniofacial surgery, hand and microsurgery, oral and maxillofacial surgery, orthopedics and otolaryngology. Additionally, the plastic surgery team works hand in hand with numerous other departments on multi-disciplinary treatment teams to care for patients with complex congenital anomalies. To learn more about the Department of Plastic Surgery at Children's Hospital Boston, visit: childrenshospital.org/plastic. Children's Hospital Boston is home to the world's largest research enterprise based at a pediatric medical center, where its discoveries have benefited both children and adults since 1869. More than 500 scientists, including nine members of the National Academy of Sciences, seven members of the Institute of Medicine and 13 members of the Howard Hughes Medical Institute comprise Children's research community. Founded as a 20-bed hospital for children, Children's Hospital Boston today is a 397-bed comprehensive center for pediatric and adolescent health care grounded in the values of excellence in patient care and sensitivity to the complex needs and diversity of children and families. Children's also is the primary pediatric teaching affiliate of Harvard Medical School. For more information about the hospital and its research visit: www.childrenshospital.org/newsroom. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. chh_2494 http://www.or-live.com/childrenshospitalboston/2494 http://www.or-live.com/childrenshospitalboston/2494 BOSTON, Massachusetts–On Wednesday, January 28, 2009 at 4 p.m. EST, during a LIVE Webcast, specialists at Children's Hospital Boston will show excerpts from a surgical procedure performed to repair frontal encephalocele (protruding brain tissue through an opening in the skull which also causes elongation of the orbits and forehead) and a life-threatening arachnoid cyst in a young patient who traveled to Children's from Haiti. Diagnosis and surgical treatment of the arachnoid cyst; removal of the encephalocele to expose the opening in the skull; and reconstruction of the elongated forehead bones, orbital areas and nose will be discussed, as well as lifelong management for patients with this anomaly. Additionally, David Walton, MD, a physician with Partners in Health, will share his perspective on the medical care required by a child with encephalocele, and the journey that this family had to take to bring the child from a developing nation to Children's, where he received world-class care. John Meara, MD, DMD, MBA, plastic surgeon-in-chief at Children's Hospital Boston and associate professor at Harvard Medical School will discuss this patient's diagnosis and treatment for encephalocele during the January Webcast. He will be joined by Edward Smith, MD, assistant in Neurosurgery at Children's Hospital Boston and assistant professor at Harvard Medical School, who will comment on diagnosis and treatment of the arachnoid cyst. This 60-minute Webcast is part of Children's ongoing effort to bring advanced care and technology to specialists and referring physicians around the world, and to educate patients and families about the latest and most innovative medical treatments available. About encephalocele Encephalocele is a rare defect, characterized by sac-like protrusions of the meninges (membranes that cover the brain) through openings in the skull. Encephalocele can present in various locations on a patients head – either as a groove down the middle of the skull, between the forehead and nose or on the back side of the skull. Severity varies depending on its location. Although the exact cause is unknown, encephalocele is the result of the neural tube in the brain failing to close completely during fetal development and occurs rarely, at a rate of one per 5,000 live births worldwide. Ethnic, genetic and environmental factors, as well as parental age, can all influence the likelihood of encephalocele, which can also occur in families with a history of spina bifida. If surgical treatment is successful, and developmental delays have not occurred, a patient will likely develop normally. In cases where neurologic and developmental damage has occurred, specialists will focus on minimizing both mental and physical disabilities. Dr. Meara will narrate the reparative surgery performed on the 11-month-old patient. After the removal of the protruding brain tissue, Dr. Meara reconstructed the elongated forehead bones, orbital areas and created support for a new nose. About arachnoid cysts Arachnoid cysts are fluid collections within the space around the brain that are thought to be made during the development of the child before birth. They are sacs of normal spinal fluid, contained by a thin membrane called the "arachnoid" (like a spider web). These arachnoid cysts are very common, with the majority being found incidentally, such as in this patient's case. Most of these cysts do not need any treatment whatsoever and have no effect on the normal development of the brain. However, a small number of arachnoid cysts, like the one found in this patient's neurological exam, are large enough to put excessive pressure on the surrounding brain and require surgical treatment. Dr. Smith will narrate the craniotomy, opening holes in the "bubble" of the cyst (fenestration) and the creation of a drainage path. Children with arachnoid cysts who require treatment often do quite well. Hospital stays are usually short, ranging from overnight to a few days. Children's Department of Plastic Surgery is one of the largest of its kind in the country. In addition to formal training in plastic surgery, the team's eight surgeons have had specialized training in various sub-specialty areas of plastic surgery, including cleft and craniofacial surgery, hand and microsurgery, oral and maxillofacial surgery, orthopedics and otolaryngology. Additionally, the plastic surgery team works hand in hand with numerous other departments on multi-disciplinary treatment teams to care for patients with complex congenital anomalies. To learn more about the Department of Plastic Surgery at Children's Hospital Boston, visit: childrenshospital.org/plastic. Children's Hospital Boston is home to the world's largest research enterprise based at a pediatric medical center, where its discoveries have benefited both children and adults since 1869. More than 500 scientists, including nine members of the National Academy of Sciences, seven members of the Institute of Medicine and 13 members of the Howard Hughes Medical Institute comprise Children's research community. Founded as a 20-bed hospital for children, Children's Hospital Boston today is a 397-bed comprehensive center for pediatric and adolescent health care grounded in the values of excellence in patient care and sensitivity to the complex needs and diversity of children and families. Children's also is the primary pediatric teaching affiliate of Harvard Medical School. For more information about the hospital and its research visit: www.childrenshospital.org/newsroom. ]]> Craniofacial Procedure to Treat Encephalocele http://www.or-live.com/childrenshospitalboston/2494 BOSTON, Massachusetts–On Wednesday, January 28, 2009 at 4 p.m. EST, during a LIVE Webcast, specialists at Children's Hospital Boston will show excerpts from a surgical procedure performed to repair frontal encephalocele (protruding brain tissue through an opening in the skull which also causes elongation of the orbits and forehead) and a life-threatening arachnoid cyst in a young patient who traveled to Children's from Haiti. Diagnosis and surgical treatment of the arachnoid cyst; removal of the encephalocele to expose the opening in the skull; and reconstruction of the elongated forehead bones, orbital areas and nose will be discussed, as well as lifelong management for patients with this anomaly. Additionally, David Walton, MD, a physician with Partners in Health, will share his perspective on the medical care required by a child with encephalocele, and the journey that this family had to take to bring the child from a developing nation to Children's, where he received world-class care. John Meara, MD, DMD, MBA, plastic surgeon-in-chief at Children's Hospital Boston and associate professor at Harvard Medical School will discuss this patient's diagnosis and treatment for encephalocele during the January Webcast. He will be joined by Edward Smith, MD, assistant in Neurosurgery at Children's Hospital Boston and assistant professor at Harvard Medical School, who will comment on diagnosis and treatment of the arachnoid cyst. This 60-minute Webcast is part of Children's ongoing effort to bring advanced care and technology to specialists and referring physicians around the world, and to educate patients and families about the latest and most innovative medical treatments available. About encephalocele Encephalocele is a rare defect, characterized by sac-like protrusions of the meninges (membranes that cover the brain) through openings in the skull. Encephalocele can present in various locations on a patients head – either as a groove down the middle of the skull, between the forehead and nose or on the back side of the skull. Severity varies depending on its location. Although the exact cause is unknown, encephalocele is the result of the neural tube in the brain failing to close completely during fetal development and occurs rarely, at a rate of one per 5,000 live births worldwide. Ethnic, genetic and environmental factors, as well as parental age, can all influence the likelihood of encephalocele, which can also occur in families with a history of spina bifida. If surgical treatment is successful, and developmental delays have not occurred, a patient will likely develop normally. In cases where neurologic and developmental damage has occurred, specialists will focus on minimizing both mental and physical disabilities. Dr. Meara will narrate the reparative surgery performed on the 11-month-old patient. After the removal of the protruding brain tissue, Dr. Meara reconstructed the elongated forehead bones, orbital areas and created support for a new nose. About arachnoid cysts Arachnoid cysts are fluid collections within the space around the brain that are thought to be made during the development of the child before birth. They are sacs of normal spinal fluid, contained by a thin membrane called the "arachnoid" (like a spider web). These arachnoid cysts are very common, with the majority being found incidentally, such as in this patient's case. Most of these cysts do not need any treatment whatsoever and have no effect on the normal development of the brain. However, a small number of arachnoid cysts, like the one found in this patient's neurological exam, are large enough to put excessive pressure on the surrounding brain and require surgical treatment. Dr. Smith will narrate the craniotomy, opening holes in the "bubble" of the cyst (fenestration) and the creation of a drainage path. Children with arachnoid cysts who require treatment often do quite well. Hospital stays are usually short, ranging from overnight to a few days. Children's Department of Plastic Surgery is one of the largest of its kind in the country. In addition to formal training in plastic surgery, the team's eight surgeons have had specialized training in various sub-specialty areas of plastic surgery, including cleft and craniofacial surgery, hand and microsurgery, oral and maxillofacial surgery, orthopedics and otolaryngology. Additionally, the plastic surgery team works hand in hand with numerous other departments on multi-disciplinary treatment teams to care for patients with complex congenital anomalies. To learn more about the Department of Plastic Surgery at Children's Hospital Boston, visit: childrenshospital.org/plastic. Children's Hospital Boston is home to the world's largest research enterprise based at a pediatric medical center, where its discoveries have benefited both children and adults since 1869. More than 500 scientists, including nine members of the National Academy of Sciences, seven members of the Institute of Medicine and 13 members of the Howard Hughes Medical Institute comprise Children's research community. Founded as a 20-bed hospital for children, Children's Hospital Boston today is a 397-bed comprehensive center for pediatric and adolescent health care grounded in the values of excellence in patient care and sensitivity to the complex needs and diversity of children and families. Children's also is the primary pediatric teaching affiliate of Harvard Medical School. For more information about the hospital and its research visit: www.childrenshospital.org/newsroom. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. waf_2384 http://www.or-live.com/WFUBMC/2384 http://www.or-live.com/WFUBMC/2384 WINSTON-SALEM, N.C. – Gastroenterologists from the Hepatobiliary and Pancreatic (HBP) Disorders Service at Wake Forest University Baptist Medical Center will perform Endoscopic Ultrasonography (EUS) and Endoscopic Retrograde Cholangiopancreatography (ERCP) during a single procedure in a live webcast at noon on Tuesday, January 15, 2009. John (Jerry) Evans, M.D. will perform the procedures. The webcast will be moderated by co-hosts John Baillie, M.B., Ch.B, F.R.C.P., F.A.C.G., an internationally recognized expert in the diagnosis and management of HBP disorders, and Girish Mishra, M.D., director of the EUS Service. EUS is used to examine the lining and walls of the upper and lower digestive tracts. ERCP provides access for diagnosing and, increasingly, treating problems involving the bile ducts, gallbladder and pancreas. Many hepatobiliary and pancreatic disorders, including cancers of the digestive system, require one or both of these procedures and Wake Forest Baptist is among a small number of medical centers offering both procedures under a single sedation. EUS allows the physician to determine the extent of the cancer as well as to assess the cancer's depth and whether it has spread to adjacent lymph glands or nearby vital structures such as major blood vessels. The HPB Disorders Service at Wake Forest Baptist is one of the most active in the state, seeing more than 1,000 outpatients a year and performing approximately 800 ERCPs annually. Wake Forest University Baptist Medical Center (www.wfubmc.edu) is an academic health system comprised of North Carolina Baptist Hospital, Brenner Children's Hospital, Wake Forest University Physicians, and Wake Forest University Health Sciences, which operates the university's School of Medicine and Piedmont Triad Research Park. The system comprises 1,154 acute care, rehabilitation and long-term care beds and has been ranked as one of "America's Best Hospitals" by U.S. News and World Report since 1993. Wake Forest Baptist is ranked 32nd in the nation by America's Top Doctors for the number of its doctors considered best by their peers. The institution ranks in the top third in funding by the National Institutes of Health and fourth in the Southeast in revenues from its licensed intellectual property. ]]> Diagnosing and Treating Digestive Tract Disorders http://www.or-live.com/WFUBMC/2384 WINSTON-SALEM, N.C. – Gastroenterologists from the Hepatobiliary and Pancreatic (HBP) Disorders Service at Wake Forest University Baptist Medical Center will perform Endoscopic Ultrasonography (EUS) and Endoscopic Retrograde Cholangiopancreatography (ERCP) during a single procedure in a live webcast at noon on Tuesday, January 15, 2009. John (Jerry) Evans, M.D. will perform the procedures. The webcast will be moderated by co-hosts John Baillie, M.B., Ch.B, F.R.C.P., F.A.C.G., an internationally recognized expert in the diagnosis and management of HBP disorders, and Girish Mishra, M.D., director of the EUS Service. EUS is used to examine the lining and walls of the upper and lower digestive tracts. ERCP provides access for diagnosing and, increasingly, treating problems involving the bile ducts, gallbladder and pancreas. Many hepatobiliary and pancreatic disorders, including cancers of the digestive system, require one or both of these procedures and Wake Forest Baptist is among a small number of medical centers offering both procedures under a single sedation. EUS allows the physician to determine the extent of the cancer as well as to assess the cancer's depth and whether it has spread to adjacent lymph glands or nearby vital structures such as major blood vessels. The HPB Disorders Service at Wake Forest Baptist is one of the most active in the state, seeing more than 1,000 outpatients a year and performing approximately 800 ERCPs annually. Wake Forest University Baptist Medical Center (www.wfubmc.edu) is an academic health system comprised of North Carolina Baptist Hospital, Brenner Children's Hospital, Wake Forest University Physicians, and Wake Forest University Health Sciences, which operates the university's School of Medicine and Piedmont Triad Research Park. The system comprises 1,154 acute care, rehabilitation and long-term care beds and has been ranked as one of "America's Best Hospitals" by U.S. News and World Report since 1993. Wake Forest Baptist is ranked 32nd in the nation by America's Top Doctors for the number of its doctors considered best by their peers. The institution ranks in the top third in funding by the National Institutes of Health and fourth in the Southeast in revenues from its licensed intellectual property. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. ens_2314 http://www.or-live.com/EthiconEndo-Surgery/2314 http://www.or-live.com/EthiconEndo-Surgery/2314 Join surgeons, Drs. Joseph Amaral, Paul Curcillo, Santiago Horgan, and Barry McKernan, for a free one-hour live webcast highlighting minimally invasive techniques and advances in minimally invasive gallbladder surgery.  The doctors will focus on the evolution of techniques from the introduction of laparoscopic cholecystectomy through single port cholecystectomy and NOTES, and the benefits of these techniques to patients.   The Evolution of Lap Chole The live program will be composed of four parts that begin with the introduction of laparoscopic cholecystectomy and early evolution of the procedure. Next will be a discussion of various energy modalities used in minimally invasive surgery followed by an in-depth demonstration of single port access cholecystectomy. Finally the potential future of minimally invasive surgery will follow with a discussion of NOTES (Natural Orifice Transluminal Endoscopic Surgery). The webcast will originate from  the Drexel University College of Medicine in Philadelphia, Pennsylvania.  Audience members may participate in the live program by sending their questions directly to the surgeons.  An archive of the program will be posted following the webcast and can be accessed through this OR-live website. Presenters Joseph F. Amaral, MD (moderator) Professor of Surgery Brown University Providence, Rhode Island Paul G. Curcillo II, MD, FACS Director of Robotics and Minimally Invasive Surgery  Vice Chairman and Associate Professor, Department of Surgery Drexel University College of Medicine. Philadelphia, Pennsylvania Santiago Horgan, MD Professor of Surgery Director of Minimally Invasive Surgery University of California, San Diego Medical Center San Diego, California J. Barry McKernan, MD, PhD, FACS Center for Videoscopic and Laser Surgery Woodstock, Georgia Clinical Professor of Surgery Medical College of Georgia Augusta, Georgia This presentation may include demonstration of the use of surgical devices; it is not intended to be used as a surgical training guide.  Other surgeons may employ different techniques.  Individual surgeon preference and experience, as well as patient needs, should always dictate variation in procedure steps.  Before using any medical device, including those demonstrated or referenced in this presentation, review all packet inserts, with particular attention to the indications, contraindications, warnings and precautions and steps of use of the device.   Before performing any new procedure, including those demonstrated or referenced in this presentation, ensure that adequate training has been obtained.  DSL 08-1226.2 Ethicon Endo-Surgery, Inc. 2008 ]]> 20 Years Later . . . The Evolution of Lap Chole http://www.or-live.com/EthiconEndo-Surgery/2314 Join surgeons, Drs. Joseph Amaral, Paul Curcillo, Santiago Horgan, and Barry McKernan, for a free one-hour live webcast highlighting minimally invasive techniques and advances in minimally invasive gallbladder surgery.  The doctors will focus on the evolution of techniques from the introduction of laparoscopic cholecystectomy through single port cholecystectomy and NOTES, and the benefits of these techniques to patients.   The Evolution of Lap Chole The live program will be composed of four parts that begin with the introduction of laparoscopic cholecystectomy and early evolution of the procedure. Next will be a discussion of various energy modalities used in minimally invasive surgery followed by an in-depth demonstration of single port access cholecystectomy. Finally the potential future of minimally invasive surgery will follow with a discussion of NOTES (Natural Orifice Transluminal Endoscopic Surgery). The webcast will originate from  the Drexel University College of Medicine in Philadelphia, Pennsylvania.  Audience members may participate in the live program by sending their questions directly to the surgeons.  An archive of the program will be posted following the webcast and can be accessed through this OR-live website. Presenters Joseph F. Amaral, MD (moderator) Professor of Surgery Brown University Providence, Rhode Island Paul G. Curcillo II, MD, FACS Director of Robotics and Minimally Invasive Surgery  Vice Chairman and Associate Professor, Department of Surgery Drexel University College of Medicine. Philadelphia, Pennsylvania Santiago Horgan, MD Professor of Surgery Director of Minimally Invasive Surgery University of California, San Diego Medical Center San Diego, California J. Barry McKernan, MD, PhD, FACS Center for Videoscopic and Laser Surgery Woodstock, Georgia Clinical Professor of Surgery Medical College of Georgia Augusta, Georgia This presentation may include demonstration of the use of surgical devices; it is not intended to be used as a surgical training guide.  Other surgeons may employ different techniques.  Individual surgeon preference and experience, as well as patient needs, should always dictate variation in procedure steps.  Before using any medical device, including those demonstrated or referenced in this presentation, review all packet inserts, with particular attention to the indications, contraindications, warnings and precautions and steps of use of the device.   Before performing any new procedure, including those demonstrated or referenced in this presentation, ensure that adequate training has been obtained.  DSL 08-1226.2 Ethicon Endo-Surgery, Inc. 2008 surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. saf_2381 http://www.or-live.com/stfrancis/2381 http://www.or-live.com/stfrancis/2381 The Bariatric Center at Saint Francis Hospital and Medical Center is proud to offer a web cast featuring Laparoscopic Roux-en-Y Gastric Bypass Surgery. Director of Bariatric Surgery, Ioannis Raftopoulos, M.D., Ph.D., performs the surgery with commentary provided by Jeffrey Steinberg, M.D., Chairman of the Department of Surgery at Saint Francis. Laparoscopic Roux-en-Y Gastric Bypass Surgery is the most common weight loss surgery performed in the U.S. today. Using leading-edge technology, Roux-en-Y Gastric Bypass Surgery is now performed with a laparoscopic approach. This involves the use of "key-hole" rather than large incisions, as was traditionally required resulting in a quicker recovery time. At the Bariatric Center at Saint Francis, the laparoscopic approach has been successful in all our gastric bypass patients. Laparoscopic Roux-en-Y Gastric Bypass Surgery helps patients to lose weight through malabsorption, reducing the body's ability to absorb calories and nutrients from food; and through restriction, limiting the amount of food a person can eat. Malabsorption is achieved by rerouting food past a large part of the stomach and a portion of the small intestine. To restrict food intake, a small stomach pouch is created with the use of special stapling devices. According to Dr. Raftopoulos, and based on outcomes at the Bariatric Center at Saint Francis, patients are expected to lose up to 100 percent of their excess weight after Laparoscopic Roux-en-Y Gastric Bypass without weight regain, as long as compliance to medical follow-up, nutritional and lifestyle recommendations is maintained. Laparoscopic Roux-en-Y Gastric Bypass Surgery has also been shown to improve or resolve several other medical conditions such as hypertension, sleep apnea, diabetes, hyperlipidemia, acid reflux disease, urinary stress incontinence, infertility and fatty liver disease. For more information on Laparoscopic Roux-en-Y Gastric Bypass Surgery as well as other weight loss procedures, please visit the website of the Bariatric Center at Saint Francis at www.stfranciscare.com or call 1-800-642-9230. ]]> Laparoscopic Roux-en-Y Gastric Bypass Surgery http://www.or-live.com/stfrancis/2381 The Bariatric Center at Saint Francis Hospital and Medical Center is proud to offer a web cast featuring Laparoscopic Roux-en-Y Gastric Bypass Surgery. Director of Bariatric Surgery, Ioannis Raftopoulos, M.D., Ph.D., performs the surgery with commentary provided by Jeffrey Steinberg, M.D., Chairman of the Department of Surgery at Saint Francis. Laparoscopic Roux-en-Y Gastric Bypass Surgery is the most common weight loss surgery performed in the U.S. today. Using leading-edge technology, Roux-en-Y Gastric Bypass Surgery is now performed with a laparoscopic approach. This involves the use of "key-hole" rather than large incisions, as was traditionally required resulting in a quicker recovery time. At the Bariatric Center at Saint Francis, the laparoscopic approach has been successful in all our gastric bypass patients. Laparoscopic Roux-en-Y Gastric Bypass Surgery helps patients to lose weight through malabsorption, reducing the body's ability to absorb calories and nutrients from food; and through restriction, limiting the amount of food a person can eat. Malabsorption is achieved by rerouting food past a large part of the stomach and a portion of the small intestine. To restrict food intake, a small stomach pouch is created with the use of special stapling devices. According to Dr. Raftopoulos, and based on outcomes at the Bariatric Center at Saint Francis, patients are expected to lose up to 100 percent of their excess weight after Laparoscopic Roux-en-Y Gastric Bypass without weight regain, as long as compliance to medical follow-up, nutritional and lifestyle recommendations is maintained. Laparoscopic Roux-en-Y Gastric Bypass Surgery has also been shown to improve or resolve several other medical conditions such as hypertension, sleep apnea, diabetes, hyperlipidemia, acid reflux disease, urinary stress incontinence, infertility and fatty liver disease. For more information on Laparoscopic Roux-en-Y Gastric Bypass Surgery as well as other weight loss procedures, please visit the website of the Bariatric Center at Saint Francis at www.stfranciscare.com or call 1-800-642-9230. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. saf_2381 http://www.or-live.com/stfrancis/2381 http://www.or-live.com/stfrancis/2381 The Bariatric Center at Saint Francis Hospital and Medical Center is proud to offer a web cast featuring Laparoscopic Roux-en-Y Gastric Bypass Surgery. Director of Bariatric Surgery, Ioannis Raftopoulos, M.D., Ph.D., performs the surgery with commentary provided by Jeffrey Steinberg, M.D., Chairman of the Department of Surgery at Saint Francis. Laparoscopic Roux-en-Y Gastric Bypass Surgery is the most common weight loss surgery performed in the U.S. today. Using leading-edge technology, Roux-en-Y Gastric Bypass Surgery is now performed with a laparoscopic approach. This involves the use of "key-hole" rather than large incisions, as was traditionally required resulting in a quicker recovery time. At the Bariatric Center at Saint Francis, the laparoscopic approach has been successful in all our gastric bypass patients. Laparoscopic Roux-en-Y Gastric Bypass Surgery helps patients to lose weight through malabsorption, reducing the body's ability to absorb calories and nutrients from food; and through restriction, limiting the amount of food a person can eat. Malabsorption is achieved by rerouting food past a large part of the stomach and a portion of the small intestine. To restrict food intake, a small stomach pouch is created with the use of special stapling devices. According to Dr. Raftopoulos, and based on outcomes at the Bariatric Center at Saint Francis, patients are expected to lose up to 100 percent of their excess weight after Laparoscopic Roux-en-Y Gastric Bypass without weight regain, as long as compliance to medical follow-up, nutritional and lifestyle recommendations is maintained. Laparoscopic Roux-en-Y Gastric Bypass Surgery has also been shown to improve or resolve several other medical conditions such as hypertension, sleep apnea, diabetes, hyperlipidemia, acid reflux disease, urinary stress incontinence, infertility and fatty liver disease. For more information on Laparoscopic Roux-en-Y Gastric Bypass Surgery as well as other weight loss procedures, please visit the website of the Bariatric Center at Saint Francis at www.stfranciscare.com or call 1-800-642-9230. ]]> Laparoscopic Roux-en-Y Gastric Bypass Surgery http://www.or-live.com/stfrancis/2381 The Bariatric Center at Saint Francis Hospital and Medical Center is proud to offer a web cast featuring Laparoscopic Roux-en-Y Gastric Bypass Surgery. Director of Bariatric Surgery, Ioannis Raftopoulos, M.D., Ph.D., performs the surgery with commentary provided by Jeffrey Steinberg, M.D., Chairman of the Department of Surgery at Saint Francis. Laparoscopic Roux-en-Y Gastric Bypass Surgery is the most common weight loss surgery performed in the U.S. today. Using leading-edge technology, Roux-en-Y Gastric Bypass Surgery is now performed with a laparoscopic approach. This involves the use of "key-hole" rather than large incisions, as was traditionally required resulting in a quicker recovery time. At the Bariatric Center at Saint Francis, the laparoscopic approach has been successful in all our gastric bypass patients. Laparoscopic Roux-en-Y Gastric Bypass Surgery helps patients to lose weight through malabsorption, reducing the body's ability to absorb calories and nutrients from food; and through restriction, limiting the amount of food a person can eat. Malabsorption is achieved by rerouting food past a large part of the stomach and a portion of the small intestine. To restrict food intake, a small stomach pouch is created with the use of special stapling devices. According to Dr. Raftopoulos, and based on outcomes at the Bariatric Center at Saint Francis, patients are expected to lose up to 100 percent of their excess weight after Laparoscopic Roux-en-Y Gastric Bypass without weight regain, as long as compliance to medical follow-up, nutritional and lifestyle recommendations is maintained. Laparoscopic Roux-en-Y Gastric Bypass Surgery has also been shown to improve or resolve several other medical conditions such as hypertension, sleep apnea, diabetes, hyperlipidemia, acid reflux disease, urinary stress incontinence, infertility and fatty liver disease. For more information on Laparoscopic Roux-en-Y Gastric Bypass Surgery as well as other weight loss procedures, please visit the website of the Bariatric Center at Saint Francis at www.stfranciscare.com or call 1-800-642-9230. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. crd_2488 http://www.or-live.com/Cardica/2488 http://www.or-live.com/Cardica/2488 REDWOOD CITY, Calif. – September 23, 2008 -- Cardica, Inc. (Nasdaq: CRDC) today announced the webcast of a robot-assisted, closed-chest coronary artery bypass graft (CABG) procedure performed by internationally-renowned cardiothoracic surgeon Sudhir Srivastava, M.D., of the University of Chicago Medical Center, using Cardica's C-Port® Flex-A® Anastomosis System. Husam H. Balkhy, M.D., chairman of the Department of Cardiac and Vascular Surgery and head of the robotics program at The Wisconsin Heart Hospital, moderates the procedure and explains critical aspects of the surgery. During the procedure, Dr. Srivastava used Intuitive Surgical's da Vinci® Surgical System robot in combination with Cardica's C-Port® Flex-A® system, an automated device that deploys tiny, stainless steel staples to attach the bypass vessel graft to the coronary artery, a connection known as an anastomosis. By automating the attachment of blood vessel grafts, the C-Port® Flex-A® system replaces traditional hand-sewn sutures. The robotic CABG procedure was performed off-pump, meaning while the heart is still beating, without the need to use a heart-lung machine and without the need to create a sternotomy, which splits the breastbone (sternum) to gain access to the heart. Dr. Srivastava performed the surgery on a 79-year-old male patient with 2-vessel coronary artery disease to his left anterior descending and obtuse marginal coronary arteries. Following the surgery, the patient did extremely well and resumed his routine activities within two weeks. "Robotic, closed-chest, off-pump CABG surgery generally provides numerous patient benefits, including quicker surgery, a shorter hospital stay, less scarring, significantly faster recovery and return to everyday activity, and reduced risk of complications," said Dr. Srivastava, director of robotic and minimally-invasive cardiac surgery at The University of Chicago Medical Center. "Because the C-Port® Flex-A® system helps facilitate robotic minimally-invasive cardiac surgery, I expect more cardiac surgeons to adopt minimally-invasive CABG procedures." To date, Dr. Srivastava has completed 34 anastomoses in single and multi-vessel beating heart da Vinci revascularization procedures using the C-Port® Flex-A® system through small incisions in the chest cavity that create finger-size ports. Of 32 grafts studied, all were determined to be patent, or open, based on an analysis of pre-discharge angiography. "I believe the C-Port® Flex-A® system represents a breakthrough in distal anastomosis devices. It facilitates and simplifies robotic CABG procedures, thereby allowing more surgeons to offer patients minimally-invasive cardiac surgery," said Dr. Balkhy. "Because the C-Port® Flex-A® system can be used to create anastomoses on a beating heart, the patient may not need cardiopulmonary bypass or cardioplegic arrest of the heart, which can be associated with adverse outcomes." The C-Port System Advantage Cardica's C-Port systems are designed to enable automated, reliable and reproducible connections of blood vessels during CABG surgery. Unlike most hand-sewn anastomoses, Cardica's C-Port systems enable a compliant anastomosis that can expand and contract with blood-flow. The C-Port® Flex-A® system is designed to deploy staples around the periphery of the anastomosis to help provide leak-proof sealing without the need for additional stitches at either end of the anastomosis. It can be used in either on- or off-pump CABG procedures. The C-Port® Flex-A® system has a flexible, rather than rigid, shaft and is designed to create compliant anastomoses in vessels as small as 1 millimeter in internal diameter. Importantly, the flexible shaft is designed to allow surgeons to position the device to create a secure connection even in difficult to reach areas of the heart. About Intuitive's Products The da Vinci® Surgical System consists of a surgeon's viewing and control console having an integrated, high-performance InSite® 3-D vision system, a patient-side cart consisting of three or four robotic arms that position and precisely maneuver endoscopic instruments and an endoscope, and a variety of articulating EndoWrist® Instruments. By integrating computer-enhanced technology with surgeons' technical skills, Intuitive believes that its system enables surgeons to perform better surgery in a manner never before experienced. The da Vinci® Surgical System seamlessly and directly translates the surgeon's natural hand, wrist and finger movements on instrument controls at the surgeon's console outside the patient's body into corresponding micro-movements of the instrument tips positioned inside the patient through small puncture incisions, or ports. About Cardica, Inc. Cardica is a leading provider of automated anastomosis systems for coronary artery bypass graft (CABG) surgery. By replacing hand-sewn sutures with easy-to-use automated systems, Cardica's products provide cardiovascular surgeons with rapid, reliable and consistently reproducible anastomoses, or connections of blood vessels, often considered the most critical aspect of the CABG procedure. Cardica's C-Port® Distal Anastomosis Systems are marketed in Europe and the United States. The PAS-Port® Proximal Anastomosis System is marketed in Europe and Japan, and Cardica has received 510(k) clearance to market the PAS-Port system in the United States. Cardica also is developing additional devices with Cook Medical to facilitate vascular closure and other surgical procedures. Forward-Looking Statements This press release contains "forward-looking" statements, including statements relating to the impact of the adoption of Cardica's C-Port systems on the future use of closed-chest CABG procedures and potential patient benefits related thereto. Any statements contained in this press release that are not historical facts may be deemed to be forward-looking statements. The words "believe", "may," "expect" and similar expressions are intended to identify forward-looking statements. There are a number of important factors that could cause Cardica's results to differ materially from those indicated by these forward-looking statements, including risks associated with market acceptance of Cardica's C-Port systems and long-term patency of CABG grafts completed with Cardica's C-Port systems, as well as other risks detailed from time to time in Cardica's SEC reports, including its Annual Report on Form 10-K for the year ended June 30, 2008. Cardica expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein. You are encouraged to read the company's reports filed with the U.S. Securities and Exchange Commission, available at www.sec.gov. ]]> CARDICA C-PORT® ANASTOMOSIS SYSTEMS http://www.or-live.com/Cardica/2488 REDWOOD CITY, Calif. – September 23, 2008 -- Cardica, Inc. (Nasdaq: CRDC) today announced the webcast of a robot-assisted, closed-chest coronary artery bypass graft (CABG) procedure performed by internationally-renowned cardiothoracic surgeon Sudhir Srivastava, M.D., of the University of Chicago Medical Center, using Cardica's C-Port® Flex-A® Anastomosis System. Husam H. Balkhy, M.D., chairman of the Department of Cardiac and Vascular Surgery and head of the robotics program at The Wisconsin Heart Hospital, moderates the procedure and explains critical aspects of the surgery. During the procedure, Dr. Srivastava used Intuitive Surgical's da Vinci® Surgical System robot in combination with Cardica's C-Port® Flex-A® system, an automated device that deploys tiny, stainless steel staples to attach the bypass vessel graft to the coronary artery, a connection known as an anastomosis. By automating the attachment of blood vessel grafts, the C-Port® Flex-A® system replaces traditional hand-sewn sutures. The robotic CABG procedure was performed off-pump, meaning while the heart is still beating, without the need to use a heart-lung machine and without the need to create a sternotomy, which splits the breastbone (sternum) to gain access to the heart. Dr. Srivastava performed the surgery on a 79-year-old male patient with 2-vessel coronary artery disease to his left anterior descending and obtuse marginal coronary arteries. Following the surgery, the patient did extremely well and resumed his routine activities within two weeks. "Robotic, closed-chest, off-pump CABG surgery generally provides numerous patient benefits, including quicker surgery, a shorter hospital stay, less scarring, significantly faster recovery and return to everyday activity, and reduced risk of complications," said Dr. Srivastava, director of robotic and minimally-invasive cardiac surgery at The University of Chicago Medical Center. "Because the C-Port® Flex-A® system helps facilitate robotic minimally-invasive cardiac surgery, I expect more cardiac surgeons to adopt minimally-invasive CABG procedures." To date, Dr. Srivastava has completed 34 anastomoses in single and multi-vessel beating heart da Vinci revascularization procedures using the C-Port® Flex-A® system through small incisions in the chest cavity that create finger-size ports. Of 32 grafts studied, all were determined to be patent, or open, based on an analysis of pre-discharge angiography. "I believe the C-Port® Flex-A® system represents a breakthrough in distal anastomosis devices. It facilitates and simplifies robotic CABG procedures, thereby allowing more surgeons to offer patients minimally-invasive cardiac surgery," said Dr. Balkhy. "Because the C-Port® Flex-A® system can be used to create anastomoses on a beating heart, the patient may not need cardiopulmonary bypass or cardioplegic arrest of the heart, which can be associated with adverse outcomes." The C-Port System Advantage Cardica's C-Port systems are designed to enable automated, reliable and reproducible connections of blood vessels during CABG surgery. Unlike most hand-sewn anastomoses, Cardica's C-Port systems enable a compliant anastomosis that can expand and contract with blood-flow. The C-Port® Flex-A® system is designed to deploy staples around the periphery of the anastomosis to help provide leak-proof sealing without the need for additional stitches at either end of the anastomosis. It can be used in either on- or off-pump CABG procedures. The C-Port® Flex-A® system has a flexible, rather than rigid, shaft and is designed to create compliant anastomoses in vessels as small as 1 millimeter in internal diameter. Importantly, the flexible shaft is designed to allow surgeons to position the device to create a secure connection even in difficult to reach areas of the heart. About Intuitive's Products The da Vinci® Surgical System consists of a surgeon's viewing and control console having an integrated, high-performance InSite® 3-D vision system, a patient-side cart consisting of three or four robotic arms that position and precisely maneuver endoscopic instruments and an endoscope, and a variety of articulating EndoWrist® Instruments. By integrating computer-enhanced technology with surgeons' technical skills, Intuitive believes that its system enables surgeons to perform better surgery in a manner never before experienced. The da Vinci® Surgical System seamlessly and directly translates the surgeon's natural hand, wrist and finger movements on instrument controls at the surgeon's console outside the patient's body into corresponding micro-movements of the instrument tips positioned inside the patient through small puncture incisions, or ports. About Cardica, Inc. Cardica is a leading provider of automated anastomosis systems for coronary artery bypass graft (CABG) surgery. By replacing hand-sewn sutures with easy-to-use automated systems, Cardica's products provide cardiovascular surgeons with rapid, reliable and consistently reproducible anastomoses, or connections of blood vessels, often considered the most critical aspect of the CABG procedure. Cardica's C-Port® Distal Anastomosis Systems are marketed in Europe and the United States. The PAS-Port® Proximal Anastomosis System is marketed in Europe and Japan, and Cardica has received 510(k) clearance to market the PAS-Port system in the United States. Cardica also is developing additional devices with Cook Medical to facilitate vascular closure and other surgical procedures. Forward-Looking Statements This press release contains "forward-looking" statements, including statements relating to the impact of the adoption of Cardica's C-Port systems on the future use of closed-chest CABG procedures and potential patient benefits related thereto. Any statements contained in this press release that are not historical facts may be deemed to be forward-looking statements. The words "believe", "may," "expect" and similar expressions are intended to identify forward-looking statements. There are a number of important factors that could cause Cardica's results to differ materially from those indicated by these forward-looking statements, including risks associated with market acceptance of Cardica's C-Port systems and long-term patency of CABG grafts completed with Cardica's C-Port systems, as well as other risks detailed from time to time in Cardica's SEC reports, including its Annual Report on Form 10-K for the year ended June 30, 2008. Cardica expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein. You are encouraged to read the company's reports filed with the U.S. Securities and Exchange Commission, available at www.sec.gov. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. crd_2488 http://www.or-live.com/Cardica/2488 http://www.or-live.com/Cardica/2488 REDWOOD CITY, Calif. – September 23, 2008 -- Cardica, Inc. (Nasdaq: CRDC) today announced the webcast of a robot-assisted, closed-chest coronary artery bypass graft (CABG) procedure performed by internationally-renowned cardiothoracic surgeon Sudhir Srivastava, M.D., of the University of Chicago Medical Center, using Cardica's C-Port® Flex-A® Anastomosis System. Husam H. Balkhy, M.D., chairman of the Department of Cardiac and Vascular Surgery and head of the robotics program at The Wisconsin Heart Hospital, moderates the procedure and explains critical aspects of the surgery. During the procedure, Dr. Srivastava used Intuitive Surgical's da Vinci® Surgical System robot in combination with Cardica's C-Port® Flex-A® system, an automated device that deploys tiny, stainless steel staples to attach the bypass vessel graft to the coronary artery, a connection known as an anastomosis. By automating the attachment of blood vessel grafts, the C-Port® Flex-A® system replaces traditional hand-sewn sutures. The robotic CABG procedure was performed off-pump, meaning while the heart is still beating, without the need to use a heart-lung machine and without the need to create a sternotomy, which splits the breastbone (sternum) to gain access to the heart. Dr. Srivastava performed the surgery on a 79-year-old male patient with 2-vessel coronary artery disease to his left anterior descending and obtuse marginal coronary arteries. Following the surgery, the patient did extremely well and resumed his routine activities within two weeks. "Robotic, closed-chest, off-pump CABG surgery generally provides numerous patient benefits, including quicker surgery, a shorter hospital stay, less scarring, significantly faster recovery and return to everyday activity, and reduced risk of complications," said Dr. Srivastava, director of robotic and minimally-invasive cardiac surgery at The University of Chicago Medical Center. "Because the C-Port® Flex-A® system helps facilitate robotic minimally-invasive cardiac surgery, I expect more cardiac surgeons to adopt minimally-invasive CABG procedures." To date, Dr. Srivastava has completed 34 anastomoses in single and multi-vessel beating heart da Vinci revascularization procedures using the C-Port® Flex-A® system through small incisions in the chest cavity that create finger-size ports. Of 32 grafts studied, all were determined to be patent, or open, based on an analysis of pre-discharge angiography. "I believe the C-Port® Flex-A® system represents a breakthrough in distal anastomosis devices. It facilitates and simplifies robotic CABG procedures, thereby allowing more surgeons to offer patients minimally-invasive cardiac surgery," said Dr. Balkhy. "Because the C-Port® Flex-A® system can be used to create anastomoses on a beating heart, the patient may not need cardiopulmonary bypass or cardioplegic arrest of the heart, which can be associated with adverse outcomes." The C-Port System Advantage Cardica's C-Port systems are designed to enable automated, reliable and reproducible connections of blood vessels during CABG surgery. Unlike most hand-sewn anastomoses, Cardica's C-Port systems enable a compliant anastomosis that can expand and contract with blood-flow. The C-Port® Flex-A® system is designed to deploy staples around the periphery of the anastomosis to help provide leak-proof sealing without the need for additional stitches at either end of the anastomosis. It can be used in either on- or off-pump CABG procedures. The C-Port® Flex-A® system has a flexible, rather than rigid, shaft and is designed to create compliant anastomoses in vessels as small as 1 millimeter in internal diameter. Importantly, the flexible shaft is designed to allow surgeons to position the device to create a secure connection even in difficult to reach areas of the heart. About Intuitive's Products The da Vinci® Surgical System consists of a surgeon's viewing and control console having an integrated, high-performance InSite® 3-D vision system, a patient-side cart consisting of three or four robotic arms that position and precisely maneuver endoscopic instruments and an endoscope, and a variety of articulating EndoWrist® Instruments. By integrating computer-enhanced technology with surgeons' technical skills, Intuitive believes that its system enables surgeons to perform better surgery in a manner never before experienced. The da Vinci® Surgical System seamlessly and directly translates the surgeon's natural hand, wrist and finger movements on instrument controls at the surgeon's console outside the patient's body into corresponding micro-movements of the instrument tips positioned inside the patient through small puncture incisions, or ports. About Cardica, Inc. Cardica is a leading provider of automated anastomosis systems for coronary artery bypass graft (CABG) surgery. By replacing hand-sewn sutures with easy-to-use automated systems, Cardica's products provide cardiovascular surgeons with rapid, reliable and consistently reproducible anastomoses, or connections of blood vessels, often considered the most critical aspect of the CABG procedure. Cardica's C-Port® Distal Anastomosis Systems are marketed in Europe and the United States. The PAS-Port® Proximal Anastomosis System is marketed in Europe and Japan, and Cardica has received 510(k) clearance to market the PAS-Port system in the United States. Cardica also is developing additional devices with Cook Medical to facilitate vascular closure and other surgical procedures. Forward-Looking Statements This press release contains "forward-looking" statements, including statements relating to the impact of the adoption of Cardica's C-Port systems on the future use of closed-chest CABG procedures and potential patient benefits related thereto. Any statements contained in this press release that are not historical facts may be deemed to be forward-looking statements. The words "believe", "may," "expect" and similar expressions are intended to identify forward-looking statements. There are a number of important factors that could cause Cardica's results to differ materially from those indicated by these forward-looking statements, including risks associated with market acceptance of Cardica's C-Port systems and long-term patency of CABG grafts completed with Cardica's C-Port systems, as well as other risks detailed from time to time in Cardica's SEC reports, including its Annual Report on Form 10-K for the year ended June 30, 2008. Cardica expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein. You are encouraged to read the company's reports filed with the U.S. Securities and Exchange Commission, available at www.sec.gov. ]]> CARDICA C-PORT® ANASTOMOSIS SYSTEMS http://www.or-live.com/Cardica/2488 REDWOOD CITY, Calif. – September 23, 2008 -- Cardica, Inc. (Nasdaq: CRDC) today announced the webcast of a robot-assisted, closed-chest coronary artery bypass graft (CABG) procedure performed by internationally-renowned cardiothoracic surgeon Sudhir Srivastava, M.D., of the University of Chicago Medical Center, using Cardica's C-Port® Flex-A® Anastomosis System. Husam H. Balkhy, M.D., chairman of the Department of Cardiac and Vascular Surgery and head of the robotics program at The Wisconsin Heart Hospital, moderates the procedure and explains critical aspects of the surgery. During the procedure, Dr. Srivastava used Intuitive Surgical's da Vinci® Surgical System robot in combination with Cardica's C-Port® Flex-A® system, an automated device that deploys tiny, stainless steel staples to attach the bypass vessel graft to the coronary artery, a connection known as an anastomosis. By automating the attachment of blood vessel grafts, the C-Port® Flex-A® system replaces traditional hand-sewn sutures. The robotic CABG procedure was performed off-pump, meaning while the heart is still beating, without the need to use a heart-lung machine and without the need to create a sternotomy, which splits the breastbone (sternum) to gain access to the heart. Dr. Srivastava performed the surgery on a 79-year-old male patient with 2-vessel coronary artery disease to his left anterior descending and obtuse marginal coronary arteries. Following the surgery, the patient did extremely well and resumed his routine activities within two weeks. "Robotic, closed-chest, off-pump CABG surgery generally provides numerous patient benefits, including quicker surgery, a shorter hospital stay, less scarring, significantly faster recovery and return to everyday activity, and reduced risk of complications," said Dr. Srivastava, director of robotic and minimally-invasive cardiac surgery at The University of Chicago Medical Center. "Because the C-Port® Flex-A® system helps facilitate robotic minimally-invasive cardiac surgery, I expect more cardiac surgeons to adopt minimally-invasive CABG procedures." To date, Dr. Srivastava has completed 34 anastomoses in single and multi-vessel beating heart da Vinci revascularization procedures using the C-Port® Flex-A® system through small incisions in the chest cavity that create finger-size ports. Of 32 grafts studied, all were determined to be patent, or open, based on an analysis of pre-discharge angiography. "I believe the C-Port® Flex-A® system represents a breakthrough in distal anastomosis devices. It facilitates and simplifies robotic CABG procedures, thereby allowing more surgeons to offer patients minimally-invasive cardiac surgery," said Dr. Balkhy. "Because the C-Port® Flex-A® system can be used to create anastomoses on a beating heart, the patient may not need cardiopulmonary bypass or cardioplegic arrest of the heart, which can be associated with adverse outcomes." The C-Port System Advantage Cardica's C-Port systems are designed to enable automated, reliable and reproducible connections of blood vessels during CABG surgery. Unlike most hand-sewn anastomoses, Cardica's C-Port systems enable a compliant anastomosis that can expand and contract with blood-flow. The C-Port® Flex-A® system is designed to deploy staples around the periphery of the anastomosis to help provide leak-proof sealing without the need for additional stitches at either end of the anastomosis. It can be used in either on- or off-pump CABG procedures. The C-Port® Flex-A® system has a flexible, rather than rigid, shaft and is designed to create compliant anastomoses in vessels as small as 1 millimeter in internal diameter. Importantly, the flexible shaft is designed to allow surgeons to position the device to create a secure connection even in difficult to reach areas of the heart. About Intuitive's Products The da Vinci® Surgical System consists of a surgeon's viewing and control console having an integrated, high-performance InSite® 3-D vision system, a patient-side cart consisting of three or four robotic arms that position and precisely maneuver endoscopic instruments and an endoscope, and a variety of articulating EndoWrist® Instruments. By integrating computer-enhanced technology with surgeons' technical skills, Intuitive believes that its system enables surgeons to perform better surgery in a manner never before experienced. The da Vinci® Surgical System seamlessly and directly translates the surgeon's natural hand, wrist and finger movements on instrument controls at the surgeon's console outside the patient's body into corresponding micro-movements of the instrument tips positioned inside the patient through small puncture incisions, or ports. About Cardica, Inc. Cardica is a leading provider of automated anastomosis systems for coronary artery bypass graft (CABG) surgery. By replacing hand-sewn sutures with easy-to-use automated systems, Cardica's products provide cardiovascular surgeons with rapid, reliable and consistently reproducible anastomoses, or connections of blood vessels, often considered the most critical aspect of the CABG procedure. Cardica's C-Port® Distal Anastomosis Systems are marketed in Europe and the United States. The PAS-Port® Proximal Anastomosis System is marketed in Europe and Japan, and Cardica has received 510(k) clearance to market the PAS-Port system in the United States. Cardica also is developing additional devices with Cook Medical to facilitate vascular closure and other surgical procedures. Forward-Looking Statements This press release contains "forward-looking" statements, including statements relating to the impact of the adoption of Cardica's C-Port systems on the future use of closed-chest CABG procedures and potential patient benefits related thereto. Any statements contained in this press release that are not historical facts may be deemed to be forward-looking statements. The words "believe", "may," "expect" and similar expressions are intended to identify forward-looking statements. There are a number of important factors that could cause Cardica's results to differ materially from those indicated by these forward-looking statements, including risks associated with market acceptance of Cardica's C-Port systems and long-term patency of CABG grafts completed with Cardica's C-Port systems, as well as other risks detailed from time to time in Cardica's SEC reports, including its Annual Report on Form 10-K for the year ended June 30, 2008. Cardica expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein. You are encouraged to read the company's reports filed with the U.S. Securities and Exchange Commission, available at www.sec.gov. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. crd_2488 http://www.or-live.com/Cardica/2488 http://www.or-live.com/Cardica/2488 REDWOOD CITY, Calif. – September 23, 2008 -- Cardica, Inc. (Nasdaq: CRDC) today announced the webcast of a robot-assisted, closed-chest coronary artery bypass graft (CABG) procedure performed by internationally-renowned cardiothoracic surgeon Sudhir Srivastava, M.D., of the University of Chicago Medical Center, using Cardica's C-Port® Flex-A® Anastomosis System. Husam H. Balkhy, M.D., chairman of the Department of Cardiac and Vascular Surgery and head of the robotics program at The Wisconsin Heart Hospital, moderates the procedure and explains critical aspects of the surgery. During the procedure, Dr. Srivastava used Intuitive Surgical's da Vinci® Surgical System robot in combination with Cardica's C-Port® Flex-A® system, an automated device that deploys tiny, stainless steel staples to attach the bypass vessel graft to the coronary artery, a connection known as an anastomosis. By automating the attachment of blood vessel grafts, the C-Port® Flex-A® system replaces traditional hand-sewn sutures. The robotic CABG procedure was performed off-pump, meaning while the heart is still beating, without the need to use a heart-lung machine and without the need to create a sternotomy, which splits the breastbone (sternum) to gain access to the heart. Dr. Srivastava performed the surgery on a 79-year-old male patient with 2-vessel coronary artery disease to his left anterior descending and obtuse marginal coronary arteries. Following the surgery, the patient did extremely well and resumed his routine activities within two weeks. "Robotic, closed-chest, off-pump CABG surgery generally provides numerous patient benefits, including quicker surgery, a shorter hospital stay, less scarring, significantly faster recovery and return to everyday activity, and reduced risk of complications," said Dr. Srivastava, director of robotic and minimally-invasive cardiac surgery at The University of Chicago Medical Center. "Because the C-Port® Flex-A® system helps facilitate robotic minimally-invasive cardiac surgery, I expect more cardiac surgeons to adopt minimally-invasive CABG procedures." To date, Dr. Srivastava has completed 34 anastomoses in single and multi-vessel beating heart da Vinci revascularization procedures using the C-Port® Flex-A® system through small incisions in the chest cavity that create finger-size ports. Of 32 grafts studied, all were determined to be patent, or open, based on an analysis of pre-discharge angiography. "I believe the C-Port® Flex-A® system represents a breakthrough in distal anastomosis devices. It facilitates and simplifies robotic CABG procedures, thereby allowing more surgeons to offer patients minimally-invasive cardiac surgery," said Dr. Balkhy. "Because the C-Port® Flex-A® system can be used to create anastomoses on a beating heart, the patient may not need cardiopulmonary bypass or cardioplegic arrest of the heart, which can be associated with adverse outcomes." The C-Port System Advantage Cardica's C-Port systems are designed to enable automated, reliable and reproducible connections of blood vessels during CABG surgery. Unlike most hand-sewn anastomoses, Cardica's C-Port systems enable a compliant anastomosis that can expand and contract with blood-flow. The C-Port® Flex-A® system is designed to deploy staples around the periphery of the anastomosis to help provide leak-proof sealing without the need for additional stitches at either end of the anastomosis. It can be used in either on- or off-pump CABG procedures. The C-Port® Flex-A® system has a flexible, rather than rigid, shaft and is designed to create compliant anastomoses in vessels as small as 1 millimeter in internal diameter. Importantly, the flexible shaft is designed to allow surgeons to position the device to create a secure connection even in difficult to reach areas of the heart. About Intuitive's Products The da Vinci® Surgical System consists of a surgeon's viewing and control console having an integrated, high-performance InSite® 3-D vision system, a patient-side cart consisting of three or four robotic arms that position and precisely maneuver endoscopic instruments and an endoscope, and a variety of articulating EndoWrist® Instruments. By integrating computer-enhanced technology with surgeons' technical skills, Intuitive believes that its system enables surgeons to perform better surgery in a manner never before experienced. The da Vinci® Surgical System seamlessly and directly translates the surgeon's natural hand, wrist and finger movements on instrument controls at the surgeon's console outside the patient's body into corresponding micro-movements of the instrument tips positioned inside the patient through small puncture incisions, or ports. About Cardica, Inc. Cardica is a leading provider of automated anastomosis systems for coronary artery bypass graft (CABG) surgery. By replacing hand-sewn sutures with easy-to-use automated systems, Cardica's products provide cardiovascular surgeons with rapid, reliable and consistently reproducible anastomoses, or connections of blood vessels, often considered the most critical aspect of the CABG procedure. Cardica's C-Port® Distal Anastomosis Systems are marketed in Europe and the United States. The PAS-Port® Proximal Anastomosis System is marketed in Europe and Japan, and Cardica has received 510(k) clearance to market the PAS-Port system in the United States. Cardica also is developing additional devices with Cook Medical to facilitate vascular closure and other surgical procedures. Forward-Looking Statements This press release contains "forward-looking" statements, including statements relating to the impact of the adoption of Cardica's C-Port systems on the future use of closed-chest CABG procedures and potential patient benefits related thereto. Any statements contained in this press release that are not historical facts may be deemed to be forward-looking statements. The words "believe", "may," "expect" and similar expressions are intended to identify forward-looking statements. There are a number of important factors that could cause Cardica's results to differ materially from those indicated by these forward-looking statements, including risks associated with market acceptance of Cardica's C-Port systems and long-term patency of CABG grafts completed with Cardica's C-Port systems, as well as other risks detailed from time to time in Cardica's SEC reports, including its Annual Report on Form 10-K for the year ended June 30, 2008. Cardica expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein. You are encouraged to read the company's reports filed with the U.S. Securities and Exchange Commission, available at www.sec.gov. ]]> CARDICA C-PORT® ANASTOMOSIS SYSTEMS http://www.or-live.com/Cardica/2488 REDWOOD CITY, Calif. – September 23, 2008 -- Cardica, Inc. (Nasdaq: CRDC) today announced the webcast of a robot-assisted, closed-chest coronary artery bypass graft (CABG) procedure performed by internationally-renowned cardiothoracic surgeon Sudhir Srivastava, M.D., of the University of Chicago Medical Center, using Cardica's C-Port® Flex-A® Anastomosis System. Husam H. Balkhy, M.D., chairman of the Department of Cardiac and Vascular Surgery and head of the robotics program at The Wisconsin Heart Hospital, moderates the procedure and explains critical aspects of the surgery. During the procedure, Dr. Srivastava used Intuitive Surgical's da Vinci® Surgical System robot in combination with Cardica's C-Port® Flex-A® system, an automated device that deploys tiny, stainless steel staples to attach the bypass vessel graft to the coronary artery, a connection known as an anastomosis. By automating the attachment of blood vessel grafts, the C-Port® Flex-A® system replaces traditional hand-sewn sutures. The robotic CABG procedure was performed off-pump, meaning while the heart is still beating, without the need to use a heart-lung machine and without the need to create a sternotomy, which splits the breastbone (sternum) to gain access to the heart. Dr. Srivastava performed the surgery on a 79-year-old male patient with 2-vessel coronary artery disease to his left anterior descending and obtuse marginal coronary arteries. Following the surgery, the patient did extremely well and resumed his routine activities within two weeks. "Robotic, closed-chest, off-pump CABG surgery generally provides numerous patient benefits, including quicker surgery, a shorter hospital stay, less scarring, significantly faster recovery and return to everyday activity, and reduced risk of complications," said Dr. Srivastava, director of robotic and minimally-invasive cardiac surgery at The University of Chicago Medical Center. "Because the C-Port® Flex-A® system helps facilitate robotic minimally-invasive cardiac surgery, I expect more cardiac surgeons to adopt minimally-invasive CABG procedures." To date, Dr. Srivastava has completed 34 anastomoses in single and multi-vessel beating heart da Vinci revascularization procedures using the C-Port® Flex-A® system through small incisions in the chest cavity that create finger-size ports. Of 32 grafts studied, all were determined to be patent, or open, based on an analysis of pre-discharge angiography. "I believe the C-Port® Flex-A® system represents a breakthrough in distal anastomosis devices. It facilitates and simplifies robotic CABG procedures, thereby allowing more surgeons to offer patients minimally-invasive cardiac surgery," said Dr. Balkhy. "Because the C-Port® Flex-A® system can be used to create anastomoses on a beating heart, the patient may not need cardiopulmonary bypass or cardioplegic arrest of the heart, which can be associated with adverse outcomes." The C-Port System Advantage Cardica's C-Port systems are designed to enable automated, reliable and reproducible connections of blood vessels during CABG surgery. Unlike most hand-sewn anastomoses, Cardica's C-Port systems enable a compliant anastomosis that can expand and contract with blood-flow. The C-Port® Flex-A® system is designed to deploy staples around the periphery of the anastomosis to help provide leak-proof sealing without the need for additional stitches at either end of the anastomosis. It can be used in either on- or off-pump CABG procedures. The C-Port® Flex-A® system has a flexible, rather than rigid, shaft and is designed to create compliant anastomoses in vessels as small as 1 millimeter in internal diameter. Importantly, the flexible shaft is designed to allow surgeons to position the device to create a secure connection even in difficult to reach areas of the heart. About Intuitive's Products The da Vinci® Surgical System consists of a surgeon's viewing and control console having an integrated, high-performance InSite® 3-D vision system, a patient-side cart consisting of three or four robotic arms that position and precisely maneuver endoscopic instruments and an endoscope, and a variety of articulating EndoWrist® Instruments. By integrating computer-enhanced technology with surgeons' technical skills, Intuitive believes that its system enables surgeons to perform better surgery in a manner never before experienced. The da Vinci® Surgical System seamlessly and directly translates the surgeon's natural hand, wrist and finger movements on instrument controls at the surgeon's console outside the patient's body into corresponding micro-movements of the instrument tips positioned inside the patient through small puncture incisions, or ports. About Cardica, Inc. Cardica is a leading provider of automated anastomosis systems for coronary artery bypass graft (CABG) surgery. By replacing hand-sewn sutures with easy-to-use automated systems, Cardica's products provide cardiovascular surgeons with rapid, reliable and consistently reproducible anastomoses, or connections of blood vessels, often considered the most critical aspect of the CABG procedure. Cardica's C-Port® Distal Anastomosis Systems are marketed in Europe and the United States. The PAS-Port® Proximal Anastomosis System is marketed in Europe and Japan, and Cardica has received 510(k) clearance to market the PAS-Port system in the United States. Cardica also is developing additional devices with Cook Medical to facilitate vascular closure and other surgical procedures. Forward-Looking Statements This press release contains "forward-looking" statements, including statements relating to the impact of the adoption of Cardica's C-Port systems on the future use of closed-chest CABG procedures and potential patient benefits related thereto. Any statements contained in this press release that are not historical facts may be deemed to be forward-looking statements. The words "believe", "may," "expect" and similar expressions are intended to identify forward-looking statements. There are a number of important factors that could cause Cardica's results to differ materially from those indicated by these forward-looking statements, including risks associated with market acceptance of Cardica's C-Port systems and long-term patency of CABG grafts completed with Cardica's C-Port systems, as well as other risks detailed from time to time in Cardica's SEC reports, including its Annual Report on Form 10-K for the year ended June 30, 2008. Cardica expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein. You are encouraged to read the company's reports filed with the U.S. Securities and Exchange Commission, available at www.sec.gov. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. uno_2152 http://www.or-live.com/unitedhospital/2152 http://www.or-live.com/unitedhospital/2152 Buffalo Hospital will host a live webcast of a Total Knee Replacement surgery on Thursday, December 18th. The broadcast can be viewed at www.buffalohospital.org. Dana Harms, MD, board certified orthopedic surgeon, will perform the surgery and David Labadie, MD, board certified orthopedic surgeon, will provide commentary. An artificial joint, made out of alloy and polyethylene (plastic), replaces the damaged knee. Total knee replacement (TKR) surgery may be necessary when knee conditions cause the cartilage to deteriorate to the point where there are no other options to relieve pain. Osteoarthritis, rheumatoid arthritis and knee joint injury typically create pain that may lead to a TKR. The procedure is very common, with more than 300,000 TKR surgeries being performed every year in the United States. "Patients see their activity level increase quite a bit after a total knee replacement surgery," says Dr. Harms. "The surgery really maximizes knee function by decreasing pain." Generally, a total knee replacement surgery takes about 90 minutes. Patients begin physical therapy the next day and spend about three or four days in the hospital. About Buffalo Hospital Part of Allina Hospitals and Clinics, Buffalo Hospital is a not-for-profit regional medical center committed to providing exceptional care and improving the health of the communities it serves in and around Wright County. Information about Buffalo Hospital's services, along with the latest health information, can be found online at www.buffalohospital.org. ]]> Total Knee Replacement Surgery http://www.or-live.com/unitedhospital/2152 Buffalo Hospital will host a live webcast of a Total Knee Replacement surgery on Thursday, December 18th. The broadcast can be viewed at www.buffalohospital.org. Dana Harms, MD, board certified orthopedic surgeon, will perform the surgery and David Labadie, MD, board certified orthopedic surgeon, will provide commentary. An artificial joint, made out of alloy and polyethylene (plastic), replaces the damaged knee. Total knee replacement (TKR) surgery may be necessary when knee conditions cause the cartilage to deteriorate to the point where there are no other options to relieve pain. Osteoarthritis, rheumatoid arthritis and knee joint injury typically create pain that may lead to a TKR. The procedure is very common, with more than 300,000 TKR surgeries being performed every year in the United States. "Patients see their activity level increase quite a bit after a total knee replacement surgery," says Dr. Harms. "The surgery really maximizes knee function by decreasing pain." Generally, a total knee replacement surgery takes about 90 minutes. Patients begin physical therapy the next day and spend about three or four days in the hospital. About Buffalo Hospital Part of Allina Hospitals and Clinics, Buffalo Hospital is a not-for-profit regional medical center committed to providing exceptional care and improving the health of the communities it serves in and around Wright County. Information about Buffalo Hospital's services, along with the latest health information, can be found online at www.buffalohospital.org. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. uho_2418 http://www.or-live.com/universityhospitals/2418 http://www.or-live.com/universityhospitals/2418 On Thursday, December 18, watch a radiofrequency catheter ablation for treatment of atrial fibrillation. The minimally invasive procedure will be performed by Mauricio Arruda, MD, Director of the Atrial Fibrillation Center, part of the Harrington-McLaughlin Heart and Vascular Institute at University Hospitals Case Medical Center. Additional commentary will be heard from Albert Waldo, MD, Associate Chief, Division of Cardiology at University Hospitals Case Medical Center. Atrial fibrillation, also known as AFib or AF, is the most common heart rhythm disturbance, yet remains one of the most difficult to treat effectively. During the program, viewers are urged to send questions via email, and they will be answered during the broadcast. ]]> Radiofrequency Catheter Ablation http://www.or-live.com/universityhospitals/2418 On Thursday, December 18, watch a radiofrequency catheter ablation for treatment of atrial fibrillation. The minimally invasive procedure will be performed by Mauricio Arruda, MD, Director of the Atrial Fibrillation Center, part of the Harrington-McLaughlin Heart and Vascular Institute at University Hospitals Case Medical Center. Additional commentary will be heard from Albert Waldo, MD, Associate Chief, Division of Cardiology at University Hospitals Case Medical Center. Atrial fibrillation, also known as AFib or AF, is the most common heart rhythm disturbance, yet remains one of the most difficult to treat effectively. During the program, viewers are urged to send questions via email, and they will be answered during the broadcast. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. nep_2107 http://www.or-live.com/NYP/2107 http://www.or-live.com/NYP/2107 Many physicians still conceptualize Left Ventricular Assist Devices (LVADs) as they were back in the early 1990s, unaware of design innovations and broadened indications that can immediately benefit their patients. The developmental lineage of LVADs goes back to early heart-lung bypass machines and experiments in the late 1950s, during which artificial hearts were implanted in dogs. There has been considerable work since then on both total artificial hearts and heart assist devices, and the physicians at NewYork-Presbyterian Hospital have played a major role in the research and development of this technology. LVAD design in particular has made tremendous advances over the last decade, in particular by significantly reducing size. NewYork-Presbyterian Hospital/Columbia University Medical Center has participated in feasibility trials for several years and has been active in the development of the HeartMate II (Thoratec), an LVAD device, designed to provide as much as a decade of circulatory support, which has recently received FDA approval. In addition to improved LVAD design elements, the opportunities for using an LVAD have recently expanded. There are now three presentations for which an LVAD might be used. The original indication was as a ‘bridge to transplant,' representing perhaps 85% of all LVAD procedures in the United States. "This is for patients already in the queue waiting for a heart transplant, but who for reasons of size, blood type, scarcity, etc., need a heart assist device because they are getting worse while they are waiting," explained Jonathan M. Chen, MD, Director of Pediatric Cardiovascular Surgery at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, and Associate Professor of Cardiothoracic Surgery at Weill Cornell Medical College. NewYork-Presbyterian/ Cornell has recently begun its own LVAD program, whose development is being assisted by the considerable LVAD experience at NewYork-Presbyterian/Columbia. Another category of LVAD use, accounting for less than 5% of procedures, is termed ‘bridge to recovery,' of which there are two subcategories. "The first is the acute cardiac failure patient, such as those suffering acute myocardial infarction or myocarditis," explained Yoshifumi Naka, MD, the Director of Cardiac Transplantation and Director of the Mechanical Circulatory Support Programs at both NewYork-Presbyterian Hospital/Columbia University Medical Center and NewYork-Presbyterian Hospital/Weill Cornell Medical Center. "These patients eventually recover their native heart function, at which we explant the devices." The second subcategory is the chronic heart failure patient, a minority of whom can recover heart function. The final category of LVAD use is ‘destination therapy,' employed in patients who are not transplant-eligible but have advanced heart failure. "Reasons for not transplanting include age," Dr. Naka explained, noting that NewYork-Presbyterian/Columbia offers heart transplants up through age 72. "Let's say you have a 73-year-old patient with severe heart failure who is not actively dying but is not doing well. Those patients' prognoses are miserable, with a one-year survival of about 25% without an LVAD. Prognosis is actually less than any solid tumor." Implanting the LVAD can boost survival and enhance quality of life, an important finding that was demonstrated in the landmark REMATCH (Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart failure) trial (NEJM 2001;345:1435). Destination therapy amounts to about 10% of LVAD procedures, but that may not be enough. "If you do the math, there should be a lot of people out there who are candidates for destination therapy," said Dr. Chen. "Unfortunately, this message hasn't gotten out to the public and some physicians are not as familiar as they should be with it." Those interested in learning more about LVAD design innovations and details of LVAD implantation should view this webcast, which includes commentary from these and other experts at NewYork-Presbyterian Hospital. ]]> LVAD: Advancements in Technology and Outcomes http://www.or-live.com/NYP/2107 Many physicians still conceptualize Left Ventricular Assist Devices (LVADs) as they were back in the early 1990s, unaware of design innovations and broadened indications that can immediately benefit their patients. The developmental lineage of LVADs goes back to early heart-lung bypass machines and experiments in the late 1950s, during which artificial hearts were implanted in dogs. There has been considerable work since then on both total artificial hearts and heart assist devices, and the physicians at NewYork-Presbyterian Hospital have played a major role in the research and development of this technology. LVAD design in particular has made tremendous advances over the last decade, in particular by significantly reducing size. NewYork-Presbyterian Hospital/Columbia University Medical Center has participated in feasibility trials for several years and has been active in the development of the HeartMate II (Thoratec), an LVAD device, designed to provide as much as a decade of circulatory support, which has recently received FDA approval. In addition to improved LVAD design elements, the opportunities for using an LVAD have recently expanded. There are now three presentations for which an LVAD might be used. The original indication was as a ‘bridge to transplant,' representing perhaps 85% of all LVAD procedures in the United States. "This is for patients already in the queue waiting for a heart transplant, but who for reasons of size, blood type, scarcity, etc., need a heart assist device because they are getting worse while they are waiting," explained Jonathan M. Chen, MD, Director of Pediatric Cardiovascular Surgery at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, and Associate Professor of Cardiothoracic Surgery at Weill Cornell Medical College. NewYork-Presbyterian/ Cornell has recently begun its own LVAD program, whose development is being assisted by the considerable LVAD experience at NewYork-Presbyterian/Columbia. Another category of LVAD use, accounting for less than 5% of procedures, is termed ‘bridge to recovery,' of which there are two subcategories. "The first is the acute cardiac failure patient, such as those suffering acute myocardial infarction or myocarditis," explained Yoshifumi Naka, MD, the Director of Cardiac Transplantation and Director of the Mechanical Circulatory Support Programs at both NewYork-Presbyterian Hospital/Columbia University Medical Center and NewYork-Presbyterian Hospital/Weill Cornell Medical Center. "These patients eventually recover their native heart function, at which we explant the devices." The second subcategory is the chronic heart failure patient, a minority of whom can recover heart function. The final category of LVAD use is ‘destination therapy,' employed in patients who are not transplant-eligible but have advanced heart failure. "Reasons for not transplanting include age," Dr. Naka explained, noting that NewYork-Presbyterian/Columbia offers heart transplants up through age 72. "Let's say you have a 73-year-old patient with severe heart failure who is not actively dying but is not doing well. Those patients' prognoses are miserable, with a one-year survival of about 25% without an LVAD. Prognosis is actually less than any solid tumor." Implanting the LVAD can boost survival and enhance quality of life, an important finding that was demonstrated in the landmark REMATCH (Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart failure) trial (NEJM 2001;345:1435). Destination therapy amounts to about 10% of LVAD procedures, but that may not be enough. "If you do the math, there should be a lot of people out there who are candidates for destination therapy," said Dr. Chen. "Unfortunately, this message hasn't gotten out to the public and some physicians are not as familiar as they should be with it." Those interested in learning more about LVAD design innovations and details of LVAD implantation should view this webcast, which includes commentary from these and other experts at NewYork-Presbyterian Hospital. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. ins_2272 http://www.or-live.com/daVinci/2272 http://www.or-live.com/daVinci/2272 The Cleveland Clinic and Intuitive Surgical, Inc. will present a live webcast featuring a roundtable discussion on the treatment of asymptomatic mitral valve disease. Moderator Julie Huang, M.D., staff cardiologist in the Section of Clinical Cardiology, Department of Cardiovascular Medicine; Brian P. Griffin, MD, FACC, staff cardiologist in the Section of Cardiovascular Imaging, Department of Cardiovascular Medicine; A. Marc Gillinov, M.D., staff cardiac surgeon; and Tomislav Mihaljevic, MD, Attending Surgeon, Department of Thoracic and Cardiovascular Surgery — all of the Cleveland Clinic Heart and Vascular Institute — will discuss mitral valve prolapse, treatment options and surgery guidelines for asymptomatic patients. The panelists will review the potential benefits of da Vinci® Mitral Valve Repair, a minimally invasive, sternum-sparing procedure in detail, and discuss its merits as the primary treatment option for asymptomatic mitral valve disease. Following this discussion, the panel will conduct a live question and answer session with viewers.    ]]> Early Intervention in the Treatment of Mitral Valve Disease http://www.or-live.com/daVinci/2272 The Cleveland Clinic and Intuitive Surgical, Inc. will present a live webcast featuring a roundtable discussion on the treatment of asymptomatic mitral valve disease. Moderator Julie Huang, M.D., staff cardiologist in the Section of Clinical Cardiology, Department of Cardiovascular Medicine; Brian P. Griffin, MD, FACC, staff cardiologist in the Section of Cardiovascular Imaging, Department of Cardiovascular Medicine; A. Marc Gillinov, M.D., staff cardiac surgeon; and Tomislav Mihaljevic, MD, Attending Surgeon, Department of Thoracic and Cardiovascular Surgery — all of the Cleveland Clinic Heart and Vascular Institute — will discuss mitral valve prolapse, treatment options and surgery guidelines for asymptomatic patients. The panelists will review the potential benefits of da Vinci® Mitral Valve Repair, a minimally invasive, sternum-sparing procedure in detail, and discuss its merits as the primary treatment option for asymptomatic mitral valve disease. Following this discussion, the panel will conduct a live question and answer session with viewers.    surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. ins_2272 http://www.or-live.com/daVinci/2272 http://www.or-live.com/daVinci/2272 The Cleveland Clinic and Intuitive Surgical, Inc. will present a live webcast featuring a roundtable discussion on the treatment of asymptomatic mitral valve disease. Moderator Julie Huang, M.D., staff cardiologist in the Section of Clinical Cardiology, Department of Cardiovascular Medicine; Brian P. Griffin, MD, FACC, staff cardiologist in the Section of Cardiovascular Imaging, Department of Cardiovascular Medicine; A. Marc Gillinov, M.D., staff cardiac surgeon; and Tomislav Mihaljevic, MD, Attending Surgeon, Department of Thoracic and Cardiovascular Surgery — all of the Cleveland Clinic Heart and Vascular Institute — will discuss mitral valve prolapse, treatment options and surgery guidelines for asymptomatic patients. The panelists will review the potential benefits of da Vinci® Mitral Valve Repair, a minimally invasive, sternum-sparing procedure in detail, and discuss its merits as the primary treatment option for asymptomatic mitral valve disease. Following this discussion, the panel will conduct a live question and answer session with viewers.    ]]> Early Intervention in the Treatment of Mitral Valve Disease http://www.or-live.com/daVinci/2272 The Cleveland Clinic and Intuitive Surgical, Inc. will present a live webcast featuring a roundtable discussion on the treatment of asymptomatic mitral valve disease. Moderator Julie Huang, M.D., staff cardiologist in the Section of Clinical Cardiology, Department of Cardiovascular Medicine; Brian P. Griffin, MD, FACC, staff cardiologist in the Section of Cardiovascular Imaging, Department of Cardiovascular Medicine; A. Marc Gillinov, M.D., staff cardiac surgeon; and Tomislav Mihaljevic, MD, Attending Surgeon, Department of Thoracic and Cardiovascular Surgery — all of the Cleveland Clinic Heart and Vascular Institute — will discuss mitral valve prolapse, treatment options and surgery guidelines for asymptomatic patients. The panelists will review the potential benefits of da Vinci® Mitral Valve Repair, a minimally invasive, sternum-sparing procedure in detail, and discuss its merits as the primary treatment option for asymptomatic mitral valve disease. Following this discussion, the panel will conduct a live question and answer session with viewers.    surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. nep_2554 http://www.or-live.com/NYP/2554 http://www.or-live.com/NYP/2554 It may be somewhat surprising that there are many recent positive developments in the treatment of clinical depression. One development that has had an enormous impact are findings from large, federally funded studies like the "Sequenced Treatment Alternatives to Relieve Depression" (STAR*D) trial, which sought to elucidate the effectiveness of antidepressants. "They found in the STAR*D that about a third of patients will respond and experience a full remission to the first drug, and about another one third will have a partial response, so from the start two thirds of people will get about 50% better or more," said Richard Alan Friedman, MD, the Director of the Psychopharmacology Clinic, Department of Psychiatry, at Weill Cornell Medical Center, NewYork-Presbyterian Hospital. "That still leaves a third of patients who don't respond, but if you keep treating them, you pick up an additional successful fraction with each new treatment. So those who don't respond to three or four antidepressant treatments probably are going to equal about 15% of the depressed sample. In my experience, and that of my colleagues, if you are very persistent and methodical over time and do not give up, you can get almost anybody better. In the past, many people who were called treatment-resistant just didn't get really good treatment." Dr. Friedman is also a Professor of Clinical Psychiatry at Weill Cornell Medical College. David A. Kahn, MD, Clinical Professor and Vice Chair for Clinical Affairs, Department of Psychiatry, Columbia University Medical Center, NewYork-Presbyterian Hospital and the New York State Psychiatric Institute, agreed. "The rates in the STAR*D study of response when medications were combined were slightly greater than when medications were simply switched from one to another. So there is often a reason to combine antidepressants." Clinicians will look to combine medications if the patient with depression has tolerated the initial drug well, and a mix of different mechanisms of action is often preferable. Dr. Kahn offered an example: "Most commonly an SSRI [selective serotonin reuptake inhibitor] might be the first medication, but the second addition might be a combination with buproprion, or even a combination with such medications as lithium, thyroid hormone, or buspirone, none of which would be used as a solitary antidepressant agent, but all three of which can augment the response to antidepressants." Other options, like an SNRI (serotonin norepinephrine reuptake inhibitor), nefazodone, mirtazapine, the tricyclic antidepressants, MAO inhibitors, and others, all have their place and all can be extraordinarily valuable, although several require a great deal of expertise because of the significant burden of side effects. Promising pharmacologic clinical trials on new agents are, of course, ongoing. Another recent development is a renewed appreciation for the role that psychotherapy and other nonpharmacologic treatments can play in treating depression. "The evidence for the value of psychotherapy was developed later than the scientific evidence supporting medication," Dr. Kahn said. The result is that psychotherapy has been underutilized by people with depression, despite there being excellent forms of psychotherapy—e.g., cognitive behavioral therapy and interpersonal therapy—that research has found are effective in treating these patients. Further, the evidence seems to suggest that the best treatment for depression incorporates both psychotherapy and pharmacologic treatment. Electroconvulsive therapy is still the gold standard in nonpharmacologic somatic treatment, though other brain-stimulation treatments are now emerging. One is transcranial magnetic stimulation, recently approved by the FDA, which applies focused magnetic stimulation to certain areas of the brain of the patient, who is awake yet experiences no subjective sensations while receiving treatment. Response rates so far have rivaled those found with medication, but without serious side effects. Whether and how it can be combined with pharmacologic therapy, and whether it is successful in medication-refractory patients, are questions that are still subject to research. Vagal nerve stimulation, also FDA-approved, is used for patients with medication-resistant depression. Small amounts of electricity are used to stimulate the vagus nerve with a surgically-implanted electrode. Although success rates for this modality are not high, some responses can be dramatic. Another form of somatic treatment, which is still experimental, is deep brain stimulation in which surgically implanted electrodes stimulate the ventral tegmental area, located deep at the base of the brain. The promising nature of these developments underscores, however, that care for major depression is multifactorial, complicated, and specialized. It is vital that primary care providers—who by dint of sheer numbers treat many more cases of depression than the nation's psychiatrists—know when to refer their patients with major depression. Both Drs. Friedman and Kahn cited a few specific signs: If, at initial evaluation, the patient says they want to hurt or kill themselves or appears to be suicidal. (There are screening instruments for depression specifically designed for primary care providers, such as the PRIME-MD Patient Health Questionnaire, that the physician should not hesitate to use.) If the patient is psychotic, having delusions or hallucinations, or shows signs of a marked thought disorder. If the patient has a history of manic episodes or a diagnosis of bipolar disorder. If there is a history of complicated psychiatric problems like substance abuse disorder or a personality disorder. If the patient has a history of a failed treatment for depression. Treatment for these patients is often quite complicated and requires the expertise of a psychiatrist's care. Dr. Kahn summarized the attitude at NewYork-Presbyterian: "What excites me is making sure that patients who come here are not going for one treatment just because they walked in the door of a doctor who knows how to do one thing well, but that they instead meet an expert who is familiar with a wide range of clinical and research treatments so that we can design therapy using all that is available—sophisticated psychopharmacology, expertly delivered psychotherapy, the possibility of brain stimulation techniques—all of which rest on the foundation of an accurate diagnosis and gaining a full understanding of that person as a human being , knowing what he or she experiences in life, what their hopes and dreams are, what their family is like, what the context of their work is like—all the things that we need to know to try to make that individual feel better." Treatment for depression has come a long way. Those interested in learning the state of the art on the care of the patient with depression should watch this webcast featuring Drs. Friedman and Kahn, leaders in psychiatry and examples of the expertise available at NewYork-Presbyterian Hospital. ]]> Advances in Treating Depression http://www.or-live.com/NYP/2554 It may be somewhat surprising that there are many recent positive developments in the treatment of clinical depression. One development that has had an enormous impact are findings from large, federally funded studies like the "Sequenced Treatment Alternatives to Relieve Depression" (STAR*D) trial, which sought to elucidate the effectiveness of antidepressants. "They found in the STAR*D that about a third of patients will respond and experience a full remission to the first drug, and about another one third will have a partial response, so from the start two thirds of people will get about 50% better or more," said Richard Alan Friedman, MD, the Director of the Psychopharmacology Clinic, Department of Psychiatry, at Weill Cornell Medical Center, NewYork-Presbyterian Hospital. "That still leaves a third of patients who don't respond, but if you keep treating them, you pick up an additional successful fraction with each new treatment. So those who don't respond to three or four antidepressant treatments probably are going to equal about 15% of the depressed sample. In my experience, and that of my colleagues, if you are very persistent and methodical over time and do not give up, you can get almost anybody better. In the past, many people who were called treatment-resistant just didn't get really good treatment." Dr. Friedman is also a Professor of Clinical Psychiatry at Weill Cornell Medical College. David A. Kahn, MD, Clinical Professor and Vice Chair for Clinical Affairs, Department of Psychiatry, Columbia University Medical Center, NewYork-Presbyterian Hospital and the New York State Psychiatric Institute, agreed. "The rates in the STAR*D study of response when medications were combined were slightly greater than when medications were simply switched from one to another. So there is often a reason to combine antidepressants." Clinicians will look to combine medications if the patient with depression has tolerated the initial drug well, and a mix of different mechanisms of action is often preferable. Dr. Kahn offered an example: "Most commonly an SSRI [selective serotonin reuptake inhibitor] might be the first medication, but the second addition might be a combination with buproprion, or even a combination with such medications as lithium, thyroid hormone, or buspirone, none of which would be used as a solitary antidepressant agent, but all three of which can augment the response to antidepressants." Other options, like an SNRI (serotonin norepinephrine reuptake inhibitor), nefazodone, mirtazapine, the tricyclic antidepressants, MAO inhibitors, and others, all have their place and all can be extraordinarily valuable, although several require a great deal of expertise because of the significant burden of side effects. Promising pharmacologic clinical trials on new agents are, of course, ongoing. Another recent development is a renewed appreciation for the role that psychotherapy and other nonpharmacologic treatments can play in treating depression. "The evidence for the value of psychotherapy was developed later than the scientific evidence supporting medication," Dr. Kahn said. The result is that psychotherapy has been underutilized by people with depression, despite there being excellent forms of psychotherapy—e.g., cognitive behavioral therapy and interpersonal therapy—that research has found are effective in treating these patients. Further, the evidence seems to suggest that the best treatment for depression incorporates both psychotherapy and pharmacologic treatment. Electroconvulsive therapy is still the gold standard in nonpharmacologic somatic treatment, though other brain-stimulation treatments are now emerging. One is transcranial magnetic stimulation, recently approved by the FDA, which applies focused magnetic stimulation to certain areas of the brain of the patient, who is awake yet experiences no subjective sensations while receiving treatment. Response rates so far have rivaled those found with medication, but without serious side effects. Whether and how it can be combined with pharmacologic therapy, and whether it is successful in medication-refractory patients, are questions that are still subject to research. Vagal nerve stimulation, also FDA-approved, is used for patients with medication-resistant depression. Small amounts of electricity are used to stimulate the vagus nerve with a surgically-implanted electrode. Although success rates for this modality are not high, some responses can be dramatic. Another form of somatic treatment, which is still experimental, is deep brain stimulation in which surgically implanted electrodes stimulate the ventral tegmental area, located deep at the base of the brain. The promising nature of these developments underscores, however, that care for major depression is multifactorial, complicated, and specialized. It is vital that primary care providers—who by dint of sheer numbers treat many more cases of depression than the nation's psychiatrists—know when to refer their patients with major depression. Both Drs. Friedman and Kahn cited a few specific signs: If, at initial evaluation, the patient says they want to hurt or kill themselves or appears to be suicidal. (There are screening instruments for depression specifically designed for primary care providers, such as the PRIME-MD Patient Health Questionnaire, that the physician should not hesitate to use.) If the patient is psychotic, having delusions or hallucinations, or shows signs of a marked thought disorder. If the patient has a history of manic episodes or a diagnosis of bipolar disorder. If there is a history of complicated psychiatric problems like substance abuse disorder or a personality disorder. If the patient has a history of a failed treatment for depression. Treatment for these patients is often quite complicated and requires the expertise of a psychiatrist's care. Dr. Kahn summarized the attitude at NewYork-Presbyterian: "What excites me is making sure that patients who come here are not going for one treatment just because they walked in the door of a doctor who knows how to do one thing well, but that they instead meet an expert who is familiar with a wide range of clinical and research treatments so that we can design therapy using all that is available—sophisticated psychopharmacology, expertly delivered psychotherapy, the possibility of brain stimulation techniques—all of which rest on the foundation of an accurate diagnosis and gaining a full understanding of that person as a human being , knowing what he or she experiences in life, what their hopes and dreams are, what their family is like, what the context of their work is like—all the things that we need to know to try to make that individual feel better." Treatment for depression has come a long way. Those interested in learning the state of the art on the care of the patient with depression should watch this webcast featuring Drs. Friedman and Kahn, leaders in psychiatry and examples of the expertise available at NewYork-Presbyterian Hospital. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. bse_2305 http://www.or-live.com/bonsecours/2305 http://www.or-live.com/bonsecours/2305 Join physicians and health experts from Bon Secours St. Francis Health System as the gather for a roundtable discussion on maintaining bone health and treatment options available to patients, including Kyphoplasty. Osteoporosis affects over 44 million Americans, and more than 80% of those are women. Nearly one in two women over 50 will suffer an osteoporotic fracture over their lifetime. During the webcast, viewers are invited to e-mail any questions they have on the topic to the panelists. ]]> Focus on Women: Osteoporosis and Bone Health http://www.or-live.com/bonsecours/2305 Join physicians and health experts from Bon Secours St. Francis Health System as the gather for a roundtable discussion on maintaining bone health and treatment options available to patients, including Kyphoplasty. Osteoporosis affects over 44 million Americans, and more than 80% of those are women. Nearly one in two women over 50 will suffer an osteoporotic fracture over their lifetime. During the webcast, viewers are invited to e-mail any questions they have on the topic to the panelists. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. con_2500 http://www.or-live.com/conformis/2500 http://www.or-live.com/conformis/2500 Boston, MA - On October 9, 2008 at 6:00pm EDT, OR-Live will broadcast a live surgery from Brigham and Women's Hospital utilizing a novel, personalized knee implant. The new prosthetic, the ConforMIS iDuo, is a bicompartmental resurfacing implant designed for patients whose arthritic damage is limited to either the medial or lateral compartments of the knee, in addition to the patellofemoral compartment. The implant resurfaces only the affected areas, offering a minimally invasive, bone preserving option for younger patients that does not compromise their ability to move to a traditional total knee replacement in the future. The procedure also preserves the anterior and posterior cruciate ligaments, which help to maintain knee kinematics. Dr. Tom Minas, Director of the Cartilage Repair Center at Brigham and Women's Hospital, and Dr. Wolfgang Fitz, Associate Orthopaedic Surgeon at Brigham and Women's Hospital will perform the surgery. The webcast will be moderated by Dr. Thomas Thornhill, MD, Chief of Orthopaedics at Brigham and Women's. The implant is created through an advanced image-to-implant process that utilizes CT scans from a patient to create a virtual model of a patient's knee. The implant, as well as the cutting and placement guides used for the surgery, are custom designed and manufactured to match each patient's knee anatomy. To assure precise implantation, the surgeons will utilize patient-specific instruments designed from the same scans as the implant, including data on the patient's biomechanical axis. The patient-specific cutting and placement guides reduce the number of steps during surgery and provide precise guidance to accurately place the instruments, simplifying the surgical technique. This personalized approach eliminates many of the bone cuts required in traditional surgery, helping to reduce surgical and recovery times. More than 80 patient-specific, partial knee resurfacing procedures have been performed worldwide. Viewers will have the opportunity to email questions to the surgeons during the procedure. ]]> Patient-Specific, Bicompartmental Knee Resurfacing Implant http://www.or-live.com/conformis/2500 Boston, MA - On October 9, 2008 at 6:00pm EDT, OR-Live will broadcast a live surgery from Brigham and Women's Hospital utilizing a novel, personalized knee implant. The new prosthetic, the ConforMIS iDuo, is a bicompartmental resurfacing implant designed for patients whose arthritic damage is limited to either the medial or lateral compartments of the knee, in addition to the patellofemoral compartment. The implant resurfaces only the affected areas, offering a minimally invasive, bone preserving option for younger patients that does not compromise their ability to move to a traditional total knee replacement in the future. The procedure also preserves the anterior and posterior cruciate ligaments, which help to maintain knee kinematics. Dr. Tom Minas, Director of the Cartilage Repair Center at Brigham and Women's Hospital, and Dr. Wolfgang Fitz, Associate Orthopaedic Surgeon at Brigham and Women's Hospital will perform the surgery. The webcast will be moderated by Dr. Thomas Thornhill, MD, Chief of Orthopaedics at Brigham and Women's. The implant is created through an advanced image-to-implant process that utilizes CT scans from a patient to create a virtual model of a patient's knee. The implant, as well as the cutting and placement guides used for the surgery, are custom designed and manufactured to match each patient's knee anatomy. To assure precise implantation, the surgeons will utilize patient-specific instruments designed from the same scans as the implant, including data on the patient's biomechanical axis. The patient-specific cutting and placement guides reduce the number of steps during surgery and provide precise guidance to accurately place the instruments, simplifying the surgical technique. This personalized approach eliminates many of the bone cuts required in traditional surgery, helping to reduce surgical and recovery times. More than 80 patient-specific, partial knee resurfacing procedures have been performed worldwide. Viewers will have the opportunity to email questions to the surgeons during the procedure. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. tag_2332 http://www.or-live.com/tgh/2332 http://www.or-live.com/tgh/2332 Join physicians Raviender Bukkapatnam, MD and Lennox Hoyte, MD, MSEE, FACOG as they present the implant of an InterStim® Therapy from Tampa General Hospital in Tampa, FL, live December 4 at 4pm ET. InterStim® Therapy is indicated for the treatment of urinary retention and the symptoms of overactive bladder in patients who have failed or could not tolerate more conservative treatments. ]]> InterStim® Therapy for Bladder Control Problems http://www.or-live.com/tgh/2332 Join physicians Raviender Bukkapatnam, MD and Lennox Hoyte, MD, MSEE, FACOG as they present the implant of an InterStim® Therapy from Tampa General Hospital in Tampa, FL, live December 4 at 4pm ET. InterStim® Therapy is indicated for the treatment of urinary retention and the symptoms of overactive bladder in patients who have failed or could not tolerate more conservative treatments. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. nom_2259 http://www.or-live.com/NMH/2259 http://www.or-live.com/NMH/2259 Achalasia is a rare esophageal disease that affects thousands of people in the United States, most of whom are in their 20s to 50s, and often presents symptoms that mimic those of acid reflux, such as difficulty swallowing, heart burn and chest pain. Difficult to diagnose and often mismanaged, achalasia is the inability of the muscles in the lower esophageal sphincter to relax during swallowing in order to move food down the esophagus and into the stomach. Nathaniel Soper, MD, renowned gastrointestinal surgeon and chief of surgery at Northwestern Memorial Hospital, will perform a minimally invasive surgery to treat achalasia, called laparoscopic Heller myotomy, during a live interactive Webcast on Tuesday, December 2, at 3 p.m. Dr. Soper and a team of surgeons at Northwestern Memorial perform 50-100 operations per year to treat achalasia, which is more than any other center in Illinois. "This minimally invasive procedure is the best option for patients with achalasia as medication typically has no effect, and endoscopic treatments often must be frequently repeated," said Dr. Soper. "Surgery involves cutting the esophageal sphincter muscle to allow food and liquid to flow into the stomach and provides immediate improvement in most patients." The surgery to correct achalasia limits complications and allows most patients to return to work and daily activities within a week following surgery. Dr. Soper has been at the forefront of less-invasive surgical alternatives and joined the Minimally Invasive Surgery Program at Northwestern Memorial in 2003. As director of the program, he has been instrumental in pioneering minimally invasive procedures in Chicago, including natural orifice transluminal endoscopic surgery, or NOTES, which involves the removal of organs through the mouth or vagina. "Minimally invasive surgeries are the wave of the future," adds Dr. Soper. "There has been an upward trend in these types of operations over the last 20 years and I think we will continue to see more traditional surgeries becoming less invasive." ]]> Achalasia Treatment http://www.or-live.com/NMH/2259 Achalasia is a rare esophageal disease that affects thousands of people in the United States, most of whom are in their 20s to 50s, and often presents symptoms that mimic those of acid reflux, such as difficulty swallowing, heart burn and chest pain. Difficult to diagnose and often mismanaged, achalasia is the inability of the muscles in the lower esophageal sphincter to relax during swallowing in order to move food down the esophagus and into the stomach. Nathaniel Soper, MD, renowned gastrointestinal surgeon and chief of surgery at Northwestern Memorial Hospital, will perform a minimally invasive surgery to treat achalasia, called laparoscopic Heller myotomy, during a live interactive Webcast on Tuesday, December 2, at 3 p.m. Dr. Soper and a team of surgeons at Northwestern Memorial perform 50-100 operations per year to treat achalasia, which is more than any other center in Illinois. "This minimally invasive procedure is the best option for patients with achalasia as medication typically has no effect, and endoscopic treatments often must be frequently repeated," said Dr. Soper. "Surgery involves cutting the esophageal sphincter muscle to allow food and liquid to flow into the stomach and provides immediate improvement in most patients." The surgery to correct achalasia limits complications and allows most patients to return to work and daily activities within a week following surgery. Dr. Soper has been at the forefront of less-invasive surgical alternatives and joined the Minimally Invasive Surgery Program at Northwestern Memorial in 2003. As director of the program, he has been instrumental in pioneering minimally invasive procedures in Chicago, including natural orifice transluminal endoscopic surgery, or NOTES, which involves the removal of organs through the mouth or vagina. "Minimally invasive surgeries are the wave of the future," adds Dr. Soper. "There has been an upward trend in these types of operations over the last 20 years and I think we will continue to see more traditional surgeries becoming less invasive." surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. mas_2570 http://www.or-live.com/makosurgical/2570 http://www.or-live.com/makosurgical/2570 MAKOplasty® is a new, minimally invasive partial knee resurfacing procedure used to treat early to mid-stage knee osteoarthritis that offers a more precise and consistent result that can provide relief. The opportunity for early intervention is important as osteoarthritis is the most common form of arthritis and the leading cause of disability worldwide, according to the American Academy of Orthopedic Surgeons. MAKOplasty® takes partial knee resurfacing to a new level of precision. It is enabled by the Tactile Guidance System™ (TGS™), a surgeon-interactive tactile robotic arm and 3-D visualization system. The TGS™ allows the surgeon to make a pre-surgical plan that details the technique for bone preparation and implant positioning using a CT scan of the patient's knee. During the procedure, the system creates a three-dimensional live-action, virtual view of the patient's bone surface and correlates the image to the pre-programmed surgical plan. As the surgeon uses the robotic arm, its tactile, acoustic and visual feedback limits the bone preparation to the diseased areas and provides for more optimal implant positioning, placement and results. MAKOplasty® is a registered trademark of MAKO Surgical Corp. ]]> MAKOplasty® Robotic Arm Partial Knee Resurfacing http://www.or-live.com/makosurgical/2570 MAKOplasty® is a new, minimally invasive partial knee resurfacing procedure used to treat early to mid-stage knee osteoarthritis that offers a more precise and consistent result that can provide relief. The opportunity for early intervention is important as osteoarthritis is the most common form of arthritis and the leading cause of disability worldwide, according to the American Academy of Orthopedic Surgeons. MAKOplasty® takes partial knee resurfacing to a new level of precision. It is enabled by the Tactile Guidance System™ (TGS™), a surgeon-interactive tactile robotic arm and 3-D visualization system. The TGS™ allows the surgeon to make a pre-surgical plan that details the technique for bone preparation and implant positioning using a CT scan of the patient's knee. During the procedure, the system creates a three-dimensional live-action, virtual view of the patient's bone surface and correlates the image to the pre-programmed surgical plan. As the surgeon uses the robotic arm, its tactile, acoustic and visual feedback limits the bone preparation to the diseased areas and provides for more optimal implant positioning, placement and results. MAKOplasty® is a registered trademark of MAKO Surgical Corp. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. stm_2526 http://www.or-live.com/stmarysmadison/2526 http://www.or-live.com/stmarysmadison/2526 Join urologists from St. Mary's Hospital in Madison, WI, for a live webcast of a robot-assisted prostatectomy. During the one-hour webcast, surgeons will remove the prostate using the da Vinci® Surgical System. Viewers may participate in the live program by emailing their questions directly to the operating room staff. An archive of the live webcast is typically available later that evening and can be accessed through this website. da Vinci® is registered trademark of Intuitive Surgical, Inc. ]]> Robotic-Assisted Prostatectomy http://www.or-live.com/stmarysmadison/2526 Join urologists from St. Mary's Hospital in Madison, WI, for a live webcast of a robot-assisted prostatectomy. During the one-hour webcast, surgeons will remove the prostate using the da Vinci® Surgical System. Viewers may participate in the live program by emailing their questions directly to the operating room staff. An archive of the live webcast is typically available later that evening and can be accessed through this website. da Vinci® is registered trademark of Intuitive Surgical, Inc. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. con_2501 http://www.or-live.com/conformis/2501 http://www.or-live.com/conformis/2501 Boston, MA – Am 20. November 2008, um 17 Uhr - Mitteleuropäischer Zeit - wird OR-Live aus der orthopädischen Universitätsklinik Regensburg im Asklepios Klinikum Bad Abbach, eine Live-Operation über das Internet übertragen. Dabei wird ein neuartiges, personalisiertes Knieimplantat zum Einsatz kommen. Diese neue Knieendoprothese, das ConforMIS iUni™ Implantat, ist ein unikompartimenteller Oberflächenersatz für Arthrose-Patienten mit degenerativen Schäden des medialen oder lateralen tibiofemoralen Kniekompartiments. Das von der amerikanischen Zulassungsbehörde FDA zugelassene und mit dem CE-Siegel versehene Implantat ist eine Weiterentwicklung der unikompartimentellen Implantattechnologie für das Kniegelenk. Das iUni wird mithilfe eines virtuellen Kniemodells der Patienten hergestellt, das anhand von CT-Aufnahmen entsteht. Das Implantat und das dazugehörige OP-Instrumentarium werden entsprechend der einzigartigen Knieanatomie des Patienten maßangefertigt. Diese Individualisierung ermöglicht eine präzise achsgerechte Ausrichtung des Implantats und eine natürliche Kniekinematik und ist im Vergleich zum herkömmlichen Kniegelenkersatz weniger invasiv. Das dabei verwendete OP-Einweginstrumentarium iJig™ wird ebenfalls auf den Patienten abgestimmt und sorgt für eine einfache und leicht erlernbare Operationstechnik. Dr. Franz Xaver Köck, Leitender Oberarzt der Orthopädischen Klinik für die Universität Regensburg im Asklepios Klinikum Bad Abbach wird den Eingriff zusammen mit Dr. Wolfgang Fitz, Orthopäde und Chirurg am Brigham and Women's Hospital in Boston, durchführen. Dr. Fitz hat das iUni System mitentwickelt und ist Fakultätsmitglied der Harvard Medical School in Boston. Die Operation wird von Professor Dr. med. Dr. h.c. Joachim Grifka, Direktor und Chefarzt der Orthopädischen Klinik für die Universität Regensburg im Asklepios Klinikum Bad Abbach und diesjähriger Präsident der Deutschen Gesellschaft für Orthopädie und Unfallchirurgie, moderiert. Die patentierte "image-to-implant" Technologie iFit™ von ConforMIS wandelt CT- und MRT-Daten in Implantate um, die entwickelt wurden, um der einzigartigen dreidimensionalen Form des Patientengelenks gerecht zu werden. Das iFit bildet die geschädigte Knochenstruktur sowie die gesamte Anatomie des betroffenen Knies exakt ab. Auf dieser Grundlage berechnet die Technologie die Größe und Form der femoralen und tibialen Komponente sowie das OP-Einweginstrumentarium. Das patientenspezifisch maßangefertigte OP-Instrumentarium hilft die Zahl der Operationsschritte zu verringern und weist dem Operateur den idealen Weg zum Gelenk. Dies vereinfacht den Eingriff. Dieser Ansatz ist knochenschonender als herkömmliche Operationsmethoden und trägt zu einer kürzen Erholungszeit der Patienten bei. Weltweit wurde dieser spezielle Eingriff bisher bei 150 Patienten durchgeführt. Teilnehmer der Live-Operation werden die Gelegenheit haben, den Chirurgen während des Eingriffs ihre Fragen per E-Mail zu stellen. Diese Übertragung ist Dank der finanziellen Unterstützung von ConforMIS, Inc. möglich. ConforMIS, iUni, iJig und iFit sind eingetragene Warenzeichen von ConforMIS, Inc. ]]> Unikompartimenteller Oberflächenersatz http://www.or-live.com/conformis/2501 Boston, MA – Am 20. November 2008, um 17 Uhr - Mitteleuropäischer Zeit - wird OR-Live aus der orthopädischen Universitätsklinik Regensburg im Asklepios Klinikum Bad Abbach, eine Live-Operation über das Internet übertragen. Dabei wird ein neuartiges, personalisiertes Knieimplantat zum Einsatz kommen. Diese neue Knieendoprothese, das ConforMIS iUni™ Implantat, ist ein unikompartimenteller Oberflächenersatz für Arthrose-Patienten mit degenerativen Schäden des medialen oder lateralen tibiofemoralen Kniekompartiments. Das von der amerikanischen Zulassungsbehörde FDA zugelassene und mit dem CE-Siegel versehene Implantat ist eine Weiterentwicklung der unikompartimentellen Implantattechnologie für das Kniegelenk. Das iUni wird mithilfe eines virtuellen Kniemodells der Patienten hergestellt, das anhand von CT-Aufnahmen entsteht. Das Implantat und das dazugehörige OP-Instrumentarium werden entsprechend der einzigartigen Knieanatomie des Patienten maßangefertigt. Diese Individualisierung ermöglicht eine präzise achsgerechte Ausrichtung des Implantats und eine natürliche Kniekinematik und ist im Vergleich zum herkömmlichen Kniegelenkersatz weniger invasiv. Das dabei verwendete OP-Einweginstrumentarium iJig™ wird ebenfalls auf den Patienten abgestimmt und sorgt für eine einfache und leicht erlernbare Operationstechnik. Dr. Franz Xaver Köck, Leitender Oberarzt der Orthopädischen Klinik für die Universität Regensburg im Asklepios Klinikum Bad Abbach wird den Eingriff zusammen mit Dr. Wolfgang Fitz, Orthopäde und Chirurg am Brigham and Women's Hospital in Boston, durchführen. Dr. Fitz hat das iUni System mitentwickelt und ist Fakultätsmitglied der Harvard Medical School in Boston. Die Operation wird von Professor Dr. med. Dr. h.c. Joachim Grifka, Direktor und Chefarzt der Orthopädischen Klinik für die Universität Regensburg im Asklepios Klinikum Bad Abbach und diesjähriger Präsident der Deutschen Gesellschaft für Orthopädie und Unfallchirurgie, moderiert. Die patentierte "image-to-implant" Technologie iFit™ von ConforMIS wandelt CT- und MRT-Daten in Implantate um, die entwickelt wurden, um der einzigartigen dreidimensionalen Form des Patientengelenks gerecht zu werden. Das iFit bildet die geschädigte Knochenstruktur sowie die gesamte Anatomie des betroffenen Knies exakt ab. Auf dieser Grundlage berechnet die Technologie die Größe und Form der femoralen und tibialen Komponente sowie das OP-Einweginstrumentarium. Das patientenspezifisch maßangefertigte OP-Instrumentarium hilft die Zahl der Operationsschritte zu verringern und weist dem Operateur den idealen Weg zum Gelenk. Dies vereinfacht den Eingriff. Dieser Ansatz ist knochenschonender als herkömmliche Operationsmethoden und trägt zu einer kürzen Erholungszeit der Patienten bei. Weltweit wurde dieser spezielle Eingriff bisher bei 150 Patienten durchgeführt. Teilnehmer der Live-Operation werden die Gelegenheit haben, den Chirurgen während des Eingriffs ihre Fragen per E-Mail zu stellen. Diese Übertragung ist Dank der finanziellen Unterstützung von ConforMIS, Inc. möglich. ConforMIS, iUni, iJig und iFit sind eingetragene Warenzeichen von ConforMIS, Inc. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. deo_2495 http://www.or-live.com/DePuy/2495 http://www.or-live.com/DePuy/2495 Join Bozeman Deaconess Hospital surgeon Dr. Dan Gannon as he presents a live hip replacement surgery using the Tri-Lock Bone Preservation Stem through the direct Anterior Approach. ]]> Hip Replacement Using the Tri-Lock® Bone Preservation Stem http://www.or-live.com/DePuy/2495 Join Bozeman Deaconess Hospital surgeon Dr. Dan Gannon as he presents a live hip replacement surgery using the Tri-Lock Bone Preservation Stem through the direct Anterior Approach. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. cov_2456 http://www.or-live.com/covidien/2456 http://www.or-live.com/covidien/2456 On Wednesday, November 19, Professor Paolo Cappabianca from Università degli Studi di Napoli Federico II in Naples, Italy, and Dr. Michael Powell from National Hospital, Queen Square London, will present on endoscopic and microscopic pituitary tumor removal and CSF leak avoidance and repair techniques. During the program, participants can send questions via email, and they will be answered during the broadcast. This program features DuraSeal dural sealant. It is intended for audiences outside the United States where DuraSeal has CE Mark approval and is indicated for use as an adjunct to standard methods of dural repair, such as sutures, to provide watertight closure, including endonasal procedures. DuraSeal (U.S.) clinical studies were assessed based on frontal, temporal, parietal, occipital and suboccipital approaches only. The endonasal approach was not studied as part of the U.S. clinical trial and is not approved in the U.S. This program is sponsored by COVIDIEN Biosurgery. ]]> Preventing Cerebrospinal Fluid Leakage in Endonasal Surgery http://www.or-live.com/covidien/2456 On Wednesday, November 19, Professor Paolo Cappabianca from Università degli Studi di Napoli Federico II in Naples, Italy, and Dr. Michael Powell from National Hospital, Queen Square London, will present on endoscopic and microscopic pituitary tumor removal and CSF leak avoidance and repair techniques. During the program, participants can send questions via email, and they will be answered during the broadcast. This program features DuraSeal dural sealant. It is intended for audiences outside the United States where DuraSeal has CE Mark approval and is indicated for use as an adjunct to standard methods of dural repair, such as sutures, to provide watertight closure, including endonasal procedures. DuraSeal (U.S.) clinical studies were assessed based on frontal, temporal, parietal, occipital and suboccipital approaches only. The endonasal approach was not studied as part of the U.S. clinical trial and is not approved in the U.S. This program is sponsored by COVIDIEN Biosurgery. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. cov_2456 http://www.or-live.com/covidien/2456 http://www.or-live.com/covidien/2456 On Wednesday, November 19, Professor Paolo Cappabianca from Università degli Studi di Napoli Federico II in Naples, Italy, and Dr. Michael Powell from National Hospital, Queen Square London, will present on endoscopic and microscopic pituitary tumor removal and CSF leak avoidance and repair techniques. During the program, participants can send questions via email, and they will be answered during the broadcast. This program features DuraSeal dural sealant. It is intended for audiences outside the United States where DuraSeal has CE Mark approval and is indicated for use as an adjunct to standard methods of dural repair, such as sutures, to provide watertight closure, including endonasal procedures. DuraSeal (U.S.) clinical studies were assessed based on frontal, temporal, parietal, occipital and suboccipital approaches only. The endonasal approach was not studied as part of the U.S. clinical trial and is not approved in the U.S. This program is sponsored by COVIDIEN Biosurgery. ]]> Preventing Cerebrospinal Fluid Leakage in Endonasal Surgery http://www.or-live.com/covidien/2456 On Wednesday, November 19, Professor Paolo Cappabianca from Università degli Studi di Napoli Federico II in Naples, Italy, and Dr. Michael Powell from National Hospital, Queen Square London, will present on endoscopic and microscopic pituitary tumor removal and CSF leak avoidance and repair techniques. During the program, participants can send questions via email, and they will be answered during the broadcast. This program features DuraSeal dural sealant. It is intended for audiences outside the United States where DuraSeal has CE Mark approval and is indicated for use as an adjunct to standard methods of dural repair, such as sutures, to provide watertight closure, including endonasal procedures. DuraSeal (U.S.) clinical studies were assessed based on frontal, temporal, parietal, occipital and suboccipital approaches only. The endonasal approach was not studied as part of the U.S. clinical trial and is not approved in the U.S. This program is sponsored by COVIDIEN Biosurgery. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. bic_2515 http://www.or-live.com/biocentric/2515 http://www.or-live.com/biocentric/2515 Join a 70-minute demonstration on the evaluation and cosmetic treatment of the face. The session will be hosted by dermatologists Susan H. Weinkle, MD, FAAD, Assistant Clinical Professor, University of South Florida, Tampa, Florida; Ashish C. Bhatia, MD, FAAD, Assistant Professor of Clinical Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois; and Wm. Philip Werschler, MD, FAAD, FAACS, Assistant Clinical Professor, University of Washington School of Medicine, Seattle, Washington. The program provides hands-on demonstration of non-surgical techniques for facial rejuvenation using the latest advances in facial-shaping agents, and emphasizing the use of combination injectable products. Videotaped sessions will illustrate methods for facial assessment and optimal techniques for injection of facial-shaping agents, including calcium hydroxylapatite (Radiesse®), collagen (Evolence®, CosmoDerm®), hyaluronic acid (Juvéderm™ Ultra, Restylane®, Perlane®), and poly-L-lactic acid (Sculptra™). This CME online activity is jointly sponsored by Postgraduate Institute for Medicine and BioCentric, Inc. and is supported by an educational grant from Dermik Aesthetics and sanofi aventis ]]> Cosmetic Patients: Are We Meeting Their Needs? http://www.or-live.com/biocentric/2515 Join a 70-minute demonstration on the evaluation and cosmetic treatment of the face. The session will be hosted by dermatologists Susan H. Weinkle, MD, FAAD, Assistant Clinical Professor, University of South Florida, Tampa, Florida; Ashish C. Bhatia, MD, FAAD, Assistant Professor of Clinical Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois; and Wm. Philip Werschler, MD, FAAD, FAACS, Assistant Clinical Professor, University of Washington School of Medicine, Seattle, Washington. The program provides hands-on demonstration of non-surgical techniques for facial rejuvenation using the latest advances in facial-shaping agents, and emphasizing the use of combination injectable products. Videotaped sessions will illustrate methods for facial assessment and optimal techniques for injection of facial-shaping agents, including calcium hydroxylapatite (Radiesse®), collagen (Evolence®, CosmoDerm®), hyaluronic acid (Juvéderm™ Ultra, Restylane®, Perlane®), and poly-L-lactic acid (Sculptra™). This CME online activity is jointly sponsored by Postgraduate Institute for Medicine and BioCentric, Inc. and is supported by an educational grant from Dermik Aesthetics and sanofi aventis surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. hah_2370 http://www.or-live.com/HartfordHospital/2370 http://www.or-live.com/HartfordHospital/2370 More than 70,000 people across the world with osteoarthritis have undergone a hip resurfacing procedure with the BIRMINGHAM HIP™ resurfacing system. Using a specialized instrument, the surgeon will remove the damaged surface of the socket to tightly support a highly-polished metal cup. The femur is similarly prepared for a polished metal cap, preserving much of the original bone. The surgeon inserts the metal cap into place and repositions the femur into the socket, yielding a metal-on-metal functional hip surface. Watch as Drs. Durgesh Nagarkatti and Mark Shekhman bring you this procedure in a live Internet broadcast, on Monday, November 17, 2008 at 6 pm EST from Hartford Hospital in Hartford, Connecticut. ]]> BIRMINGHAM HIP™ Resurfacing http://www.or-live.com/HartfordHospital/2370 More than 70,000 people across the world with osteoarthritis have undergone a hip resurfacing procedure with the BIRMINGHAM HIP™ resurfacing system. Using a specialized instrument, the surgeon will remove the damaged surface of the socket to tightly support a highly-polished metal cup. The femur is similarly prepared for a polished metal cap, preserving much of the original bone. The surgeon inserts the metal cap into place and repositions the femur into the socket, yielding a metal-on-metal functional hip surface. Watch as Drs. Durgesh Nagarkatti and Mark Shekhman bring you this procedure in a live Internet broadcast, on Monday, November 17, 2008 at 6 pm EST from Hartford Hospital in Hartford, Connecticut. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. seh_2237 http://www.or-live.com/sentara/2237 http://www.or-live.com/sentara/2237 Join surgical oncologist Dr. Richard C. Hoefer and radiation oncologists Dr. Michael Miller and Dr. Song Kang for a live lumpectomy surgery to remove early stage breast cancer and prepare the surgical site for IntraBeam®, intraoperative radiation therapy that occurs right in the operating room. IntraBeam® is a registered trademark of Carl Zeiss Meditec, Inc ]]> IntraBeam®: Intraoperative Radiation http://www.or-live.com/sentara/2237 Join surgical oncologist Dr. Richard C. Hoefer and radiation oncologists Dr. Michael Miller and Dr. Song Kang for a live lumpectomy surgery to remove early stage breast cancer and prepare the surgical site for IntraBeam®, intraoperative radiation therapy that occurs right in the operating room. IntraBeam® is a registered trademark of Carl Zeiss Meditec, Inc surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. mom_2478 http://www.or-live.com/montefiore/2478 http://www.or-live.com/montefiore/2478 "Because of the scarcity of available organs, the Cardiology Department at Montefiore-Einstein Heart Center is looking at new ways for heart disease patients to go on living with their own hearts. This is a paradigm shift in the way we approach the failing heart," says Daniel Goldstein, MD, Director of the Heart Transplant and Mechanical Assist Device Program at the Montefiore-Einstein Heart Center. On Thursday, November 13th at 7:00pm Montefiore-Einstein Heart Center will follow its award winning live webcast of a Heart Transplant with a live panel discussion about an implant of a heart pump or Left Ventricular Assist Device. "Basically, we are installing a pump in the body that will take over the function of the diseased heart that can no longer adequately supply the body with the blood it needs. We put the patient on a bypass machine and attach a tube from the left ventrical to the pump. The pump then forces the blood through another tube that is attached to the aorta. From there, the blood is dispersed through the circulatory system by the force of the pump," explains Dr. Goldstein Along with the new pump this particular patient is also participating in an experimental program that includes high doses of the drug Clenbuterol. This muscle-growth therapy has resulted in dramatic improvement in some patients. "Given that there are over 150,000 people with advanced heart failure in the United States each year and only 2,000 available hearts for transplant, we are forced to look for alternatives. Although the heart pump was originally designed as a bridge to transplant, we have discovered pump-assisted hearts can sometimes begin to repair themselves. It then made sense to begin looking for therapies that can accelerate this process. At Montefiore- Einstein Heart Center, we're the only institution in the Norhteast participating in a study that involves giving high doses of Clenbuterol to patients on a particular Assist Device. This therapy showed great promise in the U.K., sometimes resulting in the eventual removal of the pump and restoration of normal heart function," says Simon Maybaum MD, Medical Director of the Heart Transplant Program. The panel will be composed of Simon Maybaum, MD and David D'Alessandro, MD. It will be moderated by Daniel Goldstein, MD. The doctors will review video of the Ventricular Assist Device surgery performed by Dr.Goldstein and also discuss the patient's progress in the study. During the webcast, the viewing audience will be able to send live email questions to the doctors. The staff at Montefiore-Einstein Heart Center would like to cordially invite everyone to consider organ donation. As Dr. Goldstein said in accepting his Webby award , "Don't take your organs to heaven." ]]> New Options for Advanced Heart Disease http://www.or-live.com/montefiore/2478 "Because of the scarcity of available organs, the Cardiology Department at Montefiore-Einstein Heart Center is looking at new ways for heart disease patients to go on living with their own hearts. This is a paradigm shift in the way we approach the failing heart," says Daniel Goldstein, MD, Director of the Heart Transplant and Mechanical Assist Device Program at the Montefiore-Einstein Heart Center. On Thursday, November 13th at 7:00pm Montefiore-Einstein Heart Center will follow its award winning live webcast of a Heart Transplant with a live panel discussion about an implant of a heart pump or Left Ventricular Assist Device. "Basically, we are installing a pump in the body that will take over the function of the diseased heart that can no longer adequately supply the body with the blood it needs. We put the patient on a bypass machine and attach a tube from the left ventrical to the pump. The pump then forces the blood through another tube that is attached to the aorta. From there, the blood is dispersed through the circulatory system by the force of the pump," explains Dr. Goldstein Along with the new pump this particular patient is also participating in an experimental program that includes high doses of the drug Clenbuterol. This muscle-growth therapy has resulted in dramatic improvement in some patients. "Given that there are over 150,000 people with advanced heart failure in the United States each year and only 2,000 available hearts for transplant, we are forced to look for alternatives. Although the heart pump was originally designed as a bridge to transplant, we have discovered pump-assisted hearts can sometimes begin to repair themselves. It then made sense to begin looking for therapies that can accelerate this process. At Montefiore- Einstein Heart Center, we're the only institution in the Norhteast participating in a study that involves giving high doses of Clenbuterol to patients on a particular Assist Device. This therapy showed great promise in the U.K., sometimes resulting in the eventual removal of the pump and restoration of normal heart function," says Simon Maybaum MD, Medical Director of the Heart Transplant Program. The panel will be composed of Simon Maybaum, MD and David D'Alessandro, MD. It will be moderated by Daniel Goldstein, MD. The doctors will review video of the Ventricular Assist Device surgery performed by Dr.Goldstein and also discuss the patient's progress in the study. During the webcast, the viewing audience will be able to send live email questions to the doctors. The staff at Montefiore-Einstein Heart Center would like to cordially invite everyone to consider organ donation. As Dr. Goldstein said in accepting his Webby award , "Don't take your organs to heaven." surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. uho_2417 http://www.or-live.com/universityhospitals/2417 http://www.or-live.com/universityhospitals/2417 On Thursday, November 6, watch surgeons from University Hospitals Case Medical Center perform a Freestyle® Aortic Root Replacement with replacement of the ascending aorta and hemi-arch under circulatory arrest. During the program, cardiac surgeon Alan Markowitz, MD, will provide a detailed narration of the procedure. Arie Blitz, MD, will also supply additional commentary. The physicians will be available during the webcast to answer any e-mail questions from viewers. ]]> Freestyle® Aortic Root Replacement http://www.or-live.com/universityhospitals/2417 On Thursday, November 6, watch surgeons from University Hospitals Case Medical Center perform a Freestyle® Aortic Root Replacement with replacement of the ascending aorta and hemi-arch under circulatory arrest. During the program, cardiac surgeon Alan Markowitz, MD, will provide a detailed narration of the procedure. Arie Blitz, MD, will also supply additional commentary. The physicians will be available during the webcast to answer any e-mail questions from viewers. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. met_2251 http://www.methodisthealth.org/virtualbrain http://www.methodisthealth.org/virtualbrain Memphis, TN -- Methodist University Hospital, home to one of the busiest neuroscience institutes in the country, is making an innovative breakthrough in medicine by presenting the Virtual Brain Tumor Board Webcast series, beginning Wednesday, July 2, from 7 a.m. to 8 a.m. Central Daylight Time. The Virtual Brain Tumor Board webcast series is the first program of its kind. It expands on the universal tumor board concept by providing a platform where a multi-disciplinary team of experts made up of various specialties within the neuroscience field including neurosurgeons, pathologists, medical oncologists, radiation oncologists, and neuro interventional radiologists present and review difficult clinical cases and collaborate together to create the best treatment plan for each patient. Webcasting the tumor board to physicians across the country and around the world opens dialogue to improve cancer care by providing physicians the opportunity to get expert opinions from top-tier, highly respected neuro-oncology leaders. This exchange of ideas and collaboration will advance patient care by making the most progressive treatments accessible to all physicians. "Our goal is to give physicians in other geographic areas the chance to receive the expertise and experience from our physicians here regarding brain tumor treatment and care for their patients," said Allen K. Sills, M.D., medical director and neurosurgeon, Methodist University Hospital. The innovative educational platform of our Virtual Brain Tumor Board is designed to provide real-time collaboration and on-demand access to some of the most leading-edge treatments in brain tumor care. It also allows you to: Earn CME credits Submit your own challenging cases in advance for live review Email your questions to be answered during each live event Get a fast-paced case evaluation in real-time, with each event archived for later viewing "I think making the brain tumor conference available online is a great idea for physicians who live in rural areas and are not near academic centers," stated Frederick Harris, M.D., neurosurgeon, Duluth Clinic, Duluth, Minnesota. "It allows them to have access to expert opinions and also to have the ability to see the multi-disciplinary approach to the treatment of brain tumors." The Virtual Brain Tumor Board Webcasts will be the first Wednesday of each month starting July 2nd and will continue for five consecutive months through November at 7 a.m. Central Daylight Time. ]]> Brain Tumor Board Webcast Series http://www.methodisthealth.org/virtualbrain Memphis, TN -- Methodist University Hospital, home to one of the busiest neuroscience institutes in the country, is making an innovative breakthrough in medicine by presenting the Virtual Brain Tumor Board Webcast series, beginning Wednesday, July 2, from 7 a.m. to 8 a.m. Central Daylight Time. The Virtual Brain Tumor Board webcast series is the first program of its kind. It expands on the universal tumor board concept by providing a platform where a multi-disciplinary team of experts made up of various specialties within the neuroscience field including neurosurgeons, pathologists, medical oncologists, radiation oncologists, and neuro interventional radiologists present and review difficult clinical cases and collaborate together to create the best treatment plan for each patient. Webcasting the tumor board to physicians across the country and around the world opens dialogue to improve cancer care by providing physicians the opportunity to get expert opinions from top-tier, highly respected neuro-oncology leaders. This exchange of ideas and collaboration will advance patient care by making the most progressive treatments accessible to all physicians. "Our goal is to give physicians in other geographic areas the chance to receive the expertise and experience from our physicians here regarding brain tumor treatment and care for their patients," said Allen K. Sills, M.D., medical director and neurosurgeon, Methodist University Hospital. The innovative educational platform of our Virtual Brain Tumor Board is designed to provide real-time collaboration and on-demand access to some of the most leading-edge treatments in brain tumor care. It also allows you to: Earn CME credits Submit your own challenging cases in advance for live review Email your questions to be answered during each live event Get a fast-paced case evaluation in real-time, with each event archived for later viewing "I think making the brain tumor conference available online is a great idea for physicians who live in rural areas and are not near academic centers," stated Frederick Harris, M.D., neurosurgeon, Duluth Clinic, Duluth, Minnesota. "It allows them to have access to expert opinions and also to have the ability to see the multi-disciplinary approach to the treatment of brain tumors." The Virtual Brain Tumor Board Webcasts will be the first Wednesday of each month starting July 2nd and will continue for five consecutive months through November at 7 a.m. Central Daylight Time. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. nep_2109 http://www.or-live.com/NYP/2109 http://www.or-live.com/NYP/2109 Educational discussion featuring Dr's Peterson and Casey discussing Developments in Autism. ]]> Latest Developments in Autism: Research to Therapy http://www.or-live.com/NYP/2109 Educational discussion featuring Dr's Peterson and Casey discussing Developments in Autism. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. nep_2109 http://www.or-live.com/NYP/2109 http://www.or-live.com/NYP/2109 Educational discussion featuring Dr's Peterson and Casey discussing Developments in Autism. ]]> Latest Developments in Autism: Research to Therapy http://www.or-live.com/NYP/2109 Educational discussion featuring Dr's Peterson and Casey discussing Developments in Autism. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. ola_2470 http://www.or-live.com/ololrmc/2470 http://www.or-live.com/ololrmc/2470 Baton Rouge, LA – Our Lady of the Lake Regional Medical Center will broadcast an endoscopic sympathectomy to decrease excessive sweating in the hands, feet, under arms or face. This technique is minimally invasive with a small incision made in each side of the chest. Patients typically go home two to three hours after surgery and notice results immediately. This surgical demonstration and panel discussion will broadcast over the internet on Thursday, October 30, 6:00 pm CDT. V. Keith Rhynes, MD, General Surgeon, will demonstrate this procedure, lead a panel discussion and interact with viewers by answering their questions during the broadcast. Dr. Rhynes is a graduate of Louisiana State University Medical Center in Shreveport where he also completed his residency in general surgery. He completed his Fellowship at the University of Alabama at Birmingham. Dr. Rhynes is a Fellow of the American Board of Surgery. ]]> Endoscopic Sympathectomy http://www.or-live.com/ololrmc/2470 Baton Rouge, LA – Our Lady of the Lake Regional Medical Center will broadcast an endoscopic sympathectomy to decrease excessive sweating in the hands, feet, under arms or face. This technique is minimally invasive with a small incision made in each side of the chest. Patients typically go home two to three hours after surgery and notice results immediately. This surgical demonstration and panel discussion will broadcast over the internet on Thursday, October 30, 6:00 pm CDT. V. Keith Rhynes, MD, General Surgeon, will demonstrate this procedure, lead a panel discussion and interact with viewers by answering their questions during the broadcast. Dr. Rhynes is a graduate of Louisiana State University Medical Center in Shreveport where he also completed his residency in general surgery. He completed his Fellowship at the University of Alabama at Birmingham. Dr. Rhynes is a Fellow of the American Board of Surgery. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. uno_2151 http://www.or-live.com/unityhospital/2151 http://www.or-live.com/unityhospital/2151 For morbidly obese patients who have unsuccessfully tried to lose weight, Adjustable Gastric Banding may offer new hope. On Thursday, October 30th, at 3 p-m Central time, you can see the procedure for yourself, in a live webcast from Unity Hospital in Fridley, Minnesota. During the program, you'll learn how the procedure is performed, and hear about the benefits to patients. Join Dr. Jeffrey Baker, Surgeon and Co-Medical Director of Unity Bariatric Center and Dr. Frederick W. Johnson, Surgeon and Co-Medical Director of Unity Bariatric Center and learn how Adjustable Gastric Banding has helped improve quality of life for morbidly obese patients. Lap-Band® is a registered trademark of Allergan Inc. (NYSE:AGN) ]]> Adjustable Gastric Band Surgery http://www.or-live.com/unityhospital/2151 For morbidly obese patients who have unsuccessfully tried to lose weight, Adjustable Gastric Banding may offer new hope. On Thursday, October 30th, at 3 p-m Central time, you can see the procedure for yourself, in a live webcast from Unity Hospital in Fridley, Minnesota. During the program, you'll learn how the procedure is performed, and hear about the benefits to patients. Join Dr. Jeffrey Baker, Surgeon and Co-Medical Director of Unity Bariatric Center and Dr. Frederick W. Johnson, Surgeon and Co-Medical Director of Unity Bariatric Center and learn how Adjustable Gastric Banding has helped improve quality of life for morbidly obese patients. Lap-Band® is a registered trademark of Allergan Inc. (NYSE:AGN) surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. bse_2304 http://www.or-live.com/bonsecours/2304 http://www.or-live.com/bonsecours/2304 Greenville, SC – On Tuesday, October 28, as part of Breast Cancer Awareness Month, physicians and health experts from Bon Secours St. Francis Health System will discuss the importance of detection, treatment, and management of breast disease. Physicians will be available during this webcast to answer any viewer questions. ]]> Focus on Women: Advances in Breast Health http://www.or-live.com/bonsecours/2304 Greenville, SC – On Tuesday, October 28, as part of Breast Cancer Awareness Month, physicians and health experts from Bon Secours St. Francis Health System will discuss the importance of detection, treatment, and management of breast disease. Physicians will be available during this webcast to answer any viewer questions. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. vau_2320 http://www.or-live.com/vanderbilt/2320 http://www.or-live.com/vanderbilt/2320 Join Vanderbilt Medical Center bariatric surgeons Bill Richards, Brandon Williams and Willie Melvin for a live webcast on laparoscopic vertical sleeve gastrectomy on October 23, 2008, at 6:00 PM CDT. This procedure has been proven to reduce the production of ghrelin which reduces appetite and provides for healthy weight loss for the obese. Additionally bariatric surgery has been shown to improve medical conditions such as diabetes, sleep apnea, high blood pressure, and high cholesterol. ]]> Laparoscopic Sleeve Gastrectomy http://www.or-live.com/vanderbilt/2320 Join Vanderbilt Medical Center bariatric surgeons Bill Richards, Brandon Williams and Willie Melvin for a live webcast on laparoscopic vertical sleeve gastrectomy on October 23, 2008, at 6:00 PM CDT. This procedure has been proven to reduce the production of ghrelin which reduces appetite and provides for healthy weight loss for the obese. Additionally bariatric surgery has been shown to improve medical conditions such as diabetes, sleep apnea, high blood pressure, and high cholesterol. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. bah_2389 http://www.or-live.com/BaptistHealth/2389 http://www.or-live.com/BaptistHealth/2389 Watch gynecological oncologists Ricardo Estape, M.D., and Nicholas Lambrou, M.D., perform a hysterectomy using the da Vinci robot, which is a less invasive procedure and requires less recovery time than traditional surgical techniques. Viewers will have the choice of watching the web cast in English or Spanish. ]]> Robot-Assisted Hysterectomy http://www.or-live.com/BaptistHealth/2389 Watch gynecological oncologists Ricardo Estape, M.D., and Nicholas Lambrou, M.D., perform a hysterectomy using the da Vinci robot, which is a less invasive procedure and requires less recovery time than traditional surgical techniques. Viewers will have the choice of watching the web cast in English or Spanish. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. shm_2225 http://www.or-live.com/shawneemission/2225 http://www.or-live.com/shawneemission/2225 MERRIAM, Kan. – Shawnee Mission Medical Center (SMMC) will host a Total Knee Replacement (TKR) Live Surgery Webcast on Tuesday, Oct. 14 at 7 p.m. The Webcast will feature Robert Sharpe, MD, of Midwest Orthopaedics, PA, as he surgically reconstructs a patient's knee. Burrel Gaddy, MD, who is also with Midwest Orthopaedics, will serve as the moderator, answering questions live from the audience. A TKR is a surgical procedure done to replace a damaged knee with a prosthesis, which is an artificial joint typically made up of metal and plastic. Knee replacements may be necessary when knee conditions cause the cartilage to deteriorate to the point when there are no other options to relieve pain. Osteoarthritis, rheumatoid arthritis and knee joint injury typically create the pain that leads to a TKR. The procedure is very common, with more than 300,000 TKR surgeries being performed every year in the United States. According to Sharpe, patients who undergo a total knee replacement surgery reap a number of benefits following the procedure. "Once a patient undergoes a total knee replacement surgery, they have nearly a full range of motion in the knee and can walk on their leg almost immediately," he said. "Patients also regain a majority of the activities that they were doing prior to the knee replacement, without the pain they were enduring before." Through education, both Sharpe and Gaddy hope the TKR Webcast will help patients better understand the procedure and the positive impact most patients report on their lifestyle afterward, which according to Gaddy can be dramatic. "Patients often come into my office limping, complaining of their limited ability to perform daily activities because the discomfort is so overwhelming," he said. "The difference in the patient's ability to perform daily tasks after the procedure is remarkable." About Shawnee Mission Medical Center: Shawnee Mission Medical Center (SMMC) is a 383-bed facility with nearly 20,000 inpatient admissions and more than 195,000 outpatient admissions annually. SMMC has the busiest emergency department in Johnson County, the area's first accredited Chest Pain Emergency Center, a nationally recognized Center for Women's Health and delivers more babies each year than any other hospital in the metropolitan area. SMMC employs more than 2,700 local residents and supports an exceptional staff of 700 physicians representing 50 medical specialties, the largest medical staff in Kansas City. Visit us on the Web at ShawneeMission.org. ]]> Total Knee Replacement http://www.or-live.com/shawneemission/2225 MERRIAM, Kan. – Shawnee Mission Medical Center (SMMC) will host a Total Knee Replacement (TKR) Live Surgery Webcast on Tuesday, Oct. 14 at 7 p.m. The Webcast will feature Robert Sharpe, MD, of Midwest Orthopaedics, PA, as he surgically reconstructs a patient's knee. Burrel Gaddy, MD, who is also with Midwest Orthopaedics, will serve as the moderator, answering questions live from the audience. A TKR is a surgical procedure done to replace a damaged knee with a prosthesis, which is an artificial joint typically made up of metal and plastic. Knee replacements may be necessary when knee conditions cause the cartilage to deteriorate to the point when there are no other options to relieve pain. Osteoarthritis, rheumatoid arthritis and knee joint injury typically create the pain that leads to a TKR. The procedure is very common, with more than 300,000 TKR surgeries being performed every year in the United States. According to Sharpe, patients who undergo a total knee replacement surgery reap a number of benefits following the procedure. "Once a patient undergoes a total knee replacement surgery, they have nearly a full range of motion in the knee and can walk on their leg almost immediately," he said. "Patients also regain a majority of the activities that they were doing prior to the knee replacement, without the pain they were enduring before." Through education, both Sharpe and Gaddy hope the TKR Webcast will help patients better understand the procedure and the positive impact most patients report on their lifestyle afterward, which according to Gaddy can be dramatic. "Patients often come into my office limping, complaining of their limited ability to perform daily activities because the discomfort is so overwhelming," he said. "The difference in the patient's ability to perform daily tasks after the procedure is remarkable." About Shawnee Mission Medical Center: Shawnee Mission Medical Center (SMMC) is a 383-bed facility with nearly 20,000 inpatient admissions and more than 195,000 outpatient admissions annually. SMMC has the busiest emergency department in Johnson County, the area's first accredited Chest Pain Emergency Center, a nationally recognized Center for Women's Health and delivers more babies each year than any other hospital in the metropolitan area. SMMC employs more than 2,700 local residents and supports an exceptional staff of 700 physicians representing 50 medical specialties, the largest medical staff in Kansas City. Visit us on the Web at ShawneeMission.org. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. nep_2105 http://www.or-live.com/NYP/2105 http://www.or-live.com/NYP/2105 Head and neck surgery is a diverse regional subspecialty, whose central focus is treatment of oncologic disorders of the neck. "Neck dissection is relevant to treatment of such disorders as squamous cell cancers of the upper aerodigestive tract, tongue cancer, laryngeal cancer, thyroid cancer, salivary gland cancer, and skin cancers of the head/neck region, including melanoma," explained William I. Kuhel, MD, the Director of the Head and Neck Service, Department of Otorhinolaryngology, at NewYork-Presbyterian/Weill Cornell Medical Center, and Associate Professor of Clinical Otorhinolaryngology at Weill Cornell Medical School. "For many years, the radical neck dissection was the standard operation for removal of metastatic disease involving the lymph nodes in the neck, but that operation evolved into what are referred to as modified and selective neck dissections, which spare some of the important structures in the neck," said Dr. Kuhel. Salvatore M. Caruana, MD, the Director of the Division of Head and Neck Surgery at NewYork-Presbyterian/Columbia University Medical Center, and Assistant Clinical Professor of Otolaryngology and Head and Neck Surgery at Columbia University College of Physicians and Surgeons, explained further. "The trend these days is to do smaller operations to get the same effect. Over the years it has become clear that certain areas of a radical neck dissection do not have to be included for diseases at specific levels. Our knowledge base has allowed us to make smaller operations to address the same problems." Greater experience has also allowed for more common use of adjuvant therapies, such as radiation and chemotherapy, he added. "We may sometimes simply remove the largest mass in the neck and give chemoradiotherapy for the rest." Physicians interested in learning the latest developments in head and neck surgery should view this webcast, which features Drs. Caruana and Kuhel, both leaders in the field, who represent the campuses of NewYork-Presbyterian Hospital. "Although advancements in imaging often enable us to more accurately assess the status of the neck, high-tech intraoperative technology is really not a driver in the discussion of this particular topic," said Dr. Kuhel. "Our progress has been based on a better understanding of patterns of lymphatic spread to the lymph nodes in the neck, advances in surgical skill, and better imaging, and these factors have enabled us to progress to the application of selective neck dissections, which spare certain lymph node groups in the neck." "We have more accurate staging because of our better imaging techniques," Dr. Caruana said, "and, because of our historical data, we better understand what is and is not necessary. These selective operations hopefully lead to less postoperative debility from the operation." The neck has been mapped out into six distinct levels, useful when comparing results from different tumor types. Historical data show, for example, that a tumor of the supraglottic larynx might generally spread to levels 2, 3 and 4. "Over the years we have learned that we don't have to perform a neck dissection to levels 1-5 when addressing levels 2-4 will do, since that is almost certainly where the tumor is going to be," Dr. Caruana explained. "And that means a smaller operation, less morbidity for the patient, and greater preservation of normal, unaffected tissue." Despite important advances that have been made in reducing the morbidity from the surgical treatment of head and neck cancer, the mortality for head and neck squamous cell cancer has not improved during the past thirty years. "Surgeons have taken satisfaction in the fact that the functional outcomes are better even though the cure rate hasn't been improved," Dr. Kuhel said. "There have been huge advances in terms of reconstruction with microvascular free flaps." New surgical approaches, new chemotherapeutic agents, and greater understanding of the molecular mechanisms of disease are all being utilized to try to improve the outcomes of patients with head and neck cancer. One new approach is natural orifice surgery, as explained by Dr. Caruana. "We are doing transoral laser microsurgery where we take certain tumors out through the mouth, obviating the need for a tracheostomy. Patients can usually swallow sooner than with a big open procedure, and we can sometimes lower the dose of radiation therapy, or even eliminate the need for radiation completely." Another hopeful area is the ongoing development of new chemotherapeutic agents, as well as new regimens using molecular targeted therapy (MTT). "MTT cells are designed to correct a molecular defect in the tumor," explained Dr. Caruana. "For instance, one of the major defects in the case of medullary thyroid cancer is a defect in the tyrosine kinase receptor. If you give MTT that blocks the function of that receptor, you have now in effect eliminated the fact that there is this defect." Dr. Kuhel agreed. "The answer in terms of cancer is going to come from a better understanding of the molecular basis of the disease. When I was in medical school I heard lectures on the treatment of stomach ulcers, which discussed surgery, the cutting of certain nerves in the stomach, debate about whether it should be done endoscopically, etc. Ultimately, however, our knowledge improved to the point where we now know that these ulcers were caused by an infection. I believe that eventually when we understand the molecular mechanisms of cancer, head and neck surgery will become very anachronistic." ]]> Evolution in Head and Neck Surgery: http://www.or-live.com/NYP/2105 Head and neck surgery is a diverse regional subspecialty, whose central focus is treatment of oncologic disorders of the neck. "Neck dissection is relevant to treatment of such disorders as squamous cell cancers of the upper aerodigestive tract, tongue cancer, laryngeal cancer, thyroid cancer, salivary gland cancer, and skin cancers of the head/neck region, including melanoma," explained William I. Kuhel, MD, the Director of the Head and Neck Service, Department of Otorhinolaryngology, at NewYork-Presbyterian/Weill Cornell Medical Center, and Associate Professor of Clinical Otorhinolaryngology at Weill Cornell Medical School. "For many years, the radical neck dissection was the standard operation for removal of metastatic disease involving the lymph nodes in the neck, but that operation evolved into what are referred to as modified and selective neck dissections, which spare some of the important structures in the neck," said Dr. Kuhel. Salvatore M. Caruana, MD, the Director of the Division of Head and Neck Surgery at NewYork-Presbyterian/Columbia University Medical Center, and Assistant Clinical Professor of Otolaryngology and Head and Neck Surgery at Columbia University College of Physicians and Surgeons, explained further. "The trend these days is to do smaller operations to get the same effect. Over the years it has become clear that certain areas of a radical neck dissection do not have to be included for diseases at specific levels. Our knowledge base has allowed us to make smaller operations to address the same problems." Greater experience has also allowed for more common use of adjuvant therapies, such as radiation and chemotherapy, he added. "We may sometimes simply remove the largest mass in the neck and give chemoradiotherapy for the rest." Physicians interested in learning the latest developments in head and neck surgery should view this webcast, which features Drs. Caruana and Kuhel, both leaders in the field, who represent the campuses of NewYork-Presbyterian Hospital. "Although advancements in imaging often enable us to more accurately assess the status of the neck, high-tech intraoperative technology is really not a driver in the discussion of this particular topic," said Dr. Kuhel. "Our progress has been based on a better understanding of patterns of lymphatic spread to the lymph nodes in the neck, advances in surgical skill, and better imaging, and these factors have enabled us to progress to the application of selective neck dissections, which spare certain lymph node groups in the neck." "We have more accurate staging because of our better imaging techniques," Dr. Caruana said, "and, because of our historical data, we better understand what is and is not necessary. These selective operations hopefully lead to less postoperative debility from the operation." The neck has been mapped out into six distinct levels, useful when comparing results from different tumor types. Historical data show, for example, that a tumor of the supraglottic larynx might generally spread to levels 2, 3 and 4. "Over the years we have learned that we don't have to perform a neck dissection to levels 1-5 when addressing levels 2-4 will do, since that is almost certainly where the tumor is going to be," Dr. Caruana explained. "And that means a smaller operation, less morbidity for the patient, and greater preservation of normal, unaffected tissue." Despite important advances that have been made in reducing the morbidity from the surgical treatment of head and neck cancer, the mortality for head and neck squamous cell cancer has not improved during the past thirty years. "Surgeons have taken satisfaction in the fact that the functional outcomes are better even though the cure rate hasn't been improved," Dr. Kuhel said. "There have been huge advances in terms of reconstruction with microvascular free flaps." New surgical approaches, new chemotherapeutic agents, and greater understanding of the molecular mechanisms of disease are all being utilized to try to improve the outcomes of patients with head and neck cancer. One new approach is natural orifice surgery, as explained by Dr. Caruana. "We are doing transoral laser microsurgery where we take certain tumors out through the mouth, obviating the need for a tracheostomy. Patients can usually swallow sooner than with a big open procedure, and we can sometimes lower the dose of radiation therapy, or even eliminate the need for radiation completely." Another hopeful area is the ongoing development of new chemotherapeutic agents, as well as new regimens using molecular targeted therapy (MTT). "MTT cells are designed to correct a molecular defect in the tumor," explained Dr. Caruana. "For instance, one of the major defects in the case of medullary thyroid cancer is a defect in the tyrosine kinase receptor. If you give MTT that blocks the function of that receptor, you have now in effect eliminated the fact that there is this defect." Dr. Kuhel agreed. "The answer in terms of cancer is going to come from a better understanding of the molecular basis of the disease. When I was in medical school I heard lectures on the treatment of stomach ulcers, which discussed surgery, the cutting of certain nerves in the stomach, debate about whether it should be done endoscopically, etc. Ultimately, however, our knowledge improved to the point where we now know that these ulcers were caused by an infection. I believe that eventually when we understand the molecular mechanisms of cancer, head and neck surgery will become very anachronistic." surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. nep_2105 http://www.or-live.com/NYP/2105 http://www.or-live.com/NYP/2105 Head and neck surgery is a diverse regional subspecialty, whose central focus is treatment of oncologic disorders of the neck. "Neck dissection is relevant to treatment of such disorders as squamous cell cancers of the upper aerodigestive tract, tongue cancer, laryngeal cancer, thyroid cancer, salivary gland cancer, and skin cancers of the head/neck region, including melanoma," explained William I. Kuhel, MD, the Director of the Head and Neck Service, Department of Otorhinolaryngology, at NewYork-Presbyterian/Weill Cornell Medical Center, and Associate Professor of Clinical Otorhinolaryngology at Weill Cornell Medical School. "For many years, the radical neck dissection was the standard operation for removal of metastatic disease involving the lymph nodes in the neck, but that operation evolved into what are referred to as modified and selective neck dissections, which spare some of the important structures in the neck," said Dr. Kuhel. Salvatore M. Caruana, MD, the Director of the Division of Head and Neck Surgery at NewYork-Presbyterian/Columbia University Medical Center, and Assistant Clinical Professor of Otolaryngology and Head and Neck Surgery at Columbia University College of Physicians and Surgeons, explained further. "The trend these days is to do smaller operations to get the same effect. Over the years it has become clear that certain areas of a radical neck dissection do not have to be included for diseases at specific levels. Our knowledge base has allowed us to make smaller operations to address the same problems." Greater experience has also allowed for more common use of adjuvant therapies, such as radiation and chemotherapy, he added. "We may sometimes simply remove the largest mass in the neck and give chemoradiotherapy for the rest." Physicians interested in learning the latest developments in head and neck surgery should view this webcast, which features Drs. Caruana and Kuhel, both leaders in the field, who represent the campuses of NewYork-Presbyterian Hospital. "Although advancements in imaging often enable us to more accurately assess the status of the neck, high-tech intraoperative technology is really not a driver in the discussion of this particular topic," said Dr. Kuhel. "Our progress has been based on a better understanding of patterns of lymphatic spread to the lymph nodes in the neck, advances in surgical skill, and better imaging, and these factors have enabled us to progress to the application of selective neck dissections, which spare certain lymph node groups in the neck." "We have more accurate staging because of our better imaging techniques," Dr. Caruana said, "and, because of our historical data, we better understand what is and is not necessary. These selective operations hopefully lead to less postoperative debility from the operation." The neck has been mapped out into six distinct levels, useful when comparing results from different tumor types. Historical data show, for example, that a tumor of the supraglottic larynx might generally spread to levels 2, 3 and 4. "Over the years we have learned that we don't have to perform a neck dissection to levels 1-5 when addressing levels 2-4 will do, since that is almost certainly where the tumor is going to be," Dr. Caruana explained. "And that means a smaller operation, less morbidity for the patient, and greater preservation of normal, unaffected tissue." Despite important advances that have been made in reducing the morbidity from the surgical treatment of head and neck cancer, the mortality for head and neck squamous cell cancer has not improved during the past thirty years. "Surgeons have taken satisfaction in the fact that the functional outcomes are better even though the cure rate hasn't been improved," Dr. Kuhel said. "There have been huge advances in terms of reconstruction with microvascular free flaps." New surgical approaches, new chemotherapeutic agents, and greater understanding of the molecular mechanisms of disease are all being utilized to try to improve the outcomes of patients with head and neck cancer. One new approach is natural orifice surgery, as explained by Dr. Caruana. "We are doing transoral laser microsurgery where we take certain tumors out through the mouth, obviating the need for a tracheostomy. Patients can usually swallow sooner than with a big open procedure, and we can sometimes lower the dose of radiation therapy, or even eliminate the need for radiation completely." Another hopeful area is the ongoing development of new chemotherapeutic agents, as well as new regimens using molecular targeted therapy (MTT). "MTT cells are designed to correct a molecular defect in the tumor," explained Dr. Caruana. "For instance, one of the major defects in the case of medullary thyroid cancer is a defect in the tyrosine kinase receptor. If you give MTT that blocks the function of that receptor, you have now in effect eliminated the fact that there is this defect." Dr. Kuhel agreed. "The answer in terms of cancer is going to come from a better understanding of the molecular basis of the disease. When I was in medical school I heard lectures on the treatment of stomach ulcers, which discussed surgery, the cutting of certain nerves in the stomach, debate about whether it should be done endoscopically, etc. Ultimately, however, our knowledge improved to the point where we now know that these ulcers were caused by an infection. I believe that eventually when we understand the molecular mechanisms of cancer, head and neck surgery will become very anachronistic." ]]> Evolution in Head and Neck Surgery: http://www.or-live.com/NYP/2105 Head and neck surgery is a diverse regional subspecialty, whose central focus is treatment of oncologic disorders of the neck. "Neck dissection is relevant to treatment of such disorders as squamous cell cancers of the upper aerodigestive tract, tongue cancer, laryngeal cancer, thyroid cancer, salivary gland cancer, and skin cancers of the head/neck region, including melanoma," explained William I. Kuhel, MD, the Director of the Head and Neck Service, Department of Otorhinolaryngology, at NewYork-Presbyterian/Weill Cornell Medical Center, and Associate Professor of Clinical Otorhinolaryngology at Weill Cornell Medical School. "For many years, the radical neck dissection was the standard operation for removal of metastatic disease involving the lymph nodes in the neck, but that operation evolved into what are referred to as modified and selective neck dissections, which spare some of the important structures in the neck," said Dr. Kuhel. Salvatore M. Caruana, MD, the Director of the Division of Head and Neck Surgery at NewYork-Presbyterian/Columbia University Medical Center, and Assistant Clinical Professor of Otolaryngology and Head and Neck Surgery at Columbia University College of Physicians and Surgeons, explained further. "The trend these days is to do smaller operations to get the same effect. Over the years it has become clear that certain areas of a radical neck dissection do not have to be included for diseases at specific levels. Our knowledge base has allowed us to make smaller operations to address the same problems." Greater experience has also allowed for more common use of adjuvant therapies, such as radiation and chemotherapy, he added. "We may sometimes simply remove the largest mass in the neck and give chemoradiotherapy for the rest." Physicians interested in learning the latest developments in head and neck surgery should view this webcast, which features Drs. Caruana and Kuhel, both leaders in the field, who represent the campuses of NewYork-Presbyterian Hospital. "Although advancements in imaging often enable us to more accurately assess the status of the neck, high-tech intraoperative technology is really not a driver in the discussion of this particular topic," said Dr. Kuhel. "Our progress has been based on a better understanding of patterns of lymphatic spread to the lymph nodes in the neck, advances in surgical skill, and better imaging, and these factors have enabled us to progress to the application of selective neck dissections, which spare certain lymph node groups in the neck." "We have more accurate staging because of our better imaging techniques," Dr. Caruana said, "and, because of our historical data, we better understand what is and is not necessary. These selective operations hopefully lead to less postoperative debility from the operation." The neck has been mapped out into six distinct levels, useful when comparing results from different tumor types. Historical data show, for example, that a tumor of the supraglottic larynx might generally spread to levels 2, 3 and 4. "Over the years we have learned that we don't have to perform a neck dissection to levels 1-5 when addressing levels 2-4 will do, since that is almost certainly where the tumor is going to be," Dr. Caruana explained. "And that means a smaller operation, less morbidity for the patient, and greater preservation of normal, unaffected tissue." Despite important advances that have been made in reducing the morbidity from the surgical treatment of head and neck cancer, the mortality for head and neck squamous cell cancer has not improved during the past thirty years. "Surgeons have taken satisfaction in the fact that the functional outcomes are better even though the cure rate hasn't been improved," Dr. Kuhel said. "There have been huge advances in terms of reconstruction with microvascular free flaps." New surgical approaches, new chemotherapeutic agents, and greater understanding of the molecular mechanisms of disease are all being utilized to try to improve the outcomes of patients with head and neck cancer. One new approach is natural orifice surgery, as explained by Dr. Caruana. "We are doing transoral laser microsurgery where we take certain tumors out through the mouth, obviating the need for a tracheostomy. Patients can usually swallow sooner than with a big open procedure, and we can sometimes lower the dose of radiation therapy, or even eliminate the need for radiation completely." Another hopeful area is the ongoing development of new chemotherapeutic agents, as well as new regimens using molecular targeted therapy (MTT). "MTT cells are designed to correct a molecular defect in the tumor," explained Dr. Caruana. "For instance, one of the major defects in the case of medullary thyroid cancer is a defect in the tyrosine kinase receptor. If you give MTT that blocks the function of that receptor, you have now in effect eliminated the fact that there is this defect." Dr. Kuhel agreed. "The answer in terms of cancer is going to come from a better understanding of the molecular basis of the disease. When I was in medical school I heard lectures on the treatment of stomach ulcers, which discussed surgery, the cutting of certain nerves in the stomach, debate about whether it should be done endoscopically, etc. Ultimately, however, our knowledge improved to the point where we now know that these ulcers were caused by an infection. I believe that eventually when we understand the molecular mechanisms of cancer, head and neck surgery will become very anachronistic." surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. cpi_2327 http://www.or-live.com/cpi/2327 http://www.or-live.com/cpi/2327 In the Pediatric Epilepsy Surgery Program at Children's Hospital of Pittsburgh of UPMC, patients with epilepsy are offered an effective surgical treatment when conventional medication therapy fails to control or stop their seizures. The program's specialists are able to identify children who are unlikely to respond to further medications, and its distinctive surgical therapies can dramatically improve the lives of these children. On Thursday, October 9, at 8:00AM EDT, Children's Hospital of Pittsburgh of UPMC will present a Pediatric Grand Rounds lecture titled "Curing Epilepsy: Improved Procedures, Improved Outcomes" The presenters, P. David Adelson, MD, and Deborah L. Holder, MD, are surgical director and medical director, respectively, of Children's Pediatric Epilepsy Surgery Program, one of the most advanced, successful and busiest such programs in the nation. Drs. Adelson and Holder will discuss the current status and future developments in pediatric epilepsy surgery. ]]> Curing Epilepsy: Improved Procedures, Improved Outcomes http://www.or-live.com/cpi/2327 In the Pediatric Epilepsy Surgery Program at Children's Hospital of Pittsburgh of UPMC, patients with epilepsy are offered an effective surgical treatment when conventional medication therapy fails to control or stop their seizures. The program's specialists are able to identify children who are unlikely to respond to further medications, and its distinctive surgical therapies can dramatically improve the lives of these children. On Thursday, October 9, at 8:00AM EDT, Children's Hospital of Pittsburgh of UPMC will present a Pediatric Grand Rounds lecture titled "Curing Epilepsy: Improved Procedures, Improved Outcomes" The presenters, P. David Adelson, MD, and Deborah L. Holder, MD, are surgical director and medical director, respectively, of Children's Pediatric Epilepsy Surgery Program, one of the most advanced, successful and busiest such programs in the nation. Drs. Adelson and Holder will discuss the current status and future developments in pediatric epilepsy surgery. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. nep_2108 http://www.or-live.com/nyp/2108 http://www.or-live.com/nyp/2108 CENTER FOR PRENATAL PEDIATRICS At the Center for Prenatal Pediatrics, pregnancy involves caring for two patients – mother and baby. In high-risk cases where the baby has a birth defect, the mother may need specialized adult care while the fetus requires a pediatric focus. The Center's patients benefit from a long tradition of professional collaboration between specialty areas and physicians at Morgan Stanley Children's Hospital of NewYork-Presbyterian Hospital and Columbia University Medical Center. Through years of experience, it has become clear to our renowned experts that optimal care for these complex cases is best achieved through a systematic approach of interdisciplinary collaboration. Our Center of leading specialists provides a full range of prenatal diagnostic testing, specialist consultations, genetic counseling and pregnancy management with planning for future pediatric care. Early diagnosis, thorough evaluation and ongoing monitoring allow both physicians and families to maximize prenatal information for the medical and emotional preparation of the birth of an affected baby. We believe this interdisciplinary and united approach increases positive pediatric outcomes. At the Center for Prenatal Pediatrics we are setting new standards of care and support for pregnant women and their families. This webcast will feature prenatal pediatric patient cases that focus on the integrated capabilities of our interdisciplinary team with a focus on cardiac care. A FOCUS ON CARDIOLOGY Our Cardiology Center has a history of innovations in pediatric diagnostic and interventional cardiology and pediatric cardiac surgery, as well as medical education and basic clinical research in these areas. Our cardiology program is one of the largest and most preeminent pediatric cardiology and cardiac surgery centers in the nation. We have great success in the dealing with the most complex cases including diagnosis and treatment of congenital and acquired heart disease in neonates, infants, children, adolescents, and young adults. Our Cardiology Center has the only pediatric catheterization laboratories in metropolitan New York dedicated to pediatric pulmonary hypertension and arrhythmia studies, as well as diagnostic and therapeutic interventions, such as radiofrequency ablation for cardiac arrhythmias and balloon valvuloplasty. We perform hundreds of pediatric cardiac surgical procedures and cardiac catheterizations. We have one of the areas most prominent pediatric echocardiology program and one of the most outstanding fetal echocardiography centers in the world; a dedicated pediatric arrhythmia management and electrophysiology program; the largest pediatric cardiac transplant and pediatric heart failure center in the U.S.; the region's only pediatric pulmonary hypertension center and an active preventive cardiology service. ]]> Prenatal Heart Diagnosis http://www.or-live.com/nyp/2108 CENTER FOR PRENATAL PEDIATRICS At the Center for Prenatal Pediatrics, pregnancy involves caring for two patients – mother and baby. In high-risk cases where the baby has a birth defect, the mother may need specialized adult care while the fetus requires a pediatric focus. The Center's patients benefit from a long tradition of professional collaboration between specialty areas and physicians at Morgan Stanley Children's Hospital of NewYork-Presbyterian Hospital and Columbia University Medical Center. Through years of experience, it has become clear to our renowned experts that optimal care for these complex cases is best achieved through a systematic approach of interdisciplinary collaboration. Our Center of leading specialists provides a full range of prenatal diagnostic testing, specialist consultations, genetic counseling and pregnancy management with planning for future pediatric care. Early diagnosis, thorough evaluation and ongoing monitoring allow both physicians and families to maximize prenatal information for the medical and emotional preparation of the birth of an affected baby. We believe this interdisciplinary and united approach increases positive pediatric outcomes. At the Center for Prenatal Pediatrics we are setting new standards of care and support for pregnant women and their families. This webcast will feature prenatal pediatric patient cases that focus on the integrated capabilities of our interdisciplinary team with a focus on cardiac care. A FOCUS ON CARDIOLOGY Our Cardiology Center has a history of innovations in pediatric diagnostic and interventional cardiology and pediatric cardiac surgery, as well as medical education and basic clinical research in these areas. Our cardiology program is one of the largest and most preeminent pediatric cardiology and cardiac surgery centers in the nation. We have great success in the dealing with the most complex cases including diagnosis and treatment of congenital and acquired heart disease in neonates, infants, children, adolescents, and young adults. Our Cardiology Center has the only pediatric catheterization laboratories in metropolitan New York dedicated to pediatric pulmonary hypertension and arrhythmia studies, as well as diagnostic and therapeutic interventions, such as radiofrequency ablation for cardiac arrhythmias and balloon valvuloplasty. We perform hundreds of pediatric cardiac surgical procedures and cardiac catheterizations. We have one of the areas most prominent pediatric echocardiology program and one of the most outstanding fetal echocardiography centers in the world; a dedicated pediatric arrhythmia management and electrophysiology program; the largest pediatric cardiac transplant and pediatric heart failure center in the U.S.; the region's only pediatric pulmonary hypertension center and an active preventive cardiology service. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. wam_2190 http://www.or-live.com/prohealthcare/2190 http://www.or-live.com/prohealthcare/2190 On October 8 at 12:00 p.m. CDT, ProHealth Care will present a panel discussion at Waukesha Memorial Hospital on CyberKnife, one of the world's most sophisticated cancer treatment technologies. The panel will include Bobby Koneru, MD, radiation oncologist; Hendrikus Krouwer, MD, PhD, neuro-oncologist; and Kenneth Reichert, MD, neurosurgeon, and will be moderated by Michael McCrea, PhD, executive director of ProHealth Care's Neuroscience Center. The panel will discuss the case of a brain tumor patient treated with CyberKnife as well as the CyberKnife treatment process CyberKnife® is a registered trademark of Accuray ]]> Revolutionizing Cancer Treatment with CyberKnife http://www.or-live.com/prohealthcare/2190 On October 8 at 12:00 p.m. CDT, ProHealth Care will present a panel discussion at Waukesha Memorial Hospital on CyberKnife, one of the world's most sophisticated cancer treatment technologies. The panel will include Bobby Koneru, MD, radiation oncologist; Hendrikus Krouwer, MD, PhD, neuro-oncologist; and Kenneth Reichert, MD, neurosurgeon, and will be moderated by Michael McCrea, PhD, executive director of ProHealth Care's Neuroscience Center. The panel will discuss the case of a brain tumor patient treated with CyberKnife as well as the CyberKnife treatment process CyberKnife® is a registered trademark of Accuray surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. wam_2190 http://www.or-live.com/prohealthcare/2190 http://www.or-live.com/prohealthcare/2190 On October 8 at 12:00 p.m. CDT, ProHealth Care will present a panel discussion at Waukesha Memorial Hospital on CyberKnife, one of the world's most sophisticated cancer treatment technologies. The panel will include Bobby Koneru, MD, radiation oncologist; Hendrikus Krouwer, MD, PhD, neuro-oncologist; and Kenneth Reichert, MD, neurosurgeon, and will be moderated by Michael McCrea, PhD, executive director of ProHealth Care's Neuroscience Center. The panel will discuss the case of a brain tumor patient treated with CyberKnife as well as the CyberKnife treatment process CyberKnife® is a registered trademark of Accuray ]]> Revolutionizing Cancer Treatment with CyberKnife http://www.or-live.com/prohealthcare/2190 On October 8 at 12:00 p.m. CDT, ProHealth Care will present a panel discussion at Waukesha Memorial Hospital on CyberKnife, one of the world's most sophisticated cancer treatment technologies. The panel will include Bobby Koneru, MD, radiation oncologist; Hendrikus Krouwer, MD, PhD, neuro-oncologist; and Kenneth Reichert, MD, neurosurgeon, and will be moderated by Michael McCrea, PhD, executive director of ProHealth Care's Neuroscience Center. The panel will discuss the case of a brain tumor patient treated with CyberKnife as well as the CyberKnife treatment process CyberKnife® is a registered trademark of Accuray surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. nom_2258 http://www.or-live.com/NMH/2258 http://www.or-live.com/NMH/2258 Richard Fessler, MD, PhD, a renowned spinal surgeon at Chicago's Northwestern Memorial Hospital, will demonstrate the use of minimally invasive surgery to treat scoliosis during a live interactive webcast on October 7th at 3 p.m. CDT. Dr. Fessler and the team at Northwestern Memorial pioneered the minimally invasive procedure, which is transforming the way scoliosis patients are treated by offering an approach that puts less stress on the body, leads to a faster recovery and a shorter rehabilitation period following surgery. Whereas traditional scoliosis surgery is disruptive to tissues and often requires a dissection of muscles running from the shoulder blades to the waistline, the minimally invasive approach is performed through muscle sparing small dilations. "With minimally invasive scoliosis surgery, we don't have to dissect the muscle which has tremendous benefit to the patient and allows them to return to everyday life within weeks," commented Dr. Fessler. "There is also less blood loss and a lower risk of infection." Fessler has been on the cutting edge of minimally invasive spinal surgery since the early 1990s and has developed many of the now widely-used techniques and surgical tools. He has also played a significant role in converting nearly two dozen operations into minimally invasive surgeries. Minimally invasive scoliosis surgery is available to patients between the ages of 25 to 75, with the older percentile growing at the fastest rate. "The baby boomers are the fastest growing segment of the U.S. population and they're a group that wants to stay active. These conditions are extremely disabling, so there's an increased need for treatment options that allow patients to maintain a good quality of life," says Fessler. Scoliosis, an abnormal curvature of the spine, affects about 6 million people in the United States and can limit activity, cause debilitating pain, reduce respiratory function and diminish self-esteem. In addition to scoliosis, Fessler treats lumbar stenosis, lumbar fusion, vertibrectomy and spinal cord tumors, and similar problems in the cervical and thoracic spine. The October 7th webcast is open to patients who are seeking information about scoliosis surgery, as well as clinicians and surgeons. Colleagues of Dr. Fessler will moderate the webcast and address questions from viewers during the surgery. ]]> Scoliosis Surgery: A Minimally Invasive Approach http://www.or-live.com/NMH/2258 Richard Fessler, MD, PhD, a renowned spinal surgeon at Chicago's Northwestern Memorial Hospital, will demonstrate the use of minimally invasive surgery to treat scoliosis during a live interactive webcast on October 7th at 3 p.m. CDT. Dr. Fessler and the team at Northwestern Memorial pioneered the minimally invasive procedure, which is transforming the way scoliosis patients are treated by offering an approach that puts less stress on the body, leads to a faster recovery and a shorter rehabilitation period following surgery. Whereas traditional scoliosis surgery is disruptive to tissues and often requires a dissection of muscles running from the shoulder blades to the waistline, the minimally invasive approach is performed through muscle sparing small dilations. "With minimally invasive scoliosis surgery, we don't have to dissect the muscle which has tremendous benefit to the patient and allows them to return to everyday life within weeks," commented Dr. Fessler. "There is also less blood loss and a lower risk of infection." Fessler has been on the cutting edge of minimally invasive spinal surgery since the early 1990s and has developed many of the now widely-used techniques and surgical tools. He has also played a significant role in converting nearly two dozen operations into minimally invasive surgeries. Minimally invasive scoliosis surgery is available to patients between the ages of 25 to 75, with the older percentile growing at the fastest rate. "The baby boomers are the fastest growing segment of the U.S. population and they're a group that wants to stay active. These conditions are extremely disabling, so there's an increased need for treatment options that allow patients to maintain a good quality of life," says Fessler. Scoliosis, an abnormal curvature of the spine, affects about 6 million people in the United States and can limit activity, cause debilitating pain, reduce respiratory function and diminish self-esteem. In addition to scoliosis, Fessler treats lumbar stenosis, lumbar fusion, vertibrectomy and spinal cord tumors, and similar problems in the cervical and thoracic spine. The October 7th webcast is open to patients who are seeking information about scoliosis surgery, as well as clinicians and surgeons. Colleagues of Dr. Fessler will moderate the webcast and address questions from viewers during the surgery. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. nom_2258 http://www.or-live.com/NMH/2258 http://www.or-live.com/NMH/2258 Richard Fessler, MD, PhD, a renowned spinal surgeon at Chicago's Northwestern Memorial Hospital, will demonstrate the use of minimally invasive surgery to treat scoliosis during a live interactive webcast on October 7th at 3 p.m. CDT. Dr. Fessler and the team at Northwestern Memorial pioneered the minimally invasive procedure, which is transforming the way scoliosis patients are treated by offering an approach that puts less stress on the body, leads to a faster recovery and a shorter rehabilitation period following surgery. Whereas traditional scoliosis surgery is disruptive to tissues and often requires a dissection of muscles running from the shoulder blades to the waistline, the minimally invasive approach is performed through muscle sparing small dilations. "With minimally invasive scoliosis surgery, we don't have to dissect the muscle which has tremendous benefit to the patient and allows them to return to everyday life within weeks," commented Dr. Fessler. "There is also less blood loss and a lower risk of infection." Fessler has been on the cutting edge of minimally invasive spinal surgery since the early 1990s and has developed many of the now widely-used techniques and surgical tools. He has also played a significant role in converting nearly two dozen operations into minimally invasive surgeries. Minimally invasive scoliosis surgery is available to patients between the ages of 25 to 75, with the older percentile growing at the fastest rate. "The baby boomers are the fastest growing segment of the U.S. population and they're a group that wants to stay active. These conditions are extremely disabling, so there's an increased need for treatment options that allow patients to maintain a good quality of life," says Fessler. Scoliosis, an abnormal curvature of the spine, affects about 6 million people in the United States and can limit activity, cause debilitating pain, reduce respiratory function and diminish self-esteem. In addition to scoliosis, Fessler treats lumbar stenosis, lumbar fusion, vertibrectomy and spinal cord tumors, and similar problems in the cervical and thoracic spine. The October 7th webcast is open to patients who are seeking information about scoliosis surgery, as well as clinicians and surgeons. Colleagues of Dr. Fessler will moderate the webcast and address questions from viewers during the surgery. ]]> Scoliosis Surgery: A Minimally Invasive Approach http://www.or-live.com/NMH/2258 Richard Fessler, MD, PhD, a renowned spinal surgeon at Chicago's Northwestern Memorial Hospital, will demonstrate the use of minimally invasive surgery to treat scoliosis during a live interactive webcast on October 7th at 3 p.m. CDT. Dr. Fessler and the team at Northwestern Memorial pioneered the minimally invasive procedure, which is transforming the way scoliosis patients are treated by offering an approach that puts less stress on the body, leads to a faster recovery and a shorter rehabilitation period following surgery. Whereas traditional scoliosis surgery is disruptive to tissues and often requires a dissection of muscles running from the shoulder blades to the waistline, the minimally invasive approach is performed through muscle sparing small dilations. "With minimally invasive scoliosis surgery, we don't have to dissect the muscle which has tremendous benefit to the patient and allows them to return to everyday life within weeks," commented Dr. Fessler. "There is also less blood loss and a lower risk of infection." Fessler has been on the cutting edge of minimally invasive spinal surgery since the early 1990s and has developed many of the now widely-used techniques and surgical tools. He has also played a significant role in converting nearly two dozen operations into minimally invasive surgeries. Minimally invasive scoliosis surgery is available to patients between the ages of 25 to 75, with the older percentile growing at the fastest rate. "The baby boomers are the fastest growing segment of the U.S. population and they're a group that wants to stay active. These conditions are extremely disabling, so there's an increased need for treatment options that allow patients to maintain a good quality of life," says Fessler. Scoliosis, an abnormal curvature of the spine, affects about 6 million people in the United States and can limit activity, cause debilitating pain, reduce respiratory function and diminish self-esteem. In addition to scoliosis, Fessler treats lumbar stenosis, lumbar fusion, vertibrectomy and spinal cord tumors, and similar problems in the cervical and thoracic spine. The October 7th webcast is open to patients who are seeking information about scoliosis surgery, as well as clinicians and surgeons. Colleagues of Dr. Fessler will moderate the webcast and address questions from viewers during the surgery. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. uho_2415 http://www.or-live.com/universityhospitals/2415 http://www.or-live.com/universityhospitals/2415 Cleveland – On Tuesday, October 7, watch surgeons from University Hospitals Case Medical Center perform a nipple sparing mastectomy with complete reconstruction. This breast-preserving procedure provides patients undergoing mastectomy with an excellent cosmetic outcome. Julian Kim, MD, FACS, and Hooman Soltanian, MD, will be available during this interactive panel discussion to answer any viewer questions. ]]> Nipple Sparing Mastectomy with Reconstruction http://www.or-live.com/universityhospitals/2415 Cleveland – On Tuesday, October 7, watch surgeons from University Hospitals Case Medical Center perform a nipple sparing mastectomy with complete reconstruction. This breast-preserving procedure provides patients undergoing mastectomy with an excellent cosmetic outcome. Julian Kim, MD, FACS, and Hooman Soltanian, MD, will be available during this interactive panel discussion to answer any viewer questions. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. met_2250 http://www.methodisthealth.org/virtualbrain http://www.methodisthealth.org/virtualbrain Memphis, TN -- Methodist University Hospital, home to one of the busiest neuroscience institutes in the country, is making an innovative breakthrough in medicine by presenting the Virtual Brain Tumor Board Webcast series, beginning Wednesday, July 2, from 7 a.m. to 8 a.m. Central Daylight Time. The Virtual Brain Tumor Board webcast series is the first program of its kind. It expands on the universal tumor board concept by providing a platform where a multi-disciplinary team of experts made up of various specialties within the neuroscience field including neurosurgeons, pathologists, medical oncologists, radiation oncologists, and neuro interventional radiologists present and review difficult clinical cases and collaborate together to create the best treatment plan for each patient. Webcasting the tumor board to physicians across the country and around the world opens dialogue to improve cancer care by providing physicians the opportunity to get expert opinions from top-tier, highly respected neuro-oncology leaders. This exchange of ideas and collaboration will advance patient care by making the most progressive treatments accessible to all physicians. "Our goal is to give physicians in other geographic areas the chance to receive the expertise and experience from our physicians here regarding brain tumor treatment and care for their patients," said Allen K. Sills, M.D., medical director and neurosurgeon, Methodist University Hospital. The innovative educational platform of our Virtual Brain Tumor Board is designed to provide real-time collaboration and on-demand access to some of the most leading-edge treatments in brain tumor care. It also allows you to: Earn CME credits Submit your own challenging cases in advance for live review Email your questions to be answered during each live event Get a fast-paced case evaluation in real-time, with each event archived for later viewing "I think making the brain tumor conference available online is a great idea for physicians who live in rural areas and are not near academic centers," stated Frederick Harris, M.D., neurosurgeon, Duluth Clinic, Duluth, Minnesota. "It allows them to have access to expert opinions and also to have the ability to see the multi-disciplinary approach to the treatment of brain tumors." The Virtual Brain Tumor Board Webcasts will be the first Wednesday of each month starting July 2nd and will continue for five consecutive months through November at 7 a.m. Central Daylight Time. ]]> Brain Tumor Board Webcast Series http://www.methodisthealth.org/virtualbrain Memphis, TN -- Methodist University Hospital, home to one of the busiest neuroscience institutes in the country, is making an innovative breakthrough in medicine by presenting the Virtual Brain Tumor Board Webcast series, beginning Wednesday, July 2, from 7 a.m. to 8 a.m. Central Daylight Time. The Virtual Brain Tumor Board webcast series is the first program of its kind. It expands on the universal tumor board concept by providing a platform where a multi-disciplinary team of experts made up of various specialties within the neuroscience field including neurosurgeons, pathologists, medical oncologists, radiation oncologists, and neuro interventional radiologists present and review difficult clinical cases and collaborate together to create the best treatment plan for each patient. Webcasting the tumor board to physicians across the country and around the world opens dialogue to improve cancer care by providing physicians the opportunity to get expert opinions from top-tier, highly respected neuro-oncology leaders. This exchange of ideas and collaboration will advance patient care by making the most progressive treatments accessible to all physicians. "Our goal is to give physicians in other geographic areas the chance to receive the expertise and experience from our physicians here regarding brain tumor treatment and care for their patients," said Allen K. Sills, M.D., medical director and neurosurgeon, Methodist University Hospital. The innovative educational platform of our Virtual Brain Tumor Board is designed to provide real-time collaboration and on-demand access to some of the most leading-edge treatments in brain tumor care. It also allows you to: Earn CME credits Submit your own challenging cases in advance for live review Email your questions to be answered during each live event Get a fast-paced case evaluation in real-time, with each event archived for later viewing "I think making the brain tumor conference available online is a great idea for physicians who live in rural areas and are not near academic centers," stated Frederick Harris, M.D., neurosurgeon, Duluth Clinic, Duluth, Minnesota. "It allows them to have access to expert opinions and also to have the ability to see the multi-disciplinary approach to the treatment of brain tumors." The Virtual Brain Tumor Board Webcasts will be the first Wednesday of each month starting July 2nd and will continue for five consecutive months through November at 7 a.m. Central Daylight Time. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health slp3D, Inc. stm_2089 http://www.or-live.com/stmarysmadison/2089 http://www.or-live.com/stmarysmadison/2089 Boy or girl??? Share in the miracle of birth with one family as their newborn is delivered via Cesarean section live from St. Mary's Hospital in Madison, Wisconsin. The team caring for mom and baby will include Drs. Chris Federman and Kristine Bathke, obstetricians with Dean Health System and Dr. F.J. Rubner, neonatologist with Neonatology Resources of Wisconsin. During the 30- to 45-minute webcast viewers also will be invited to email questions to the care team. ]]> Cesarean Section Delivery http://www.or-live.com/stmarysmadison/2089 Boy or girl??? Share in the miracle of birth with one family as their newborn is delivered via Cesarean section live from St. Mary's Hospital in Madison, Wisconsin. The team caring for mom and baby will include Drs. Chris Federman and Kristine Bathke, obstetricians with Dean Health System and Dr. F.J. Rubner, neonatologist with Neonatology Resources of Wisconsin. During the 30- to 45-minute webcast viewers also will be invited to email questions to the care team. surgery, broadcast, webcast, live, health, operation, operating room slp3D, Inc. Health